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CHAPTER I 
Introduction
 
1.1 Overview 
   High-throughput gene expression profiling technologies such as microarray, RNA-Sequencing 
(RNA-Seq) and parallel real-time polymerase chain reaction (RT-PCR) have revolutionized the 
study of gene expression and function and opened a new era in biology [1-5]. These methods can 
simultaneously measure the expression levels of hundreds to tens of thousands of genes in different 
biological samples and can provide global insights for understanding the associations between 
gene expression and complex biological processes [1]. 
   The microarray technology, debuted in late 1990s [6], has become a regular and standard tool 
for genomic research [1,5]. The principle of this technology involves the hybridization of 
fluorescently labelled cDNAs with synthetic DNA probes on custom-designed chips, and the gene 
expression levels are measured by the florescence signals of the probes [2,5]. Despite its 
limitations compared with the most recent RNA-Seq technology such as high background noise 
due to cross-hybridization and the limited range of the detection of gene expression due to both 
background noise and signal saturation [2], microarray is still an important tool for gene expression 
analysis [1,5] and has enabled researchers to conduct large-scale studies to identify the associations 
between gene expression and diseases in humans [7,8] at a relative low cost. 
   As an alternative to microarray, the RNA-Seq technology has rapidly evolved as a powerful and 
widely-used tool for gene expression studies [2,3,9] since its debut in biomedical research in the 
late 2000s [10-13]. RNA-Seq uses the technology of massive parallel sequencing (next generation 
sequencing, NGS) to sequence the cDNAs that are reverse-transcribed from RNAs of different 
biological samples, and generates millions of short reads [2,3,10]. These reads are aligned to the 
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reference genome and the number of reads mapped to a certain region on the genome of interest 
(called the genomic feature, such as gene, exon or isoform) are summarized and used to measure 
the abundance of the genomic feature in the biological sample [3,14,15]. Compared with 
microarray, RNA-Seq not only has the advantages of lower background noise and broader range 
of gene expression measure [16], but also can be used to detect new transcripts through de novo 
transcriptome reconstruction, to perform differential expression analysis for alternative spliced 
isoforms and to estimate allele-specific expression [1-3,9,16,17].  
1.2 Differential expression analysis in high-throughput gene expression data 
   Differential expression analysis, which refers to the identification of genomic features that are 
significantly different in abundance between distinct groups of biological samples (these groups 
are called biological conditions) or significantly associated with a given outcome or response 
variable [15,18,19], is one of the most important goals in high-throughput gene expression studies 
[19].  
In general, most of the current statistical methods used for differential expression analysis in 
high-throughput gene expression data can be classified into two groups: parametric methods and 
non-parametric methods. The parametric methods have distributional assumptions for the gene 
expression data. For microarray data, the florescence intensities are often treated as continuous 
variables and gene expression values are commonly assumed to follow a log-normal distribution 
after proper normalizations and background noise subtraction [5,20]. Therefore, the linear-model 
based methods are widely used for modelling microarray gene expression data [5,20], and the 
limma package [20] is one well-known method among them. For a comprehensive review of other 
types of statistical methods used in microarray analysis, see [5]. For RNA-Seq, the nature of the 
gene expression data are the counts of short reads mapped to genomic features, therefore statistical 
models for count data, such as Poisson [9,21] or negative binomial regression models [22-24], are 
proposed to model RNA-Seq data. In addition to the count-based modelling approaches, other 
researchers have proposed to first apply transformations to the read count data from RNA-Seq to 
make the data to be continuous and roughly follow the log-normal distribution, then apply the 
linear-model based methods developed for microarray data analysis to RNA-Seq data [25,26]. A 
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list of software tools for differential expression analysis in RNA-Seq are given in Chapter 8 of [3] 
and comparisons of different methods can be found in [15,18]. 
As alternatives to the parametric methods discussed above, non-parametric approaches also 
have been developed and used for differential expression analysis with both microarrays [27] and 
RNA-Seq data [14,28-30]. For those non-parametric methods, a summary statistic is computed as 
the test statistic based on the gene expression data, and then resampling based methods such as 
permutation [14,27,28,30] or bootstrap [29] are used to estimate the empirical distribution of the 
test statistic under the null hypothesis that there is no differential expression between biological 
conditions. Compared with parametric approaches, non-parametric methods do not have the 
relative strong distributional assumptions for the gene expression data and therefore are more 
robust when the distributional assumptions of the parametric approaches are violated and outliers 
exist in the data [14,28,29]. In fact, some researchers argue that in large sample size RNA-Seq 
experiments where the variations between biological samples tend to be large and outliers (one 
sample has a large number of read counts for a particular gene) often present, the assumed 
distributions of the parametric approaches tend to be violated, and as a consequence the results of 
those parametric approaches are not reliable [14]. 
On the other hand, the parametric approaches are more efficient and powerful for testing 
differential expression than the non-parametric methods when the assumed distribution is a good 
approximation of the gene expression data [14,15,22,23]. Furthermore, adjusting confounding 
variables can be easily achieved in parametric regression models [20,22,23,26], but is not 
straightforward in those non-parametric methods. Lastly but importantly, usually a large number 
of resamples is needed for obtaining reliable estimations of small p-values for those resampling-
based non-parametric approaches [27,31], which requires intensive computational efforts. 
Therefore, non-parametric approaches usually take longer computational time than parametric 
methods. 
In recent years, RNA-Seq has also been widely used for the study of alternative splicing in 
humans and model organisms [10,11,16,32], and the detection of differential splicing from RNA-
Seq is an important research direction. Several statistical approaches have been proposed towards 
this end. One type of those approaches is exon-based, which focuses on the detection of differential 
usage of exons, such as DEXSeq [33], rMATS[34], DSGseq[35], and SplicingCompass[36]. The 
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other type of those approaches is isoform-based, which focuses on the detection of differential 
expression of isoforms across different biological conditions, such as Cufflinks/Cuffdiff 2 [37], 
rDiff-parametric [38], BitSeq [39] and EBSeq [40]. Comparisons of some of those methods can 
be found in [41]. It should be noted that the aforementioned methods are all based on known 
isoform annotations. More recently, methods that enable the detection of differential usage of 
novel exons and splice junctions have also been developed, and one notable method is JunctionSeq 
[42], which can be applied to the scenario where the alternatively spliced isoforms are not 
annotated [42]. 
Despite the significant progress in the development of statistical methodologies and 
bioinformatics tools for the analysis of high-throughput gene expression data, there is still a 
growing need for novel statistical methods and efficient computational algorithms. One reason is 
that new types of data and complex study designs emerge as the technology continue to evolve. 
As a highlighted example, single-cell RNA-seq (scRNA-seq), which enables researchers to 
examine mRNA expression at the resolution of individual cells, is a novel technology attracting 
considerate attention these days [43-46]. Compared with regular RNA-Seq experiments, scRNA-
seq usually has a much larger number of samples from individual cells and the gene expression 
data from scRNA-seq show notable distinct features, such as excessive zero expression values and 
high variability across samples [43,45]. Therefore, many statistical methods developed for regular 
RNA-Seq data analysis cannot be directly applied for scRNA-seq data. In summary, we can 
foresee that high-throughput gene expression profiling technologies will still be fast-growing in 
future years and large amounts of different types of data will be generated, which brings both 
opportunities and challenges for biologists, bioinformaticians and statisticians. 
1.3 Dissertation outline 
   The aim of this dissertation is to develop novel statistical and computational methods for 
differential expression analysis in high-throughput gene expression data. 
   In the first part of this dissertation, we develop statistical models for differential expression 
analysis with a variety of study designs, and this part contains three research projects, which are 
presented in Chapter II, III and IV respectively. In Chapter II, we present an efficient algorithm 
for the detection of differential expression and differential splicing of genes in RNA-Seq data. Our 
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approach considers three cases for each gene: 1) no differential expression, 2) differential 
expression without differential splicing and 3) differential splicing. We use a Poisson regression 
framework to model the read counts and use a hierarchical likelihood ratio test approach for model 
selection. Simulation studies show that our approach achieves good power for detecting 
differentially expressed or differentially spliced genes, and comparisons with competing methods 
on two real RNA-Seq datasets demonstrate that our approach provides accurate estimates of 
isoform abundances and biological meaningful rankings of differentially spliced genes. 
   In Chapter III, we present a non-parametric approach for the joint detection of differential 
expression and differential splicing of genes. We introduce a new statistic named gene-level 
differential score and use a permutation test to assess the statistical significance. The method can 
be applied to datasets with a variety of experimental designs, including those with two (unpaired 
or paired) or multiple biological conditions, and those with quantitative or survival outcomes.  
   In Chapter IV, we model single-cell gene expression data using a two-part mixed model. This 
model not only adequately accounts for the distinct features of single cell expression data, 
including extra zero expression values, high variability and clustered design, but also provides the 
flexibility of adjusting for covariates. An efficient computational algorithm, automatic 
differentiation, is used for estimating the model parameters. Comparisons with existing methods 
through simulation studies and application to real single-cell gene expression data, our approach 
achieves improved power for detecting differentially expressed genes. 
   In the second part of this dissertation, we propose novel methods to improve the computational 
efficiency of resampling-based test methods in genomic studies with focus on differential 
expression analysis, and this part contains two research projects, which are presented in Chapter 
V and VI respectively. In Chapter V, we propose a fast algorithm for evaluating small p-values 
from permutation tests based on an adaptive importance sampling approach, which uses the cross-
entropy method for finding the optimal proposal density. In Chapter VI, we develop an algorithm 
for efficient estimation of small p-values in parametric bootstrap tests, which not only uses the 
principle of the cross-entropy method to approximate the optimal proposal density, but also 
incorporates the Hamiltonian Monte Carlo method to efficiently sample from the optimal proposal 
density. Together, these methods address a critical challenge for resampling-based test methods in 
genomic studies since usually an enormous number of resamples is needed for estimating very 
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small p-values. Simulation studies and applications to real gene expression datasets demonstrate 
that our methods achieve significant gains in computational efficiency compared with existing 
methods.
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CHAPTER II 
rSeqDiff: Detecting Differential Isoform Expression from RNA-Seq Data using 
Hierarchical Likelihood Ratio Test
 
High-throughput sequencing of transcriptomes (RNA-Seq) has recently become a powerful 
tool for the study of gene expression. In this chapter, we present an efficient algorithm for the 
detection of differential expression and differential splicing of genes from RNA-Seq experiments 
across multiple conditions. Unlike existing approaches which detect differential expression of 
transcripts, our approach considers three cases for each gene: 1) no differential expression, 2) 
differential expression without differential splicing and 3) differential splicing. We specify 
statistical models characterizing each of these three cases and use hierarchical likelihood ratio test 
for model selection. Simulation studies show that our approach achieves good power for detecting 
differentially expressed or differentially spliced genes. Comparisons with competing methods on 
two real RNA-Seq datasets demonstrate that our approach provides accurate estimates of isoform 
abundances and biological meaningful rankings of differentially spliced genes. The proposed 
approach is implemented as an R package named rSeqDiff, which is available at http://www-
personal.umich.edu/~jianghui/rseqdiff/. The content of this chapter has been published previously 
in the journal PLOS ONE [47]. 
2.1 Introduction 
Alternative splicing is an important mechanism in post-transcriptional regulation of eukaryotes. 
Through alternative splicing, a single gene can produce multiple different transcript isoforms that 
usually lead to different protein isoforms with different structures and biological functions, which 
can greatly enrich the diversity of eukaryote transcriptomes [10,11,16]. Several studies also show 
that many human disease-causing mutations affect alternative splicing rather than directly 
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affecting coding sequences and ill-regulated alternative splicing events have been implicated in a 
large number of human pathologies [48-50]. Due to its vital role in biological processes such as 
gene regulation, cell differentiation, development and disease pathophysiology, there is an urgent 
need for the development of new technologies and methodologies for the study of alternative 
splicing events and the quantification of the expression of alternative isoforms. 
In recent years, high-throughput sequencing of transcriptomes (RNA-Seq) has rapidly evolved 
as a powerful tool for the study of alternative splicing in humans and model organisms 
[10,11,16,32]. Many RNA-Seq experiments have been conducted to investigate the following two 
problems: (i) the discovery of novel transcripts and (ii) the estimation and detection of 
differentially expressed transcripts. Here we focus on the second problem. Several statistical 
approaches have been proposed in recent years towards this end. One type of approach is exon-
based, which focuses on the detection of differential usage of exons [17,33,51,52]. The other type 
of approach is isoform-based, which focuses on the estimation of differential expression of 
isoforms across different biological conditions [37,39,53-55]. 
     In this chapter, we present an isoform-based approach for the detection of differential isoform 
expression from multiple RNA-Seq samples. In particular, we extend the linear Poisson model in 
[9,56] for the estimation of isoform abundances from single-end or paired-end RNA-Seq data. 
Unlike existing approaches which detect differential expression of transcripts, we consider three 
cases for each gene: 1) no differential expression, 2) differential expression without differential 
splicing and 3) differential splicing. We specify statistical models characterizing each of these three 
cases and use hierarchical likelihood ratio test for model selection. The remaining part of the 
chapter is organized as follows: We first introduce the statistical model and method, and then use 
simulations to study the type-I error and statistical power of the proposed method, followed by the 
analyses of two real RNA-Seq datasets. For the first dataset (an ESRP1 dataset published in [52]), 
we compare our approach with two other methods (MATS [52] and Cuffdiff 2 [37]) using RT-PCR 
assays performed in [52]. For the second dataset (an ASD dataset published in [57]), we present a 
genome-widely analysis of differential splicing between Autism Spectrum Disorder (ASD) and 
normal brain samples. 
2.2 Methods 
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2.2.1 Notations 
We use similar notations as in [56] to present the statistical model, which are summarized in 
Table 2.1 and explained in details below. 
 
Table 2.1 Summary of notations 
 
Symbol Meaning 
 Total number of biological conditions in the study. 
 Total number of transcripts (isoforms) of a specific gene of interest. 
 Total number of read types in the kth condition (we write Jk as J to avoid 
cluttering, but note this quantity depends on the condition k). 
 The I×Jk read sampling rate matrix for the kth condition. 
  The Jk×1 read count vector for the kth condition. 
 The K×I isoform abundance matrix for all K conditions. The kth row corresponds 
to the isoform abundance vector for the kth condition. 
 The I×1 joint isoform abundance vector for all K conditions (for model 0 only). 
1  
The I×1 basic isoform abundance vector (for model 1 only). 
 The K×1 isoform ratio vector (for model 1 only). 
 The kth element of τ which is the ratio between the isoform abundance vector for 
the kth condition and the basic isoform abundance vector, i.e. =τk 1 (for model 
1 only). 
  The likelihood functions for model 0, 1 and 2 (l0, l1 and l2 are the log-likelihood 
for each model), respectively. 
2.2.2 The linear Poisson model for multi-sample RNA-Seq data 
  We extend the linear Poisson model for one-sample RNA-Seq data in [9,56] to multiple samples. 
Assume there are K conditions in the study, and in the kth condition there are Jk distinct read types. 
A read type refers to a group of reads (single-end or paired-end) mapped to same position in a 
K
I
( )kJ J
kA
kN

0

k
k
0 1 2, ,L L L
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transcript [56]. We write Jk as J to avoid cluttering but note this quantity depends on the condition 
k. For a gene G of interest with I annotated transcripts (isoforms), we define θ as the K×I isoform 
abundance matrix for all the K conditions, where the kth row vector of this matrix, 
1, 2, ,     
T
k k k kI
 denotes the isoform abundance vector of G in the kth condition, and ki  
denotes the abundance of the ith isoform in the kth condition. Correspondingly, each condition has 
its own read sampling rate matrix 
11 1
1
 
 
 
  
k k J
k
kI kIJ
a a
A
a a
 
where 
kija  denotes the rate that read type j is sampled from isoform i in condition k. In our 
implementation we adopt the uniform sampling model in [56] for single-end reads which assumes 
all the possible read types from a transcript are generated with the same rate. For paired-end reads 
we adopt the insert length model in [56], which assumes the sampling rate of a particular paired-
end read type depends on its insert size. The sampling rate matrix Ak can be estimated based on all 
the mapped reads in condition k [56]. Each condition also has its own read count vector 
 1 2, , , 
T
k k k kJN n n n , where nkj denotes the number of reads of type j mapped to any of the I 
isoforms in condition k. Given k  and Ak, Nk is assumed to follow the one-sample linear Poisson 
model [9,56]. In particular, the probability mass function of Nk is 
 
  ·
1
·
!






kj k kj
k
n a
J
k kj
k
j kj
a e
f N
n
                                   (2.1) 
where 
1
· 


I
k kj ki kij
i
a a . 
  Given Ak and Nk for k=1,…,K, our goal is to jointly estimate θ combining the data from all the 
samples. This will be complicated by the fact that the k ’s may not be independent of each other 
under different biological situations. Therefore, we need to re-parameterize θ according to the 
underlying biological situation of whether the gene and its isoforms show differential expression. 
In particular, we propose the following three nested models (Figure 2.1) corresponding to three 
possible underlying biological situations regarding the pattern of gene expression across multiple 
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conditions.  
  Model 0 [no differential expression] characterizes the situation where none of the gene’s isoforms 
show differential expression across the K conditions (Figure 2.1B, row 1, where the hypothetical 
gene structure is given in Figure 2.1A). Under this model, all K conditions have the same isoform 
expression levels so that all the rows of θ are the same and equal to a joint isoform abundance 
vector 0 k , k=1, 2, … K. Under the assumption that the reads of each condition are generated 
independently, the joint likelihood function of 0  combining all K conditions is the product of the 
likelihood of each condition 
   
  0
0
·
0
0 0 1 2
1 1 1
·
| , , ,
!





  
   
kj
kj
n a
K K J
kj
k k
k k j kj
a e
L N N N f N
n
               (2.2) 
Model 1 [differential expression without differential splicing] characterizes the situation where 
the gene shows differential expression, but not differential splicing of its isoforms across the K 
conditions (Figure 2.1B, row 2). Under this model, the relative abundances between the isoforms 
are the same across the K conditions and the rows of θ are therefore proportional to each other. 
Accordingly, we re-parameterize θ as the outer product of a K×1 vector τ and an I×1 vector 1 , 
where 1  is the basic isoform abundance vector for all K conditions, and τ is the isoform ratio 
vector. To make the model identifiable, τ is subject to a linear constraint: 1 1|| || 1
K
kk
 

  . For 
the example of model 1 in Figure 2.1B, 1 [90,60] 
T
 and 
1 2
[ , ]
3 3
T   . If 1 2
1
    K
K
 , 
model 1 degenerates to model 0. Similarly, the joint likelihood function of 1  and τ combining all 
K conditions is 
   
1
1
( )
1
1 1 1 2 ,
1 1 1
[( )
,, ,
]
|
!
,
 
 
 
 
 
  

   
kj k kj
k
n aK K J
k kj
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k k j kj
a e
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n
     (2.3) 
Model 2 [differential splicing] characterizes the situation where the gene shows differential 
isoform usage across the K conditions (Figure 2.1B, row 3). Under this model, each condition has 
its own independent isoform abundance vector k . Therefore, the joint likelihood function is  
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Figure 2.1 Illustration of the three models. 
(A) A hypothetical gene with three exons and two isoforms in blue and red, respectively. (B) Three 
models characterizing three biological situations of the gene expression patterns between two 
conditions. The numbers of red and blue bars represent the relative abundances of the 
corresponding isoforms in the two conditions. 
 
  The parameters of each of the three models can be estimated using maximum-likelihood 
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estimation (MLE). As discussed in [56], one computational burden in solving the MLE is that J 
could be quite large, especially for paired-end RNA-Seq data. We adopt the two data reduction 
techniques introduced in [56]: (i) We take only read types with non-zero mapped reads and further 
group them to form larger read categories; (ii) For each condition k, we compute the total sampling 
rate for each isoform i as
1
J
kij
d
j
ef
kiw a  
(denote  1 2,  , 
T
k k k kJW w w w as the total sampling rate 
vector for all isoforms) without enumerating each particular sampling rate 
kija . In practice, we 
work with the reduced form of the likelihood functions for the three models, and the details of 
these data reduction techniques are given in Appendix Section A.1.
 
  Similar to the log-likelihood function for one-sample linear Poisson model given in equation (2.1) 
(see also [9,56]), all the log-likelihood functions for the above three models are concave. Therefore, 
the MLEs for all of the three models can be obtained by linear constraint convex optimization 
algorithms. In practice, we use an expectation-maximization (EM) algorithm to calculate the 
MLEs, and the details of the algorithm are given in Appendix Section A.1. 
2.2.3 Model selection using hierarchical likelihood ratio test 
  Since model 0 is nested within model 1, which is again nested within model 2, we use the 
likelihood ratio test (LRT) for model selection. For large sample size, the LRT statistics for nested 
models asymptotically follow χ2 distributions. The degrees of freedom (DF) of the three models 
are DF(model 0)=I (the free parameters are the I×1 joint isoform abundance vector 0 ), DF(model 
1)=I+K-1 (the free parameters are the I×1 basic isoform abundance vector 1  and the K×1 isoform 
abundance ratio vector τ subjects to one linear constraint 
1
1


K
kk
) and DF(model 2)=K×I (the 
free parameters are the K×I isoform abundance matrix θ), respectively. 
Given a pre-specified significance level α (e.g., 0.05), we perform model selection using the 
following hierarchical likelihood ratio test (hLRT) procedure (Table 2.2). The first round tests 
include two parallel tests which compare model 0 vs. model 1 and model 0 vs. model 2, each at 
significance level α/2. If neither of the two tests is significant, then model 0 is selected. If only one 
of the two tests is significant, model 1 or model 2 is selected accordingly. If both tests are 
significant, we perform the second round test which compares model 1 vs. model 2 at significance 
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level α and selects model 2 if this test is significant or model 1 otherwise. 
 
Table 2.2 Summary of hLRT for model selection 
 
 models being compared LRT statistics test against 
first round tests 
model 0 vs. model 1  , 1-α/2 
model 0 vs. model 2  , 1-α/2 
second round test model 1 vs. model 2  , 1-α 
 
2.2.4 Ranking of differentially spliced genes 
  When comparing between two biological conditions (e.g., normal vs. diseased), it is often useful 
to generate a ranking of genes being differentially spliced (i.e., model 2 genes). We rank model 2 
genes as follows: Suppose 1ˆ  and 2ˆ  are the estimated isoform abundance vectors for the two 
conditions, we calculate the statistic: 
1 2
1 1
1
2 1
ˆ ˆ
ˆ ˆ||
1
|2 | | || |
| || |T  
 
  , 
where ||·||1 denotes the vector L1 norm ([58] uses a similar statistic without the constant 1/2, which 
is introduced here to have 0 1T  ). Large T values indicate high level of differential splicing. 
The T value is 0 for model 0 and model 1 genes. Alternatively, genes classified in model 1 or model 
2 can also be ranked according to their p-values from the hLRT, if statistical significance is of 
major interest. 
  The proposed approach is implemented as an R package named rSeqDiff, which is available at 
http://www-personal.umich.edu/~jianghui/rseqdiff/. The analysis pipeline of using rSeqDiff is 
provided in Appendix Section A.1. 
2.3 Results 
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2.3.1 Simulation studies 
  We study the performance of our proposed hLRT approach by simulating read counts from genes 
with a wide range of abundances (from lowly expressed genes to highly expressed genes) and 
report the specificity and sensitivity of our approach for the detection of differential expression 
and differential splicing events. Detailed procedure and results of the simulation studies are given 
in Appendix Section A.3, and here we briefly outline the methods that we applied in the simulations. 
We test differential expression and differential splicing of a hypothetical gene with a well-
annotated known isoform structure (Figure A.2) between two biological conditions with 
sequencing depths of total 50 million and 55 million reads, respectively. The gene structure and 
the sequencing depths are fixed in the simulations. For each of the three models, we vary the 
expression level (denoted as G in Appendix Section A.3) of the gene within a broad range, and for 
each G we simulate the number of reads mapped to each of the two isoforms according to the three 
models [equations (2.2), (2.3) and (2.4)]. For each G, we simulate 1000 replicated pairs of samples. 
We run the hLRT with significance level α=0.05 using rSeqDiff on the 1000 simulated pairs of 
samples and report the proportions of the simulated pairs of samples for which our approach 
correctly selects the true underlying model (i.e., true classification rate). Table A.1, A.2 and A.3 in 
Appendix show the true classification rates under model 0, 1 and 2, respectively. 
In summary, the simulation studies show that our proposed hLRT approach has well controlled 
type I error rate at α=0.05 (Table A.1 in Appendix) and good statistical power for detecting 
differential expression and differential splicing for genes with moderate to high abundance in both 
conditions (Table A.2 and A.3 in Appendix). When the gene is lowly expressed in one condition 
but moderately or highly expressed in the other condition, our proposed hLRT approach still has 
good power in selecting model 1, i.e., differential expression without differential splicing. The 
power in detecting differential expression or differential splicing is low when the gene has low 
expression levels in both conditions, which is well expected. In real data analysis, genes with very 
low expression levels in all the conditions are usually filtered out prior to the analysis. By default, 
rSeqDiff filters out genes with less than 5 reads in all the conditions. 
2.3.2 Applications of rSeqDiff to real RNA-Seq datasets 
We demonstrate the practical usage of rSeqDiff and compare it with two other approaches by 
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analyzing two real RNA-Seq datasets: the ESRP1 dataset and the ASD dataset. 
Analysis of the ESRP1 dataset 
Epithelial splicing Regulatory Protein 1 (ESRP1) is a master cell-type specific regulator of 
alternative splicing that controls a global epithelial-specific splicing network [52]. This dataset 
was published in [52], where Shen et al performed single-end RNA-Seq experiments on the MDA-
MB-231 cell line with ectopic expression of the ESRP1 gene and an empty vector (EV) as control. 
The dataset contains 136 million reads for the ESRP1 sample and 120 million reads for the EV 
sample. Shen et al used this dataset to demonstrate their exon-based approach MATS for detect 
differential splicing, and performed RT-PCR assays to test for 164 exons skipping events. Since 
the biological significance of this dataset was further analyzed in a follow-up paper by Shen and 
collaborators [59], our analysis here is solely focused on the validation and comparisons of our 
proposed hLRT approach with other methods using the 164 RT-PCR tested alternative exons as 
gold standard. 
MATS is an exon-based method and its results cannot be directly compared with our isoform-
based approach. In the MATS model (Figure 2.2A, modified from [52]), exon 2 is the alternatively 
spliced exon (skipped exon) unique for the longer isoform and exon 1 and 3 are common exons 
shared by both of the two isoforms. The exon inclusion level   of the skipped exon was defined 
as the abundance ratio between the longer isoform and the sum of both the two isoforms, which 
was estimated as 
( ) / 2
( ) / 2
UJC DJC
UJC DJC SJC



 
 by MATS (Figure 2.2A). The exon inclusion level 
difference between the two conditions (ESRP1 and EV) was calculated as 1ESRP EV     . The 
genome coordinates, junctions read counts (UJC, DJC and SJC), 1ESRP  , EV  and   values 
from MATS and RT-PCR for the 164 exons are provided in [52]. We first apply rSeqDiff to these 
164 exons using only the junction read counts from [52]. We transform the “exon-exon junction 
model” (Figure 2.2A) to a “two-isoform” model (Figure 2.2B), where the hypothetical “isoform 
1” contains two “exons” each with length of 84 bp (the length of the exon-exon junction region in 
[18]) corresponding to the upstream junction (UJC) and downstream junction (DJC), respectively, 
and the hypothetical “isoform 2” contains a single “exon” with length of 84 bp corresponding to 
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the skipping junction (SJC). Hence, the abundances of “isoform 1” (
1 ) and “isoform 2” ( 2 ) 
(Figure 2.2B) are equivalent to the abundances of the longer and shorter isoforms in exon-based 
method (Figure 2.2A), respectively. The exon inclusion level   is then estimated as 
1
1 2


 


. 
For the 164 RT-PCR tested exons, we first use rSeqDiff to estimate 1  and 2  using the junction 
read counts (UJC, DJC and SJC) from [52], and then calculate
 1ESRP
 , EV and   accordingly. 
Figure 2.3A shows the scatter plot of the   values estimated by rSeqDiff (using junction reads 
only) and MATS, and Figure 2.3B shows the scatter plot of the   values estimated by rSeqDiff 
(using junction reads only) and RT-PCR (MATS and RT-PCR results are adapted from [52]). We 
can see that rSeqDiff gives very similar results as MATS when only junction reads are used, and 
overall both methods agree well with the RT-PCR assays (Figure 2.3B and Table 2.3). 
 
Table 2.3 The correlation coefficients of the   values between RT-PCR and rSeqDiff, 
MATS and Cuffdiff 2 for the 164 RT-PCR tested exons 
 rSeqDiff 
(junction reads only) 
rSeqDiff 
(all reads) 
MATS* Cuffdiff 2** 
Pearson 0.810 0.898 0.799 0.838 
Spearman 0.831 0.913 0.814 0.850 
 
*The values from RT-PCR and MATS are directly adapted from [52]. 
**Three genes failed to be tested by Cuffdiff 2 (Reported as “FAIL”) are excluded. 
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Figure 2.2 Models for estimating the exon inclusion level ψ using the junction reads. 
(A) The “exon-exon junction model” used by MATS [18]. Exon 1 and 3 are common exons shared 
by the two isoforms, and exon 2 is the skipped exon unique for the longer isoform. ψ: exon 
inclusion level; UJC: number of reads mapped to the upstream junction; DJC: number of reads 
mapped to the downstream junction; SJC: number of reads mapped to the skipping junction. (B) 
The “two-isoform model” transformed from (A). The abundances of the longer and shorter 
isoforms are  and , respectively, which are estimated using the junction read counts (UJC, 
DJC and SJC). 
 
   We then apply rSeqDiff using its default settings (detailed method is given Appendix I Section 
A.4) where all the reads mapped to exons and exon-exon junctions are used [referred as rSeqDiff 
(all reads) below]. We also run another isoform-based approach Cuffdiff 2 [37,59] on the same 
dataset (details are given in Appendix Section A.4). These two methods give the estimates of the 
abundances of all the isoforms. Based on the gene symbols and the genome coordinates of the 164 
RT-PCR tested exons in [52], we identify genes containing these exons from the results of rSeqDiff 
(all reads) and Cuffdiff 2, and calculate the   values for these exons based on the isoform 
abundances estimated by rSeqDiff (all reads) and Cuffdiff 2. Figure 2.3C shows the scatter plot of 
the   values estimated by rSeqDiff (all reads) and RT-PCR, and Table 2.3 shows the correlation 
coefficients of the   values between RT-PCR assays and the three methods, rSeqDiff, MATS 
and Cuffdiff 2, respectively. We can see that rSeqDiff (all reads) outperforms MATS and Cuffdiff 
2 significantly. 
1 2
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Figure 2.3 Comparisons of rSeqDiff, MATS, Cuffdiff 2 and RT-PCR assays.  
(A) Scatter plot of the Δψ values estimated by rSeqDiff (using junction reads only) and MATS. (B) 
Scatter plot of the Δψ values estimated by rSeqDiff (using junction reads only) and RT-PCR. (C) 
Scatter plot of the Δψ values estimated by rSeqDiff (using all reads) and RT-PCR. (D) Scatter plot 
of the log2 fold changes of isoform abundances between ESRP1 and EV estimated by rSeqDiff 
and Cuffdiff 2. Transcripts classified as model 0, model 1 and model 2 are shown in green, blue 
and red, respectively. The solid line is the regression line. The dashed line is the y=x line, which 
represents perfect agreement of the two methods. Δψ: difference of exon inclusion level between 
ESRP1 and EV; PCC: Pearson Correlation Coefficient; SCC: Spearman Correlation Coefficient.
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   One major advantage of isoform-based approaches like rSeqDiff and Cuffdiff 2 over exon-based 
approaches like MATS is that isoform-based approaches use all the reads mapped to exons and 
exon-exon junctions and incorporate the information from all the isoforms rather than using only 
the local exon structures as shown in Figure 2.2A. The structure of the full length isoforms is 
important for inferring complex alternative splicing events. Three examples out of the 164 RT-
PCR validated exons are given in Figure 2.4. In the first example (Figure 2.4A), the ARHGAP17 
gene has only two isoforms differed by an alternative exon. The isoform structure of this gene is 
relative simple, and all the three algorithms provide similar estimates which are also validated by 
RT-PCR. In the second example (Figure 2.4B), the ATP5J2 gene has four isoforms differed by an 
alternative exon in the middle and an alternative 5’ splice site on the exon at the 5’ end. For this 
gene with a relative complex isoform structure, the two isoform-based methods, Cuffdiff 2 and 
rSeqDiff, give more accurate estimates than MATS, and rSeqDiff is slightly more accurate 
according to the RT-PCR result. In the third example (Figure 2.4C), the CSF1 gene has an even 
more complex isoform structure with four isoforms differed by an alternative exon in the middle 
and two mutually exclusive exons at the 3’ end. For such an isoform structure, some isoforms 
(NM_172212 and NM_000757) can only generate upstream junction reads (UJC) for the 
alternatively spliced middle exon but not downstream junction reads (DJC). As a result, the 
estimate of MATS is less accurate than that of rSeqDiff. rSeqDiff classifies this gene as model 1, 
which is consistent with the RT-PCR result. Cuffdiff 2 fails to test (it reports as “FAIL” [59]) this 
gene due to “an ill-conditioned covariance matrix or other numerical exception prevents testing”. 
   We also compare the estimates of all the gene between rSeqDiff (all reads) and Cuffdiff 2. 
Cuffdiff 2 fails to test (it reports as “LOWDATA”, “HIDATA” or “FAIL” [59]) several hundred 
genes with relative complex isoform structures. Figure 1.3D shows the scatter plot of the log2 fold 
changes of transcript abundances between ESRP1 and EV estimated by the two approaches (genes 
with low read counts or failed to be tested by Cuffdiff 2 are excluded). Overall the two approaches 
agree well with each other (Pearson Correlation Coefficient = 0.834, Spearman Correlation 
Coefficient = 0.933), and the degree of agreement is generally higher when the alternative spliced 
transcripts are more differentially expressed: the Pearson Correlation Coefficient (PCC) and 
Spearman Correlation Coefficient (SCC) of transcripts classified in each of the three models are 
PCC=0.685, SCC=0.802 (model 0), PCC =0.827, SCC=0.932 (model 1) and PCC=0.862, 
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SCC=0.954 (model 2). 
 
Figure 2.4 Examples comparing the estimates between rSeqDiff, MATS, Cuffdiff 2 and RT-
PCR assays.  
(A) ARHGAP17 gene. (B) ATP5J2 gene. (C) CSF1 gene. The figures on the left show the gene 
structure and the coverage of reads mapped to the gene visualized in CisGenome Browser [45], 
where the horizontal tracks in the picture are (from top to bottom): genome coordinates, gene 
structures where introns are shrunken for better visualization and the coverage of reads mapped to 
the genes in ESRP1 and EV samples. The table to the right each figure shows the estimates from 
each method. 1ESRP   and EV  : exon inclusion levels in ESRP1 and EV, respectively; Δψ: 
difference of exon inclusion levels between ESRP1 and EV ( 1ESRP EV  ).
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Analysis of the ASD dataset 
  Increasing evidence has indicated that alternative splicing plays an important role in brain 
development [60,61] and the pathology of many neurological disorders [62,63]. This dataset was 
published by Voineagu et al [57], where single-end RNA-Seq experiments were performed on 
three brain samples of Autism Spectrum Disorder (ASD) patients with down-regulated A2BP1 
gene levels (a.k.a. FOX1, an important neuronal specific splicing factor that regulates alternative 
splicing in the brain) and three control brain samples with normal A2BP1 levels. 
  In [57], the authors separately pooled the reads for ASD and control to generate sufficient read 
coverage for the quantitative analysis of alternative splicing events (referred as “pooled dataset” 
below), and then used an exon-based method similar to MATS in their analysis and detected 212 
significantly differentially spliced exons (belonging to 196 unique genes). As we have shown in 
the analysis of the ESRP1 dataset, the exon-based methods provide less accurate results for 
complex alternative splicing events and cannot infer the abundances of the isoforms, here we 
analyze this pooled dataset using rSeqDiff (detailed method is given in Appendix A Section A.5). 
  rSeqDiff classifies 4,507 genes (with 6,850 transcripts) as model 0, 12,374 genes (with 19,556 
transcripts) as model 1, 1,769 genes (with 5,848 transcripts) as model 2, and 7,349 genes (with 
8,884 transcripts) are filtered out because they have less than 5 mapped reads in both conditions. 
We also run Cuffdiff 2 [37,59] on this dataset with its default settings. We find Cuffdiff 2 to be 
relatively conservative for detecting differential expression of spliced transcripts and it only 
identifies 43 transcripts as significant under default settings (FDR<0.05). Figure A.4 in Appendix 
shows the scatter plot of the log2 fold changes of transcript abundances between ASD and control 
estimated by the two approaches (genes with low read counts or failed to be tested by Cuffdiff 2 
are excluded). Similar to the analysis of the ESRP1 dataset, the two methods generate concordant 
results overall (PCC = 0.825, SCC = 0.937). The correlation coefficients for transcripts classified 
in each of the three models are PCC=0.539, SCC=0.796 (model 0), PCC =0.847, SCC=0.940 
(model 1) and PCC=0.854, SCC= 0.953 (model 2), which also show the same pattern as we 
observed in the ESRP1 dataset. We also run rSeqDiff on each individual biological replicate and 
get consistent results as the analysis on the pooled dataset (Table A.4 in Appendix). 
 The authors of [57] tested 7 differentially spliced exons with relevant neurological functions 
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using semi-quantitative RT-PCR assays, and validated 6 of them. Table 2.4 shows the ranking of 
these genes by rSeqDiff and Cuffdiff 2 (The CDC42BPA gene was not validated in [57]). rSeqDiff 
is able to detect all the 6 confirmed genes as differentially spliced (model 2) and also gives a more 
meaningful ranking of these genes than Cuffdiff 2, which might be helpful for biologists to design 
follow-up experiments. We also compare the estimates of the exon inclusion levels of the six RT-
PCR validated exons by rSeqDiff with the exon-based method in [57]. Five out of the six genes 
(except AGFG1) have concordant annotations for the skipped exons in the RefSeq annotation 
database are used in our analysis. Table A.5 in Appendix shows the comparisons between the two 
methods. Basically, rSeqDiff consistently recovers the results from the exon-based method in [57]. 
 
Table 2.4 Ranking of RT-PCR validated genes with relevant neurological functions 
 
Genes rSeqDiff Cuffdiff 2 
AGFG1 178 5841 
RPN2 166 3884 
EHBP1 281 8301 
CDC42BPA* Model 1 20470 
GRIN1 338 6803 
SORBS1 208 6313 
NRCAM 325 FAIL** 
 
*The RT-PCR result for this gene is not consistent with the exon-based method in [57], therefore 
this gene is not validated by RT-PCR. rSeqDiff classifies it in model 1. 
** FAIL: the gene has an ill-conditioned covariance matrix or other numerical exception which 
prevents Cuffdiff 2 from testing it [23]. 
 
Figure 2.5 shows three examples of genes with differential expression or differential splicing 
reported by rSeqDiff for the purpose of demonstrating rSeqDiff’s capability in dealing with very 
complex isoform structures. In the first example (Figure 2.5A-C), the NRCAM gene has five 
annotated alternative spliced isoforms (Figure 2.5A) and the estimation of their abundances 
between ASD and control is shown in Figure 2.5C. Figure 2.5B shows the differentially spliced 
exon that was validated by RT-PCR in [57]. This gene encodes a neuronal cell adhesion molecule 
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which involves in neuron-neuron adhesion and promotes directional signaling during axonal cone 
growth [64] and has been reported to be associated with ASD by two genetic association studies 
[65,66]. The second example is the BACE1 gene (Figure 2.5D-F) with six annotated alternative 
isoforms. This gene has a complex isoform structure, with an alternative 5’ splice site and an 
alternative 3’ splice site (the part in the red box of Figure 2.5D, enlarged in Figure 2.5E). The 
estimates of the abundances of the gene and its isoforms are shown in Figure 2.5F. This gene 
encodes the β-site APP cleaving enzyme 1 (BACE1), which plays an important role in the 
pathology of Alzheimer's disease [67]. Previous studies show that the isoforms of this gene have 
different enzymatic activities in the brain [68-70]. Although this gene has not been reported to be 
associated with ASD, several recent studies have showed that the expression levels of three 
BACE1 processed protein products, secreted amyloid precursor protein-α form (sAPP-α), secreted 
amyloid precursor protein-β form (sAPP-β) and amyloid-β peptide (Aβ), have substantial changes 
in severely autistic patients [71-74]. The third example is the SCIN gene (Figure 2.5G-I) with two 
alternative isoforms which differ by the mutually exclusive exons at the 5’ end (the part in the red 
box of Figure 2.5G, enlarged in Figure 2.5H). This gene is identified as model 1 by rSeqDiff, 
which has a significant higher expression level in autism than control. Also, there is no read 
mapped to the short exon unique to NM_033128 at its 5’ end (Figure 2.5H), therefore this isoform 
is estimated to have low abundances in both conditions. This gene encodes Scinderin (also known 
as Adseverin), a calcium-dependent actin filament severing protein that controls brain cortical actin 
network [75].  
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Figure 2.5 Examples demonstrating the estimates from rSeqDiff.  
(A)-(C) show NRCAM gene. (D)-(F) show BACE1 gene. (G)-(I) show SCIN gene. (A)(D)(G) 
show the gene structure and coverage of reads mapped to the gene. (B)(E)(H) show enlargement 
of the parts in the red boxes in (A)(D)(G), respectively, emphasizing the alternative spliced exons. 
In (B), the red box emphasizes the alternative exon that was validated by RT-PCR assay in [57], 
and the two red arrows represent the positions of the primers of RT-PCR (see Supplemental Figure 
8 of [57]). (C)(F)(I) show estimated abundances for each gene and its isoforms by rSeqDiff. Values 
in the brackets are the 95% confidence intervals for the estimates. 
 
2.4 Discussion 
  The two types of approaches for detecting differential transcription across multiple conditions, 
exon-based approaches and isoform-based approaches, each have their own strengths and 
weaknesses. Exon-based approaches do not rely on annotated full-length transcripts and provide 
relatively accurate inference for the differential splicing of a local exon from a gene with relative 
simple isoform structure [51,52]. However, they cannot provide estimates of isoform abundances 
and provide less accurate inference for the differential splicing of genes with complex isoform 
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structures. Isoform-based approaches can directly infer isoform abundances and are more accurate 
for estimating the differential splicing of multi-isoforms with complex splicing events. Since the 
final functional units are the protein isoforms translated from the alternatively spliced transcripts, 
isoform-based methods are more biologically informative for follow-up studies. However, 
isoform-based approaches may give inaccurate estimates if the annotation of full length transcripts 
is incorrect. We believe that isoform-based approaches will be increasingly used with the 
improvement of the transcript annotation databases. 
One limitation of our approach is that it ignores the biological variations across biological 
replicates, which will be handled in our future work by extending our model. One way to handle 
biological variations is to use the negative binomial model as implemented in edgeR [23], DEseq 
[22], DSS [76] and Cuffdiff 2 [37], where an over-dispersion parameter is introduced and estimated 
using the empirical Bayes method that borrow information from all the genes. Another way is to 
use hierarchical Bayesian models, where choosing appropriate prior distributions and efficient 
parameter estimation (typically using Markov chain Monte Carlo (MCMC) algorithms) are 
challenging. It is also possible to extend our model to more complicated experimental designs such 
as crossed experiments by incorporating the covariates into the sampling rate matrix for each 
sample, since the hLRT is generally applicable to comparisons of complex models. 
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CHAPTER III 
rSeqNP: A Non-parametric Approach for Detecting Gene Differential Expression 
and Splicing from RNA-Seq Data
 
In this chapter, we present an algorithm, rSeqNP, which implements a non-parametric approach 
to test for differential expression and splicing from RNA-Seq data. rSeqNP uses permutation tests 
to access statistical significance and can be applied to a variety of experimental designs. By 
combining information across isoforms, rSeqNP is able to detect more differentially expressed or 
spliced genes from RNA-Seq data. The package is available at http://www-
personal.umich.edu/~jianghui/rseqnp/. The content of this chapter has been published previously 
in the journal Bioinformatics [30]. 
3.1 Introduction 
High-throughput sequencing of transcriptomes (RNA-Seq) is a widely used approach to study 
gene expression [10]. Many statistical approaches have been developed to characterize gene 
expression variation across RNA-Seq experiments, and many of them are designed for testing 
differential expression (DE) of genes without considering their alternative spliced isoforms. For a 
comprehensive review, see [18]. Several recent studies have shown that directly applying the DE 
approach for detecting differential splicing (DS) may lead to erroneous results, because those 
approaches do not incorporate the complexity induced by isoform expression estimation for genes 
with multiple isoforms [37,40]. To this end, several approaches were recently developed to detect 
differential expression at isoform level [37,39,40,54]. However, there are two remaining issues: 1) 
many existing approaches only compare between two biological conditions (such as normal v.s. 
diseased) and their usages for complex experimental designs are thus limited, and 2) most existing 
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approaches assume parametric distributions (Poisson or negative binomial) for observed read 
counts which, although can achieve good performance when the distributional assumptions hold, 
may have severely deteriorated performance should the distributional assumptions be violated, and 
that is often the case especially for large sample size RNA-Seq data where outliers usually exist 
[14]. 
   Here we present rSeqNP, a non-parametric approach for testing differential expression and 
differential splicing from RNA-Seq data. rSeqNP extends a non-parametric approach for detecting 
differential expression [14] and aims at detecting both differential expression and differential 
splicing. rSeqNP can be used with a variety of RNA-Seq experimental designs, including those 
with two (unpaired or paired) or multiple biological conditions, and those with quantitative or 
survival outcomes. 
3.2 Methods 
3.2.1 Data preprocessing 
Before applying rSeqNP, the raw RNA sequence reads need to be processed to obtain the 
expression estimates of all the genes and their isoforms for each sample in the RNA-Seq study. 
This can be done using software tools like rSeq [9], RSEM [77] and Cuffdiff [37].  
3.2.2 Testing Differential Expression of genes and isoforms 
Using the estimated expression values as input, rSeqNP tests for DE of genes and isoforms 
using non-parametric statistics that are constructed based on ranks of expression values. Table 3.1 
summarizes the test statistics that are used in various study designs of RNA-Seq experiments, 
which are described in details below. 
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Table 3.1 Non-parametric statistics used by rSeqNP 
Study design Test statistic 
Two condition comparison Wilcoxon rank-sum statistic 
Paired two condition comparison Wilcoxon singed-rank statistic 
Multiple condition comparison Kruskal-Wallis statistic 
Quantitative outcomes Spearman’s rank correlation coefficient 
Survival outcomes Score statistic of the Cox proportional hazard model 
 
Notations. We summarize the notations used in this section in Table 3.2 and explain them in details 
below. 
 
Table 3.2 Notations in the Methods Section 
 
Symbol Meaning 
J Number of isoforms of a gene 
K Total number of conditions (groups), with k denoting the kth condition 
n 
Number of samples in total, with nk denoting the number of samples in the kth 
condition 
Ck Index set for samples in Group k 
θij The expression level of gene (or isoform) j in sample i 
Rij(θ) The rank of θij in θ1j,…, θnj 
yi The outcome of sample i (for quantitative outcome)  
Ri(y) The rank of yi in y1,…,yn (for quantitative outcome) 
δi 
Indicator of whether the failure of sample i is observed (δi=1) or censored (δi=0) (for 
survival outcome) 
  
   (Unpaired) Two-condition comparison. To test for differential expression of feature j (which can 
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be a gene or an isoform), suppose that θ1j,…,θnj are the expression levels of the gene (or isoform) 
j from all the samples. Suppose condition k contains nk samples (k=1 or 2 and n1+n2=n), and let 
 :  Sample  is from condition kC i i k  (k=1 or 2) and Rij(θ) be the rank of θij in θ1j,…,θnj. We use 
the two-group Wilcoxon rank-sum statistic (a.k.a. the “Mann-Whitney statistic”) to test for 
differential expression: 
1
1( 1)( )
2
j tj
t C
n n
T R 


                                           (3.1) 
Similar to [14], we set the constant term as –n1(n+1)/2 instead of the usual definition of –
n1(n1+1)/2 to make ETj=0 when feature j is not differentially expressed, and the sign of Tj indicates 
whether feature j is overexpressed (positive) or underexpressed (negative) in condition 1. Note that 
the difference between our method and [14] is that their test statistic is constructed based on the 
ranks of read counts for each feature and applying that statistic requires scaling the read counts for 
each sample by the corresponding sequencing depth. Therefore, [14] used a resampled version of 
(3.1) to perform the test. The scaling issue is not a problem here, since the Wilcoxon statistic is 
constructed based on ranks of estimated expression values (e.g., in the RPKM unit) of each feature, 
which is already scaled by the corresponding sequence depth of each sample in the quantification 
step (i.e. the “data preprocessing” step in the main text). Hence, the Wilcoxon statistic can be 
applied directly for differential expression testing in our case. Since the null distribution of the 
Wilcoxon statistic is well-studied, we compute the corresponding p-value using the standard 
method. 
   When analyzing real RNA-Seq data, some genes (isoforms) may have ties in their expression 
values (e.g. genes having zero expression values in some of the samples). A powerful and widely-
used algorithm to handle ties is the shift algorithm [78], which is implemented in the R package 
exactRankTests [79]. rSeqNP computes p-values from Wilcoxon rank-sum tests for gene and 
isoform differential expression using the wilcox.exact function in the exactRankTests package. 
   Paired two-condition comparison. If the data is paired, let ' '
1 , ,j nj    be the differences in 
expression levels for feature j (gene or isoform) between the paired samples from condition 1 and 
condition 2, and let 'n  be the number of pairs with non-zero differences. After ranking the absolute 
values of non-zero '
ij s and assign the ranks with the original signs, we use the Wilcoxon singed-
rank statistic (again centered with mean zero) to test for differential expression: 
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where ( )ijR 
 denotes the positive ranks. 
   Similar to the Wilcoxon rank-sum test, to handle ties in expression values, rSeqNP computes p-
values from Wilcoxon signed-rank tests for gene and isoform differential expression using the 
wilcox.exact function in the exactRankTests package [79]. 
   Multi-condition comparison. Suppose there are K conditions, and condition k contains nk samples 
(k=1,…,K and 
1
K
k
k
n n

 ), and let  :  Sample  is from condition kC i i k . Similar to [14], we use 
the Kruskal-Wallis statistic to test for differential expression: 
2
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                           (3.3) 
   To handle ties in expression values, we divide Tj by 
3
1
3
( )
1
G
i ii
t t
n n





 , where G is the number of 
groupings of different tied ranks and ti is the number of tied values within group i that are tied at a 
particular value. To calculate p-values, we approximate the null distribution of the corrected Tj 
statistic by a chi-square distribution with K degrees of freedom [80]. 
   Quantitative outcome. Suppose yi (i=1,…,n) is the quantitative outcome for the ith sample. 
Following [14], we use the Spearman’s rank correlation coefficient, which is the Pearson’s 
correlation between R1j(θ),…, Rnj(θ) (the ranks of θ1j,… θnj) and R1(y),…, Rn(y) (the ranks of 
y1,…yn), to test the differential expression: 
1 1({ ( ),..., ( )},{ ( ),..., ( )})j j nj nT corr R R R y R y                     (3.4) 
The p-values are calculated using the cor.test function in R. 
   Survival outcomes. In this study design, the outcome is a pair (ti, δi) for each sample, where ti is 
the survival time (ties may occur) and δi is an indicator of whether the failure is observed (δi =1) 
or censored (δi =0), i=1,…,n. For feature j, we use R1j(θ),…, Rnj(θ) as the single predictor in a Cox 
proportional hazard model. Possible ties in the survival times are handled by Breslow’s method 
[81]. Cox model uses partial likelihood, which involves only the ranks of the survival times, 
making the model semi-parametric. Following [14], we use the score statistic for differential 
testing: 
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where 
1 k it t
n
i k
A I

  , 1 ( ) k i
n
i tj jk k t
R IB 
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  , and 21 ( ) k i
n
ij j tk k t
R IC 
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  . The p-values are 
calculated by comparing 2
j
T  to a chi-square distribution with one degree of freedom [14,82]. 
3.2.3 Testing Differential Expression and Splicing of genes jointly 
   For each gene, rSeqNP also computes an overall gene-level differential score (GDS) based on 
the statistics used in testing the DE of the isoforms. Suppose that a gene has J distinct isoforms, 
and Tj is the statistic for testing the DE of the jth isoform as described in Table 3.1 (e.g., for two 
condition comparison, Tj is the Wilcoxon rank-sum statistic), the GDS is computed as 
2
1
J
jj
GDS T

 . The GDS captures both differential expression and differential splicing of the 
gene. For genes with a given number of isoforms, larger GDS indicates stronger evidence of 
differential expression and differential splicing. The GDS incorporates information from all the 
isoforms of the gene, and therefore is more comprehensive in detecting differentially expressed 
and spliced genes than simply detecting genes that contain differentially expressed isoforms. 
   Estimating P-values and FDR for tests based on GDS by a permutation plug-in method. Since 
the null distribution of the GDS is unknown, rSeqNP implements a permutation plug-in method to 
estimate the p-values and FDRs [14], which is described below. 
   To reduce computing time, rSeqNP first pools genes with the same number of isoforms together 
to get the permutated null distribution for the overall gene-level differential score (GDS). For each 
group of genes that have the same number of isoforms, suppose there are p genes in total and let 
GDSj denote the GDS for the jth gene (j=1,…,p). Following [14,83], rSeqNP implements a 
permutation plug-in method to estimate the FDR for the test based on the GDS in the following 
steps: 
(1) Compute GDS1,…, GDSp based on the data. 
(2) Permute the n outcome values B times. In the bth permutation, compute statistics 
1
,...,b b
p
GDS GDS  based on the permuted data. 
(3) For a range of values of threshold C, estimate V - the number of false-positive tests as 
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(4) The FDR at threshold C is estimated as 
0
/
C
FDR V R  , and for 
0
   (the estimated true 
proportion of null features) the usual estimate 
0 (| | )1
2 /
j
p
GDS qj
I p

   is used, where q is the 
median of all permuted values | |b
j
GDS , 1,..., ,  1,...,j p b B  . The p-value at threshold C is 
estimated as
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. 
3.3 Simulation studies 
In this section, we study the performance of rSeqNP through simulations. In the first part, we 
directly simulate the expression values (e.g., in the RPKM unit) of genes and isoforms. In the 
second part, we study more realistic situations by simulating RNA-Seq reads using the R package 
polyester [84]. All the simulations are based on unpaired two-condition comparison, which is the 
most common study design of RNA-Seq experiments. 
3.3.1 Direct simulation of expression values 
The asymptotic properties of the standard non-parametric statistics in Table 3.1 (also see 
equations 2.1 - 2.5) and the corresponding non-parametric tests based on them are well-studied in 
the literature. For example, see [80] for Wilcoxon rank-sum, Wilcoxon singed-rank, Kruskal-
Wallis tests and the test based on Spearman’s rank correlation coefficient; see [82] for the score 
test of the Cox proportional hazard model. However, the null distribution of the GDS is unknown. 
Hence, the goal here is to study the performance of the permutation test based on the GDS. 
Specifically, we perform the following two simulation studies to evaluate the type I error rate and 
the statistical power of the permutation test, respectively. We use a p-value (the calculation is 
described in Section 3.2.3) cutoff of 0.05 to call a gene as differentially expressed or spliced. 
   Evaluating the type I error rate. We simulate two-condition comparisons with equal sample sizes 
for both conditions. For a single gene, let n be the total number of samples (so that each condition 
has n/2 samples), J be the number of isoforms for each gene with j denoting the jth isoform, G be 
34 
 
the mean expression value of the gene across all the samples, Gi be the overall gene expression 
value in sample i, θij be the expression value of the jth isoform in the ith sample and ψj be the ratio 
of θij to Gi. We keep ψj to be the same across all the samples, and therefore the gene does not show 
differential splicing. The data is generated as follows: 
(1) G ~ Uniform (1, 1000). 
(2) G1,…,Gn are generated from a multivariate normal distribution truncated on the interval (0, 
10000), with mean equal to G and standard deviation uniformly drawn from 1% to 50% of G. 
(3) ψj’s are generated uniformly from (0, 1) with the constraint 
1
1
J
jj


 , and θij=Giψj. 
Table 3.3 is the summary of type I error rates from the simulations, where each cell shows the 
proportion of genes called as differentially expressed or spliced based on the simulated expression 
values from 5000 genes. We can see that for genes with different numbers of isoforms and different 
sample sizes, the type I error rates are consistently controlled at 0.05. 
 
Table 3.3 Summary of type I error rate 
 
          n   
J    
4 6 8 10 20 30 50 100 
2 0.0486 0.0438 0.0498 0.0505 0.0569 0.0492 0.0502 0.0510 
3 0.0432 0.0510 0.0544 0.0500 0.0486 0.0540 0.0506 0.0504 
4 0.0546 0.0490 0.0532 0.0468 0.0466 0.0574 0.0498 0.0484 
5 0.0468 0.0612 0.0484 0.0504 0.0518 0.0520 0.0496 0.0458 
10 0.0452 0.0524 0.0536 0.0462 0.0508 0.0448 0.0494 0.0480 
 
   Evaluating the statistical power. Again we simulate two-condition comparisons with equal 
sample sizes for both conditions. For a single gene with two isoforms (J=2), let n be the total 
number of samples (so that each condition has n/2 samples), G be the mean expression value of 
the gene across all the samples, Tkj be the mean expression value of the jth isoform in condition k 
(j=1, 2 and k=1, 2) and θij be the expression value of the jth isoform in the ith sample. The data is 
generated as follows:  
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(1) G ~ Uniform(1, 1000). 
(2) To make the gene show differential splicing, we let the expression values of the jth isoform 
between condition 1 and condition 2 differ by 0.1G: T11=0.4G, T12=0.6G; T21=T22=0.5G. 
(3) θij’s are drawn from a multivariate normal distribution truncated on the interval (0, 10000), 
with mean equal to Tkj and standard deviation uniformly drawn from 1% to 50% of Tkj. 
Table 3.4 is the summary of the statistical power, where each cell is the proportion of genes 
called as differentially expressed or spliced based on the simulated expression values from 10000 
genes. As expected, the statistical power grows with increased sample size, and become reasonably 
good for data with five or more samples in each group (i.e. n≥10, Table 3.4). 
 
Table 3.4 Summary of statistical power 
 
n 4 6 8 10 12 14 16 18 20 30 50 100 
power 0.011 0.050 0.603 0.680 0.746 0.779 0.862 0.887 0.922 0.981 0.998 1 
 
3.3.2 Simulation of RNA-Seq reads 
In this section, we study the performance of rSeqNP by simulating RNA-Seq reads using the 
R package polyester, which is specifically designed for read simulation in differential expression 
analysis from RNA-Seq data [84]. We first briefly introduce the underlying model used for 
simulation in that package: under unpaired two-condition comparison, let Yijk be the number of 
reads simulated from isoform k (k = 1, …, N; where N is the total number of isoforms) of replicate 
i (i = 1, …, nj; where nj is the number of replicates in condition j) in experimental condition j (j = 
1, 2), and the model used in polyester is: 
 Yijk ~ Negative Binomial (mean = μjk, size = γjk)                      (3.6) 
where E(Yijk) = μjk is the mean read number for isoform k in condition j under the negative binomial 
model, and γjk is the size parameter that specifies the mean – variance relationship (1/γjk is 
commonly referred to as the dispersion parameter) as: 
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and γjk = μjk/3 is the default setting in the package. The differential expressions are set by two 
parameters: fold change λk and baseline mean read number μk, which are provided by the user and 
has the following relationship with μjk: 
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             (3.8) 
Hence λk defines the level of differential expression between the two conditions. Since long 
transcripts tend to generate more reads than short ones in real RNA-Seq experiments, we introduce 
another parameter Ck as the read coverage for transcript k in the simulations to account for the 
transcript length when deciding μk (this parameter is also suggested by the authors of polyester): 
k
k k
L
C
l
                                                     (3.9) 
where Lk is the length (bp) of transcript k and l is the read length (bp). The other parameters that 
can be tuned in the package are sequencing error rate e (the package assumes uniform error model) 
and the RNA fragmentation model. See [84] for details.  
In the following simulation, we simulate single-end reads with read length l = 100 bp using the 
transcript sequences on chr1 from RefSeq hg19 (which contains 4937 isoforms belonging to 2585 
genes). The other parameters are set as: RNA fragment lengths are drawn from a normal 
distribution with mean = 250 nucleotides and standard deviation (SD) = 25 nucleotides (which is 
the default settings of the package); number of replicates n1 = n2 = 10 for each group; sequencing 
error rate e = 1%; coverage Ck’s are drawn from a normal distribution with mean = 5 and SD = 5 
truncated on the interval of [0, 20]. The differential expression (DE) is set by tuning the parameters 
fold change λk (which represents the level of DE) and the size parameter γjk (which represents the 
level of variance). Specifically, we let the first 2959 isoforms of the 4937 isoforms (belonging to 
1616 genes) be the No DE group, where the λk’s of this group is set as λk = 1; we let the next 989 
isoforms (belonging to 499 genes) be the Up-regulated DE group, and the rest 989 isoforms 
(belonging to 470 genes) be the Down-regulated DE group (The 4937 isoforms are first sorted by 
their gene and isoform names before divided as three groups, so there is no overlapping of genes 
between these groups). We tune the level of DE by assuming a distribution on the λk’s of the two 
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DE groups. Let βk = log2 λk and the following four scenarios are simulated:   
Scenario 1 - Low DE, Low variance: for Up-regulated DE group, βk’s are drawn from a normal 
distribution with mean = 0 and SD = 0.5 truncated on the interval of [log21.25, +∞); for Down-
regulated DE group, βk’s are drawn from a normal distribution with mean = 0 and SD = 0.5 
truncated on the interval of (-∞, -log21.25]; γjk = μjk/3 [which means the variance is 4μjk. See 
equation (3.8)]. 
Scenario 2 - High DE, Low variance: for Up-regulated DE group, βk’s are drawn from a normal 
distribution with mean = 0 and SD = 2 truncated on the interval of [log21.25, +∞); for Down-
regulated DE group, βk’s are drawn from a normal distribution with mean = 0 and SD = 2 truncated 
on the interval of (-∞, -log21.25]; γjk = μjk/3. 
Scenario 3 - Low DE, High variance: for Up-regulated DE group, βk’s are drawn from a normal 
distribution with mean = 0 and SD = 0.5 truncated on the interval of [log21.25, +∞); for Down-
regulated DE group, βk’s are drawn from a normal distribution with mean = 0 and SD = 0.5 
truncated on the interval of (-∞, -log21.25]; γjk = μjk/7 [which means the variance is 8μjk. See 
equation (2.8)]. 
Scenario 4 - High DE, High variance: for Up-regulated DE group, βk’s are drawn from a normal 
distribution with mean = 0 and SD = 2 truncated on the interval of [log21.25, +∞); for Down-
regulated DE group, βk’s are drawn from a normal distribution with mean = 0 and SD = 2 truncated 
on the interval of (-∞, -log21.25]; γjk = μjk/7. 
Note that in Scenarios 1 and 3, the SD of βk’s is small and fewer isoforms (genes) have high 
fold changes, hence these two scenarios are termed “Low DE”; while in Scenarios 2 and 4, the SD 
of βk’s is large and more isoforms (genes) have high fold changes, hence these two scenarios are 
termed “High DE”. 
For each scenario, the reads are simulated according to equations (3.6) - (3.9) using polyester 
and mapped to the reference transcript sequences using Bowtie (version 1.1.1) under default 
settings with number of mismatches of no more than two [85]. RSEM (version v1.2.14) is used for 
quantification of the expression values of the isoforms and genes with default settings [77]. Then 
we apply rSeqNP and EBSeq [40] to test for differential expression and splicing. For rSeqNP, FDR 
≤ 0.05 is used as the cut-off of calling a gene or isoform showing DE (here we use FDR as the 
criterion instead of p-value since we need to use the same metric for comparisons between rSeqNP 
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and EBSeq. See below); for EBSeq, posterior probability of being differentially expressed (PPDE) 
≥ 0.95 is used as the cut-off of calling a gene or isoform showing DE. PPDE is the metric reported 
by EBSeq and PPDE ≥ 0.95 corresponds to controlling FDR at 5% [40]. Specifically, we calculate 
the false discovery proportion (FDP), type I error rate and power for each testing method as 
Number of genes/isoforms from the No DE group detected as DE by the tests
Number of  genes/isoforms detected by the t
FDP
ests
  
Number of genes/isoforms from the No DE group detected as DE by the tests
type I error rate
Number of  genes/isoforms from the No DE group 

Number of genes/isoforms from the DE group detected as DE by the tests
power
Number of  genes/isoforms from the DE group 
 . 
The results are shown in Table 3.5. We also draw the ROC curves and calculate the area under 
the curve (AUC) statistics for each testing method based on the knowledge of the true differential 
status of each gene (isoform), which are shown in Figure 3.1 and Table 3.5, respectively. 
   The results show the FDPs and type I error rates are controlled at 5% in general, though some 
FDPs from rSeqNP are slightly higher than 5%. As expected, the sensitivity (power) and specificity 
for each testing method decrease from high DE to low DE scenarios, and also decrease from low 
variance to high variance scenarios. When the level of DE is low, the permutation test based on 
the GDS has higher powers and AUCs than other testing methods. When the level of DE is high, 
performances of EBSeq and rSeqNP are similar. EBSeq has slightly higher powers and AUCs 
(Table 3.5 and Figure 3.1).  
39 
 
 
Figure 3.1 ROC curves of different testing methods in each scenario of the simulations. 
(A) Low DE, Low variance (B) Low DE, High variance (C) High DE, Low variance (D) High DE, 
High variance. EBSeq.Iso and EBSeq.Gene represent the tests for isoforms and genes in EBSeq 
package, respectively. rSeqNP.WRS.Iso and rSeqNP.WRS.Gene represent the Wilcoxon rank-sum 
tests for isoforms and genes in rSeqNP package, respectively. rSeqNP.GDS represents the 
permutation test based on the GDS in rSeqNP package.
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Table 3.5 FDP, type I error rate, power and AUC of different testing methods in each scenario 
in the simulations 
 
   Low variance High variance 
Test Methodsa FDP Type I Power AUC FDP Type I Power AUC 
 
 
 
Low DE 
 
EBSeq 
Gene.D
E 
0.5% 0.7% 81.0% 0.937 1.5% 0.8% 68.7% 0.919 
Iso.DEb 2.0% 
(1.4%) 
1.0% 
(0.5%) 
77.5% 
(55.4%) 
0.906 4.3% 
(3.2%) 
1.8% 
(1.0%) 
62.6% 
(43.7%) 
0.866 
 
rSeqNP 
Gene.D
E 
3.6% 2.8% 84.3% 0.946 4.2% 1.9% 69.1% 0.903 
Iso.DEb 5.3% 
(3.1%)        
2.3% 
(1.3%) 
82.4% 
(62.6%) 
0.892 6.1% 
(4.1%) 
2.5% 
(1.4%) 
65.1%   
(46.7%) 
0.857 
GDS 4.4% 1.9% 84.5% 0.964 5.9% 2.6% 70.9% 0.944 
 
 
 
High DE 
 
EBSeq 
Gene.D
E 
1.1% 0.6% 94.5% 0.992 0.9% 0.5% 87.7% 0.982 
Iso.DEb 3.6% 
(2.0%)     
2.0% 
(1.1%) 
94.1% 
(85.2%) 
0.967 3.5% 
(2.1%) 
1.9% 
(1.2%) 
87.7% 
(81.0%) 
0.960 
 
rSeqNP 
Gene.D
E 
6.5% 3.9% 93.9% 0.966 4.2% 2.3% 87.5% 0.954 
Iso.DEb 6.4% 
(3.9%) 
3.8% 
(2.3%) 
93.4% 
(85.8%) 
0.949 5.6% 
(3.4%) 
3.1% 
(1.9%) 
87.1% 
(80.7%) 
0.940 
GDS 6.7% 4.3% 93.9% 0.963 5.8% 3.2% 87.4% 0.949 
 
a. For EBSeq, Gene.DE and Iso.DE represent the tests for genes and isoforms, respectively. For 
rSeqNP, Gene.DE and Iso.DE represent the Wilcoxon rank-sum tests for genes and isoforms, 
respectively, and GDS represents the permutation test based on GDS. 
b. % of genes (% of isoforms).
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3.4 Application to a prostate cancer RNA-Seq dataset 
   Here we apply rSeqNP to a real RNA-Seq dataset and compare it with EBSeq [40] and Cuffdiff 
[37], which are two existing approaches for detecting differential expression of genes and isoforms 
from RNA-Seq data. The dataset was generated from paired-end RNA-Seq experiments performed 
on prostate cancer samples and matched benign samples from 14 Chinese prostate cancer patients 
[86] and the raw sequence files in FSATQ format can be downloaded from the ArrayExpress 
database of the European Bioinformatics Institute with the accession number E-MTAB-567.  
   We use the RefSeq annotated genes and isoforms for the analysis, which has 24900 genes and 
45713 isoforms in total. For RSEM version 1.2.14 [77] - EBSeq version 1.5.3 [40] and Cuffdiff 
version 2.1.1 [37], we follow their user manuals and use the default parameters (RSEM-EBSeq, 
see: http://deweylab.biostat.wisc.edu/rsem/README.html; Cuffdiff, see: 
http://cufflinks.cbcb.umd.edu/manual.html). For our rSeq - rSeqNP pipeline, the script that we 
used is provided as a testing example in the user manual of rSeqNP (http://www-
personal.umich.edu/~jianghui/rseqnp/). We note that both EBSeq and Cuffdiff remove genes with 
very low expression levels from the analysis, therefore we also filter out genes with average 
expression levels less than 0.5 RPKM in rSeqNP, which yields 14791 genes and 23197 isoforms 
in the analysis. Users can set different criteria to filter out lowly expressed genes when using 
rSeqNP. Since neither EBSeq nor Cuffdiff can handle paired two-group comparison, we run all 
three programs on the dataset under the setting of unpaired two-group comparison, i.e. treat cancer 
and benign samples as two distinct groups, as well as run rSeqNP under the setting of paired two-
group comparison. For preprocessing, we use the programs suggested by each of the three 
approaches to quantify expression values for all the genes and isoforms: RSEM [77] for EBSeq, 
rSeq [9] for rSeqNP and the integrated quantification program for Cuffdiff. We compare the 
quantification results of isoform expression from rSeq, RSEM and Cuffdiff, which is shown in 
Figure B.2. The result shows that the three programs provide very consistent and similar results 
for quantification. 
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Figure 3.2 Comparison of quantification results of isoform expression by rSeq, RSEM and 
Cuffdiff. 
(A) RSEM v.s. rSeq (B) Cuffdiff v.s. rSeq. The log2 transformed estimated isoform expression 
levels in the benign tissue sample from Patient #1 are plotted. A small value (0.1) is added to the 
isoform expression values before taking logarithm. r: Pearson’s correlation coefficient; ρ: 
Spearman’s correlation coefficient. 
 
   The numbers of differentially expressed and spliced genes identified by each program is   shown 
in Table 3.6. We use FDR≤0.05 for rSeqNP and Cuffdiff, and posterior probability of being 
differentially expressed (PPDE)≥0.95 for EBSeq to call a differential event. PPDE is the metric 
reported by EBSeq and PPDE≥0.95 corresponds to controlling FDR at 5%. As expected, when 
treating the data as two distinct groups, rSeqNP detects fewer differentially expressed genes and 
isoforms, but by applying the GDS, more differentially expressed or spliced genes are detected. 
Furthermore, when accounting for the paired two group nature of the data, rSeqNP detects even 
more differential events. We find that Cuffdiff detects a much smaller number of differentially 
expressed or spliced genes, which is consistent with report from another study [87]. 
   We also compare the performance of the permutation test based on the GDS with Wilcoxon rank-
sum test and Wilcoxon signed-rank test, which is shown in Figure 3.3. When treating the data as 
unpaired two-group comparison, Wilcoxon rank-sum test identifies 3707 genes as either 
differentially expressed or differentially spliced (the union of the 3346 genes and 2792 genes in 
Table 3.6), which has a large proportion of overlap with those differential genes (4122) identified 
by the permutation test based on the GDS (Figure 3.3A). The result is similar for treating the data 
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as paired two-group comparison (5150 differential genes identified by Wilcoxon signed-rank test, 
which is the union of the 4544 genes and 4163 genes in Table 3.6, and 6050 differential genes 
identified by the permutation test based on the GDS. Figure 3.3B). But the permutation test based 
on GDS can also identify many distinct differential genes that Wilcoxon rank-sum test and 
Wilcoxon signed-rank test fail to detect, and two of such examples are given in Figure 3.4. 
  Figure 3.4 shows two individual genes to demonstrate the strength of the paired two-group 
comparison over the unpaired two-group comparison (Figure 3.4A) and the strength of the 
permutation test based on the GDS (Figure 3.4B). In Figure 3.4A, the ABDH8 gene has only one 
isoform (NM_024527), which is down-regulated in the tumor samples of all the 14 patients. The 
test results for this gene are: paired two-group Wilcoxon signed-rank test: p-value=1.22e-4, 
FDR=4.50e-3; paired two-group permutation test based on the GDS: p-value=6.79e-5, 
FDR=6.40e-4; unpaired two-group Wilcoxon rank-sum test: p-value=0.035, FDR=0.149; unpaired 
two-group test by EBSeq: PPDE=0.917 (FDR=0.083). The test based on paired two-group 
comparison can successfully capture this differential event. 
In Figure 3.4B, the PKN1 gene is identified as differential by the paired two-group permutation 
test based on the GDS (p-value=0.0392, FDR=0.0463) but not by the Wilcoxon signed-rank test 
(results for the Wilcoxon signed-rank test are: test of DE for the gene: p-value=0.583, FDR=0.706; 
test for Isoform NM_002741: p-value=0.676, FDR=0.180; test for Isoform NM_213560: p-
value=0.153, FDR=0.312). We can see that NM_002741 is down-regulated in tumor samples in 9 
out of the 14 patients, while NM_213560 is up-regulated in tumor samples in 10 out of the 14 
patients. Interestingly, the expression levels of the two isoforms show reverse directions in 9 
patients (i.e. one is down-regulated in tumor samples while the other is up-regulated in tumor 
samples). This gene might be of interest to follow up in the down-stream experiments by biologists. 
The strength of the permutation test based on the GDS is that it can capture the differential genes 
showing this type of patterns. 
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Table 3.6 Numbers of genes identified by different programs from the prostate cancer RNA-
Seq dataset 
 
 
rSeqNP   
(unpaired) 
rSeqNP 
(paired) 
EBSeq 
(unpaired) 
Cuffdiff 
(unpaired) 
Gene.DE 3346 4544 2514 14 
Isoform.DEa 
2792     
(2933) 
4163 
(4453) 
3279 
(4323) 
26 
(31) 
GDS 4122 6050 - - 
 
a. Number of genes (Number of isoforms) that are detected. 
 
 
 
Figure 3.3 Comparison of the permutation test based on the GDS with Wilcoxon rank-sum 
test (WRS) and Wilcoxon signed-rank test (WSR).  
(A) Treating the data as unpaired two-group comparison: compare the genes identified by the 
permutation test based on the GDS and by WRS. (B) Treating the data as paired two-group 
comparison: compare the genes identified by the permutation test based on the GDS and by WSR. 
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Figure 3.4 Two individual gene examples to demonstrate the strength of the paired two-group 
comparison and the permutation test based on the GDS.  
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(A) The ABHD8 gene showing the strength of the paired two-group comparison over the unpaired 
two-group comparison. (B) The PKN1 gene showing the strength of the permutation test based on 
the GDS over the Wilcoxon signed-rank test. In the bar plot, the difference of isoform expression 
levels between tumor and matched normal tissue samples are plotted for each patient. The tables 
below the plots show the estimated expression values (in RPKM unit) by rSeq for tumor (T) and 
matched normal (N) tissue samples for each patient. 
 
   Finally, we check the robustness of our non-parametric approach. We run rSeqNP without 
filtering out genes with low expression levels (i.e. using the expression values of all 24900 genes 
and 45714 isoforms as input data) and compare the results with those after filtering the noisy genes 
(see Table 3.6), which are shown in Table 3.7. We can see that the non-parametric approach is 
generally robust to noisy genes, with only several hundreds of genes affected. 
 
Table 3.7 Number of differential genes identified by rSeqNP without filtering noisy genes in 
the prostate cancer RNA-Seq dataset. 
 unpaired overlapa  paired overlapb 
Gene.DE 3209 2863  4429 4018 
Isoform.DEc 2409(2505) 2229(2317)  3516(3694) 3370(3124) 
GDS 3480 3045  5555 5457 
a. This compares the overlap with Column 1 in Table 3.6. 
b. This compares the overlap with Column 2 in Table 3.6. 
c. Number of genes (Number of isoforms) that are detected. 
3.5 Conclusion 
We present rSeqNP, a non-parametric approach for detecting differentially expressed and 
spliced genes from RNA-Seq data. It is flexible in handling various types of experimental designs. 
It is worth mentioning that, as pointed out by the reviewer, our method relies on expression 
estimates for genes and isoforms reported from upstream programs, which are typically based on 
parametric approaches. The major limitation of rSeqNP is that its power is relatively low for small 
sample size RNA-Seq data. In simulation studies, we show that the power is decent with five or 
more samples in each group for two-group comparison. If the sample size is even smaller, 
parametric approaches would be preferred. 
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CHAPTER IV 
A Two-part Mixed Model for Differential Expression Analysis in Single-cell High-
throughput Gene Expression Data
 
 
   The gene expression data generated from more recent single-cell RNA-Seq and parallel single-
cell qRT-PCR technologies enable biologists to study the function of transcriptome at the level of 
individual cells. Compared with regular RNA-Seq and qRT-PCR, single-cell gene expression data 
show notable distinct features, including excessive zero expression values, high variability and 
clustered design. In this chapter, we propose to model single-cell gene expression data using a two-
part mixed model. This model not only adequately accounts for the above features of single-cell 
expression data, but also provides the flexibility of adjusting for covariates. An efficient 
computational algorithm, automatic differentiation, is used for estimating the model parameters. 
Compared with existing methods, our approach shows improved power for detecting differential 
expressed genes in single-cell gene expression data. 
4.1 Introduction 
Recently, single-cell high-throughput gene expression profiling technologies, including single-
cell RNA-Seq (scRNA-Seq) and parallel single-cell qRT-PCR (scRT-PCR) have enabled 
researchers to examine mRNA expression at the resolution of individual cells, which provide 
further biological insights of the transcriptomes and functional genomics [43,88-90]. Compared to 
regular RNA-Seq and qRT-PCR experiments that performed on tissues (i.e. cell populations) and 
homogenous cell lines, single-cell gene expression data have the following distinct features as 
demonstrated in recent literature [43,91,92]: 
Excessive zero expression values. The proportions of genes with observed zero expression 
values in single-cell gene expression data are much larger than regular RNA-Seq or qRT-PCR data 
[43,91,92]. The reasons for this phenomena can be either biological, such that the abundance of 
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mRNA levels of certain transcripts are essentially low in individual cells, or can be technical, such 
that the extracted total amount of mRNA is low in an single cell sample [43,92]. 
High variability of expression levels across samples. It has been observed that scRNA-Seq or 
scRT-PCR data tend to show higher variability than bulk RNA-Seq or qRT-PCR data [43,92]. This 
can be explained by the differences of the designs between the two: the regular bulk RNA-Seq or 
qRT-PCR experiments are performed on the cell populations and the gene expression levels from 
those experiments are averaged across all individual cells in the population, which dilutes the 
variability of gene expression levels among individual cells [92]. 
Clustering of single-cell samples within subjects. Another notable feature of single-cell high-
throughput gene expression data is that each individual single-cell samples are randomly sampled 
from a higher-level of cluster unit (e.g. patients, animals) [44,88,89]. Therefore, the single-cell 
samples from the same subject are expected to be more homogeneous than those from different 
subjects, which has been shown in several single-cell RNA-Seq data published recently [44,88,89]. 
From a statistical point of view, this feature is called cluster effect, which should be adequately 
adjusted for in the analysis. 
   Based on the above discussions, we propose to model single-cell gene expression data using a 
two-part mixed model. This model not only adequately accounts for the above features of single-
cell expression data, but also provides the flexibility of adjusting for covariates. The rest of this 
chapter is organized as follows: First we describe the formulation of the two-part mixed model 
with a brief literature review. Then we use an efficient method, named automatic differentiation, 
to fit the model. We also discuss how to test for differential expression under this model and 
describe several methods for approximating the null distribution of the test statistics for small 
sample sizes, followed by simulations for studying the type I error rate and statistical power. 
Finally, we demonstrate our approach by applying it to two real datasets: one from scRT-PCR and 
one from scRNA-Seq. 
4.2 Methods 
4.2.1 The two-part mixed model for single-cell gene expression data 
   We first introduce the notations in this section. Assume there are m subjects and N genes in a 
scRNA-Seq experiment, and ni single cell samples extracted and sequenced for subject i (i = 1,…, 
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m). Let yijk be the normalized expression value (in the unit of RPKM/FPKM, TPM or CPM) for 
gene k (k = 1,…, N) in single-cell sample j (j = 1,…, ni) in subject i, then we model the gene 
expression value yijk using the following two-part mixed model: 
logit[Pr( 0)] log( ) ,
1
log( | 0) ,
ijk T
ijk jk k ik
ijk
T
ijk ijk jk k ik ijk
y u
y c y v e


   

    
w α
x β
                          (4.1) 
where πijk is the proportion of single cell samples with zero expression values for gene k (named 
as “zero-proportion” hereafter). In this two-part model, the zero-proportions are modelled by a 
logistic regression model (logistic or binomial part), and the log transformed non-zero 
expression values are modeled by a linear regression model (Gaussian part), where T
jk
w  and T
jk
x  
are the vectors of covariates for the binomial and Gaussian parts respectively (for example, if 
there are only two biological conditions and no other covariates to be adjusted, T
jk
w  and T
jk
x  are 
simply the vectors of 1/0 indicators for the biological conditions), 
k
α  and 
k
β  are the 
corresponding vectors of regression coefficients for the covariates T
jk
w   and T
jk
x  , eijk is the 
random error that is assumed to be distributed as 2(0,  )eN  , uik and vik are the random effects 
for subject i that account for the cluster effect which are assumed to follow the bivariate normal 
distribution 
2
2
~ ( ,  )
ik u u v
ik u v v
u
N
v
  
  
  
  
   
0  
with 2
u
  and 2
v
  as the variances for the marginal univariate normal distributions of uik and vik, 
and ρ as the correlation between them. We note that most scRNA-Seq experiments contain only 
one-level of clusters (i.e. single cells are sampled from subjects). If the study design is more 
complicated such that it may contain multi-level cluster effects, then more variance components 
for the random effects can be added in the model. Finally, a small constant c is added to the non-
zero expression levels before taking logarithms to avoid the left skewness caused by taking 
logarithms on small expression values between 0 and 1, which is often seen in RNA-Seq data. 
In the following analysis of scRNA-Seq data, c is set as 1. 
   In scRT-PCR experiment, the gene expression levels are usually measured by the expression 
threshold (et) values, which is defined as 
max
et c ct  , where cmax is the maximum number of 
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amplification cycles used in the scRT-PCR experiment and ct is the threshold cycle that the gene 
is detected by the PCR instrument [91]. The gene expression level yijk is assumed to have an 
exponential relationship with et, such that 2e
ijk
ty    (for undetected genes, et is shown as 
missing values from the PCR machine and can be treated as -∞, which gives zero expression 
values) [91]. Therefore (4.1) can also be used to model gene expression values in scRT-PCR 
data, and the definitions of the parameters are exactly the same as those in scRNA-Seq data. 
The only difference is that adding the small constant c is not necessary for scRT-PCR, as the 
non-zero gene expression levels in scRT-PCR experiments do not have many small values 
between 0 and 1 like those in scRNA-Seq data. 
   Remark on related literature: The two-part model including the binomial part and Gaussian 
part without random effects is first proposed by Duan et al for modeling the medical care data 
[93,94], where the dependent variable (medical care expenses) takes the range of any 
nonnegative value, but has a positive probability at zero (this type of data are also called 
semicontinuous data) [93-95]. Olsen et al extend the two-part model for longitudinal or 
clustered semicontinuous data by incorporating random effects for both the binomial part and 
the Gaussian part [96]. A comprehensive survey for a variety of models with applications for 
data taking non-negative values with a substantial proportion of zero values is given in [95]. 
Our two-part mixed model (named TMM hereafter) essentially follows the model formulation 
in [95,96], except the addition of a small constant c to the non-zero expression values in RNA-
Seq data [model (4.1)]. A similar, yet different two-part model without random effects is 
proposed to model the single-cell RNA-Seq data in a recent paper (named MAST hereafter) [45]. 
Instead of incorporating clustered random effects from subjects, MAST uses an empirical Bayes 
method to shrink the gene-specific variance to the global variance of all genes [45]. 
4.2.2 Model fitting for TMM 
   Since the TMM model (4.1) is fitted for each gene independently, we will drop the subscript 
k for simplicity if there is no ambiguity within the context. Following [96], the fixed-effect 
parameters of the TMM model, 
k
α and 
k
β  are estimated by maximizing the following marginal 
likelihood function of the model 
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where 
iB
L  is the conditional distribution (likelihood) of yijk given the random effect ui from the 
binomial (logistic) part 
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with ϕ(•) as the standard normal PDF [for scRT-PCR data, log(yij+1) becomes log(yij)], and 
( , )i ip u v  is the joint distribution of the random effects ui and vi. Throughout this chapter, we 
only fit the model with independent random effects ui and vi for computation efficiency, but 
note that the model with correlated random effects as discussed in Section 4.2.1 can also be 
fitted. Under the assumption that ui and vi are independently distributed as 
2(0, )
u
N    and 
2(0, )
v
N   , their joint distribution can be written as the product of two univariate normal 
distributions 
1 1( , ) [ ( )][ ( )]i ii i u v
u v
u v
p u v    
 
   
   As discussed in [96] and [95], maximizing the marginal likelihood function (4.2) involves 
numerical or stochastic approximation of the integrals, followed by maximization of the 
approximated likelihood. Several computational methods, including the Markov chain Monte 
Carlo, the expectation-maximization (EM) algorithm, the penalized quasi-likelihood (PQL) 
method, Gauss-Hermite quadrature and Laplace approximations are reviewed and discussed in 
details in [96]. Here, we use an efficient computational method, called automatic differentiation, 
to maximize the likelihood function (4.2). The automatic differentiation technique is 
implemented in the software package automatic differentiation model builder (ADMB, version 
11.4) [97,98]. Given the likelihood function written in the form of (4.2), ADMB calculates the 
Hessian matrix of the marginal likelihood function using the automatic differentiation technique, 
and the maximization of the marginal likelihood function is performed by first approximating 
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the integrals using Laplace approximations and then maximizing the approximated likelihood 
using the quasi-Newton algorithm. Descriptions of the automatic differentiation technique can 
be found in [97,98] and the details for implementation of the algorithm can be found in the 
manuals of ADMB, which are available at http://www.admb-project.org/docs/manuals. 
4.2.3 Testing for differential expression 
Testing for differential expression of genes across biological conditions under model (4.1) 
is done by testing for the fixed effects. More explicitly, (4.1) can be written as 
1 1 2 2
1 1 2 2
logit[Pr( 0)] log( ) ,
1
log( 1 | 0) ,
ij T T
ij j j i
ij
T T
ij ij j j i ij
y u
y y v e


    

     
w α w α
x β x β
                 (4.3) 
where 
1
T
j
w  and 
1
T
j
x  are the covariates of interest that we want to test for, and 
2
T
j
w  and 
2
T
j
x  are the 
covariates to be adjusted for in the model. Specifically, we are interested in testing for the 
following two effects across biological conditions: 1). Whether the zero-proportions are 
significantly different across conditions and 2). For genes with non-zero expression levels, 
whether the mean expression levels are significantly different across conditions. The two 
problems can be formulated as the following two corresponding hypothesis testing problems: 
1) Testing of the binomial part 
0 1 1 1
:  0 versus :  0
B B
H H α α  
2) Testing of the Gaussian part  
0 1 1 1
:  0 versus :  0
G G
H H β β  
and the two parts can also be tested jointly, which can improve the statistical power: 
3) Joint testing of the binomial and Gaussian parts 
0 1 1 1 1 1
:  0 and 0 versus :  0 or 0H H   α β α β  
  The individual test for the binomial part or the Gaussian part can be performed using the Wald 
test or the likelihood ratio test, and the joint test for the two parts can be performed using the 
likelihood ratio test. Under H0, the asymptotic distributions of the Wald statistic (W0) and the 
likelihood ratio statistic (L0) can be approximated by the χ2 distribution with the degrees of 
freedom equal to the differences in the numbers of parameters between H0 and H1, which is a 
widely used approach in practice [99,100]. However, for small sample sizes, the χ2 distributions 
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are not good approximations to the null distributions of the two test statistics, which, as noted 
in the literature [99,101] and as shown in simulations in Section 4.3, often show inflated type I 
error rate. Therefore, we use the following two methods for reliable estimation of p-values when 
the sample size is small: 
   The parametric bootstrap method: this approach estimates the null distribution of the test 
statistic by simulating data from the fitted model under H0, which is performed in the following 
way [101-104]: 
(1) Fit model (4.3) under H0 and generate N random samples 1,..., Ny y  from 0
ˆ
Hf . 
(2) Calculate the corresponding test statistics (i.e., Wald or likelihood ratio statistics) 
1
,( ) ), (
N
T Ty y  using the simulated samples 
1
,...,
N
y y . 
(3) Estimate the p-value as 
1
1
ˆ { ( ) }
N
l
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
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  y   (an alternative formula is 
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N

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
 y
. The two formulas give almost the same results providing N is large, so 
we use the former throughout this chapter). 
   The empirical Satterthwaite method: this method is proposed by Cai et al [105], and it is a 
general approach for approximating the null distribution of the test statistics [101,105-107]. 
Following [105,106], this method is performed in the following two steps: 
(1) Approximate the null distribution of test statistics (W0 or L0) by a scaled χ2 distribution 
2
vk  
with k as the scale parameter and v as the degrees of freedom. The parameters k and v can be 
estimated by matching the first two moments (sample mean and variance) of test statistics under 
H0 with those of 
2
vk [105,106]. The sample mean and variance of test statistics under H0 can 
be obtained using permutations or the above parametric bootstrap method with a smaller number 
of random samples.  
(2) Fit a two component normal mixture distribution 2 2
1 1 1 2 2 2( , ) ( , )N N       on 2
1 ( )( )
v
b
k
p

 , 
where 2
( )
v
b
k
p

 is the p-value obtained from the above scaled χ2 distribution 2
vk  for the bth 
permutated or bootstrapped random sample and Φ(•) is the standard normal CDF. The final p-
values are calculated as  
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where 2
vk
p

 is the p-value obtained from Step (1) and Ψ is the fitted normal mixture distribution 
2 2
1 1 1 2 2 2
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   The Satterthwaite method can estimate p-values using a smaller number of random samples 
than the parametric bootstrap method [105,106]. However, in our simulations it also shows 
inflated type I error rate when the sample size is small (see simulations in the next section).  
4.3 Simulation studies 
4.3.1 Evaluation of type I error rates 
   In this section, we evaluate type I error rates of the three methods for approximating the null 
distribution of the test statistics under H0: the χ2 distribution, the Satterthwaite method and the 
parametric bootstrap method. The simulations are performed based on the following settings: 
Assuming two biological conditions, each has m/2 subjects, and for each subject i there are ni 
single cell samples. To evaluate type I error rates, we simulate gene expression levels yijk from the 
following model under H0 (i.e. there is no difference between the two conditions): 
1
1
logit[Pr( 0)] log( ) ,
1
log( 1 | 0) ,
ijk
ijk i
ijk
ijk ijk i ij
y u
y y v e




   

    
 
with 2~ (0, )
i u
u N  , 2~ (0, )
i v
v N   and 2~ (0, )
ij e
e N   
   In this model, there is only one intercept for the fixed effect in both the binomial and Gaussian 
parts, therefore no differences in terms of zero-proportions and mean expression levels are 
expected between the two conditions. The values of the parameters are set as follows: 0.5
u
  , 
1
v
  , 0.5
e
  , 2
1
~ (0.5,0.25 )N , 2
1
~ (3,0.5 )N , ni = 20 for all i’s (i = 1,…, m). We tune the 
sample sizes by varying m for three different values 4, 10 and 20 respectively, which correspond 
to small, moderate and large sample sizes. The simulations are repeated 1,000 times for different 
m’s. For each run, we calculate the following five test statistics: Wald statistic for the Gaussian 
part; Wald statistic for the binomial part; Likelihood ratio statistic for the Gaussian part; Likelihood 
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ratio statistic for the binomial part; Likelihood ratio statistic for jointly testing the Gaussian and 
binomial parts. Then we calculate the p-values from each test using the three methods as described 
in section 4.2.3. 
   If the type I error rate is correctly controlled, the p-values from the 1000 repetitions for each m 
should be uniformly distributed within 0 to 1, so we examine each method using the quantile-
quantile plots of the p-values from the simulations (observed p-values) and the quantiles of 
uniform [0, 1] distribution (expected p-values), which are shown in Figures 4.1 to 4.5. As seen in 
these plots, all the three methods give well-controlled type I error rates for large samples sizes (m 
= 20). However, for small sample sizes (m = 10 or m = 4) the performance of controlling type I 
error rate of the three methods are ranked as (from the best to the worst): parametric bootstrap, 
Satterthwaite, the χ2 distribution. And the inflation of type I error rate is more severe for the χ2 
distribution with the test for the binomial part (Figure 4.2 and 4.4) or the joint test for the two parts 
(Figure 4.5). On the other hand, the parametric bootstrap takes the longest computational time, 
which can be overwhelming if we want to accurately estimate small p-values. As a general rule, if 
the sample size is large, then the χ2 distribution can be used. If the sample size is small, then the 
parametric bootstrap method should be preferred, with the cost of longer computational time. The 
Satterthwaite method can be considered as an alternative method for moderate sample size.  
56 
 
 
Figure 4.1 Plots of the observed versus the expected p-values for the Wald test for the 
Gaussian part under H0: no significant difference between the two conditions.  
The p-values are plotted on -log10 scale. The gray areas represent the 95% confidence interval 
bands of the expected p-values under H0. 
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Figure 4.2 Plots of the observed versus the expected p-values for the Wald test for the 
binomial part under H0: no significant difference between the two conditions.  
The p-values are plotted on -log10 scale. The gray areas represent the 95% confidence interval 
bands of the expected p-values under H0. 
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Figure 4.3 Plots of the observed versus the expected p-values for the likelihood ratio test for 
the Gaussian part under H0: no significant difference between the two conditions.  
The p-values are plotted on -log10 scale. The gray areas represent the 95% confidence interval 
bands of the expected p-values under H0. 
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Figure 4.4 Plots of the observed versus the expected p-values for the likelihood ratio test for 
the binomial part under H0: no significant difference between the two conditions.  
The p-values are plotted on -log10 scale. The gray areas represent the 95% confidence interval 
bands of the expected p-values under H0. 
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Figure 4.5 Plots of the observed versus the expected p-values for jointly testing the Gaussian 
and binomial parts under H0: no significant difference between the two conditions.  
The p-values are plotted on -log10 scale. The gray areas represent the 95% confidence interval 
bands of the expected p-values under H0. 
4.3.2 Evaluation of statistical power 
   In this section, we evaluate the statistical power of the TMM model, and compare it with a 
published method MAST [45], and the two-part model with binomial and Gaussian parts but 
without random effects (named TM hereafter). The simulations are performed based on the 
following settings: suppose there are two biological conditions, and each condition has m/2 
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subjects, and for each subject i there are ni single cell samples sequenced. To evaluate the power, 
we simulate the gene expression levels yijk from the following model under H1: 
1 2
1 2
logit[Pr( 0)] log( ) ,
1
log( 1 | 0) ,
ijk
ijk i
ijk
ijk ijk i ij
y w u
y y x v e

 
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 
    

     
 
with 2~ (0, )
i u
u N  , 2~ (0, )
i v
v N   and 2~ (0, )
ijk e
e N  . In this model, w and x are 0/1 indicators of 
the conditions, and the effect sizes are represented by the parameters 
2
  and 
2
 , which correspond 
to the log odds of zero proportions and log fold change of the mean expression values for non-zero 
genes between the two conditions. The values of the parameters are set as follows: m = 10, ni = 20 
for all i’s (i = 1,…, m), 0.5
u
  , 1
v
  , 0.5
e
  , 2
1
~ (0.25,0.25 )N , 2
1
~ (3,0.5 )N . We then 
tune the effect sizes by varying (
2
 ,
2
 ) for the following values: (0, 0), (0.25, 0.25), (0.5, 0.5),…, 
(1.5, 1.5). The simulations are repeated 1000 times for each different pairs of (
2
 ,
2
 )’s. In each 
run, we apply our model TMM with the three methods for calculating p-values (the χ2 distribution, 
the Satterthwaite and parametric bootstrap), MAST and TM respectively. The estimated power for 
each method is calculated as the proportion of p-values less than 0.05 among the 1000 repetitions. 
   Figure 4.6 is the plots of power curves for each model with different effect sizes. As expected, 
the power of each method increases with effect size. The power of TMM is consistently higher 
than the other two models, which is also expected, since we include random effects in this 
simulation setting.
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Figure 4.6 Comparisons of statistical powers of different methods.  
(A) Tests for the Gaussian part. (B) Tests for the binomial part. (C) Joint tests for the Gaussian and binomial parts. TMM: two-part 
mixed model. “Chi-square”, “Satterthwaite” and “bootstrap”: the χ2 distribution, the Satterthwaite method and parametric bootstrap 
method as described in Section 4.2.3. TM: the two-part model without random effects. The horizontal red dashed line represents the 
level of the test, which is α = 0.05.
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4.4 Application to real single cell gene expression data 
   In this section, we demonstrate our approach with application to two real single cell gene 
expression datasets: one scRT-PCR dataset and one scRNA-Seq dataset. 
4.4.1 Application to a scRT-PCR dataset 
   Here we apply the TMM model to a scRT-PCR dataset and compare the results with MAST. 
This dataset is described in [108] and is incorporated with the MAST package [45], where 456 
single cell samples of T cells from two patients with human immunodeficiency virus (HIV) are 
isolated and the expression levels of 75 genes related to the immune system function are measure 
by scRT-PCR. The activation of two immune-response proteins, T-cell receptor Vβ (TCR-Vβ) and 
CD154, are used to categorized those T cells, and the 456 single cells are divided by the following 
four different groups: TCR-Vβ+/CD154+, TCR-Vβ+/CD154-, TCR-Vβ-/CD154+ and TCR-Vβ-
/CD154-, where the TCR-Vβ+/CD154+ group is the activated T cells with normal immune 
functions [108]. The goal of the analysis is to identify differentially expressed genes across the 
above four groups. 
   We fit MAST and our TMM model to this dataset. Specifically, the covariates included in MAST 
are 
X1: a categorical variable indicating which of the above four groups the sample belongs to, where 
the TCR-Vβ+/CD154+ is coded as the reference group. This variable is the one of our interest. 
X2: a categorical variable indicating which of the two subjects that the sample is from. 
For our TMM model, X1 is included as fixed effect in both the binomial part and the Gaussian part. 
The two subjects are treated as two clusters, which are included as random effects in TMM. Since 
the number of single cell samples is large in this scRT-PCR study, the χ2 distribution is used to 
calculate p-values, and the likelihood ratio test is used to test the individual Gaussian part and 
binomial part and also to jointly test the two parts. 
   The results from MAST and TMM for the 75 genes are shown in Table 4.1, and Figure 4.7 is a 
graphical comparison of the p-values from the two methods. We can see that the results from the 
64 
 
two methods agree with each other in general, though some genes show different p-values from 
the tests for the zero-proportions (binomial part) (Figure 7). This is expected as there are only two 
clusters in this dataset, and the clustered random effects do not play a significant role in this 
example. In fact, there should be a reasonable number of mixed levels to be included in a mixed 
effect model to make it useful in practice [99]. Therefore, MAST should be preferred for this 
dataset than TMM, and the application of TMM here is for the purpose of demonstration. On the 
other hand, these results show that TMM is not essentially worse than MAST even the clustered 
random effects are not significant.
65 
 
 
Figure 4.7 Comparisons of the p-values from TMM and MAST for the scRT-PCR dataset. 
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The -log 10 of the p-values from both method are plotted. (B), (D) and (F) are respectively the zoom-in 
parts of (A), (C) and (E) on the range of 0 to 10.
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4.4.2 Application to a scRNA-Seq dataset 
   In this section, we apply the TMM model to a scRNA-Seq dataset and compare it with MAST 
and TM. This dataset is published in [44], which contains 466 single cell samples from the human 
brain tissues of 8 adults (aged from 21 to 63 years) and 4 fetuses (all aged 16 to 18 weeks), and 
the expression levels of 22,088 genes in these samples are measured by scRNA-Seq [44]. The 
dataset is available in NCBI Gene Expression Omnibus under accession number GSE67835. 
 The goal of our analysis is to identify differentially expressed genes between the adult and fetal 
brains. We fit TMM with the following two covariates as fixed effects: 
X1: a 0/1 indicator of biological conditions (adult versus fetus), which is the variable of interest. 
X2: the gender of the subjects: male and female for adults. The gender of fetus is coded as a third 
category, “undeveloped”. 
and the twelve subjects are treated as clusters, which are included as random effects in the model. 
Since the number of single cell samples is also large in this study, the p-values are estimated in the 
same way as in the scRT-PCR dataset above. We also fit the MAST and TM models, where X1 
and X2 are included as covariates in these two models. Multiple comparison adjustment is 
performed using the Benjamini–Hochberg FDR procedure [109]. 
   Figure 4.8 shows the number of differentially expressed genes identified by each method with 
FDR<0.01, and Table 4.2 shows the p-values and FDR for the top 20 differentially expressed genes 
(ranked by the p-values from the joint test for both the Gaussian and binomial parts under the 
TMM model). We can see the results from the three models show considerable overlaps (Figure 
4.8), and the top differentially expressed genes all show very significant p-values and FDR from 
all methods. Notably, the total number of differentially expressed genes detected by TMM with 
FDR<0.01 is much larger than the other two methods. 
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Figure 4.8 Number of differentially expressed genes identified by each method with 
FDR<0.01.  
(A) Gaussian part. (B) Binomial part. (C) Joint test for the Gaussian and binomial parts. 
4.5 Discussion 
   In summary, we present a two-part mixed model (TMM) for differential expression analysis with 
single cell gene expression data. This model not only adequately accounts for the distinct features 
of single cell expression data, including extra zero expression values, high variability and clustered 
design, but also provides the flexibility of adjusting for covariates. Since scRNA-Seq is still a 
developing and growing technology, it brings more challenges in data analysis than regular RNA-
Seq. These challenges can be technical (for e.g., the number of samples in scRNA-Seq is large and 
the sequencing experiments are performed in different batches [46], and also can be biological (for 
e.g., the distinct features of the single cell expression data, as discussed in Section 4.1). Several 
more recent studies show that several confounding factors often present in scRNA-Seq 
experiments that can lead to biased results. These factors can also be categorized as technical 
factors that are related to the design of experiments such as batch effects [46], or biological factors 
such as the detection rate of genes [45,46], gene lengths and GC percent[46]. These confounding 
factor can be adjusted in TMM, however planning a good study design for scRNA-Seq 
experiments to reduce the confounding factors is a more fundamental task [46]. 
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Table 4.1 Results of the gene differential expression analysis for the HIV scRT-PCR dataset. 
 
Gene Name 
MAST TMM 
Gaussian Binomial Combine Gaussian Binomial Combine 
CD40LG 2.33E-46 9.87E-18 2.82E-61 3.73E-48 3.53E-17 1.72E-62 
GAPDH 6.60E-27 8.44E-10 4.04E-34 1.78E-27 2.30E-10 2.82E-35 
TNF 1.60E-03 7.70E-22 1.13E-22 3.48E-03 1.89E-22 7.94E-23 
TGFB1 6.08E-18 2.73E-04 9.61E-20 1.75E-16 4.31E-04 5.01E-18 
IL2 1.46E-03 4.53E-18 3.06E-19 2.39E-03 3.90E-18 2.05E-19 
IL16 2.21E-01 9.21E-18 2.93E-16 4.90E-02 4.74E-18 2.42E-17 
IL2Rg 6.80E-08 1.97E-10 3.72E-16 3.11E-09 2.08E-11 2.06E-18 
CXCR4 7.89E-04 3.94E-14 1.33E-15 5.20E-04 1.71E-14 3.51E-16 
CCR7 3.60E-01 8.61E-17 4.88E-15 4.20E-01 8.38E-17 3.54E-15 
CD3d 3.69E-06 1.67E-10 1.65E-14 7.22E-07 2.33E-10 3.61E-15 
IL2Ra 9.09E-03 5.14E-13 2.08E-13 1.18E-03 1.09E-12 6.11E-14 
CD69 7.99E-06 2.06E-09 4.00E-13 3.34E-06 1.89E-09 1.80E-13 
IL10 1.75E-01 3.88E-14 5.74E-13 3.25E-02 5.85E-14 1.44E-13 
FASLG 6.47E-02 1.60E-12 3.73E-12 3.06E-02 1.33E-12 3.32E-12 
IL7R 1.23E-06 2.18E-06 5.23E-11 9.05E-08 1.68E-06 4.57E-12 
IL6ST 1.13E-03 4.49E-09 1.21E-10 1.14E-04 4.45E-08 1.12E-10 
SLAMF1 3.45E-02 4.78E-10 5.56E-10 1.05E-02 2.95E-10 9.47E-11 
IFNg 2.66E-05 1.47E-06 7.06E-10 2.39E-05 1.85E-06 5.83E-10 
CD109 8.97E-01 8.36E-10 8.06E-09 7.76E-01 7.10E-10 7.65E-09 
TNFRSF9 3.20E-01 2.38E-09 1.44E-08 2.13E-01 1.45E-09 8.35E-09 
DPP4 2.96E-01 1.35E-09 1.91E-08 4.66E-02 2.03E-08 2.38E-08 
ICOS 2.41E-05 6.80E-05 2.53E-08 8.93E-05 5.14E-04 4.77E-07 
CD28 2.14E-01 3.34E-07 1.88E-06 3.67E-01 1.17E-06 9.26E-06 
CD4 1.06E-01 1.47E-05 2.46E-05 1.04E-01 3.88E-05 6.66E-05 
CD27 1.94E-01 2.86E-05 8.73E-05 1.01E-01 5.68E-06 1.20E-05 
CD48 4.55E-01 1.69E-05 1.59E-04 3.52E-01 1.46E-06 2.14E-05 
SLAMF5 5.39E-02 3.28E-04 1.89E-04 3.34E-02 4.43E-04 1.14E-04 
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CTSD 3.11E-03 7.58E-03 2.14E-04 3.59E-04 8.01E-03 2.68E-05 
CD5 5.47E-01 3.30E-05 3.65E-04 3.80E-01 7.13E-06 4.89E-05 
TBX21 1.71E-01 1.97E-04 4.06E-04 1.17E-01 8.15E-05 1.10E-04 
CSF2 6.55E-01 2.46E-04 5.40E-04 1.00E+00 2.09E-04 5.13E-04 
CD3g 9.95E-01 1.17E-05 6.03E-04 8.13E-01 7.87E-07 3.11E-05 
TIA1 1.70E-02 1.29E-02 1.64E-03 9.89E-03 4.89E-03 3.84E-04 
CD45 2.94E-01 8.41E-04 2.56E-03 1.72E-01 2.48E-03 3.63E-03 
PECAM1 3.68E-02 1.21E-02 3.14E-03 7.98E-03 9.12E-03 5.55E-04 
NT5E 5.96E-01 2.21E-03 6.24E-03 3.77E-01 1.28E-03 3.82E-03 
LIF 7.70E-01 3.60E-03 1.17E-02 6.83E-01 1.00E+00 7.22E-01 
FOXP3 8.77E-03 2.03E-01 1.21E-02 3.65E-03 2.02E-01 6.33E-03 
TIMP1 2.18E-02 1.26E-01 1.62E-02 4.23E-02 7.55E-02 2.13E-02 
CTLA4 3.26E-01 8.50E-03 1.92E-02 4.15E-02 1.70E-02 5.31E-03 
FAS 7.88E-01 4.45E-03 3.49E-02 4.21E-01 4.76E-03 1.21E-02 
RORC 8.99E-01 1.13E-02 3.61E-02 9.52E-01 7.71E-03 2.06E-02 
CCR2 3.11E-02 2.07E-01 3.73E-02 1.42E-04 5.63E-01 9.61E-04 
BCL2 2.34E-01 3.77E-02 4.15E-02 1.56E-01 1.00E+00 1.51E-01 
PRDM1 1.36E-02 5.71E-01 5.18E-02 2.11E-03 7.40E-01 1.85E-02 
CCL3 1.48E-01 1.01E-01 6.68E-02 4.16E-01 1.00E+00 3.36E-01 
CCL2 8.07E-02 1.00E+00 8.07E-02 2.14E-01 1.00E+00 3.05E-01 
IL8 1.03E-01 2.06E-01 9.36E-02 4.31E-01 1.07E-01 1.67E-01 
CCL5 8.38E-02 2.80E-01 9.98E-02 3.18E-01 3.17E-01 2.20E-01 
TNFSF10 3.27E-01 1.49E-01 1.76E-01 3.88E-01 2.06E-02 5.12E-02 
CSF1 1.79E-01 4.38E-01 2.57E-01 1.23E-01 2.20E-01 9.77E-02 
CCR4 4.57E-01 1.79E-01 2.66E-01 4.10E-01 1.59E-01 1.48E-01 
HLADRA 1.61E-01 5.11E-01 2.73E-01 4.78E-01 1.21E-01 2.16E-01 
BAX 9.26E-01 5.98E-02 2.86E-01 9.97E-01 2.79E-02 1.94E-01 
CD38 4.60E-01 3.35E-01 4.09E-01 7.37E-01 2.11E-01 4.97E-01 
SLAMF7 5.01E-01 1.00E+00 5.01E-01 1.00E+00 1.00E+00 1.00E+00 
GATA3 1.36E-01 9.75E-01 5.11E-01 1.29E-01 8.29E-01 4.44E-01 
PCNA 8.92E-01 3.40E-01 5.52E-01 8.19E-01 1.00E+00 1.00E+00 
71 
 
MMP9 6.35E-01 1.00E+00 6.35E-01 1.00E+00 1.00E+00 1.00E+00 
ENTPD1 6.50E-01 1.00E+00 6.50E-01 2.97E-02 1.00E+00 3.10E-02 
CCL4 6.79E-01 6.22E-01 7.55E-01 1.00E+00 1.00E+00 1.00E+00 
PRF1 9.51E-01 4.12E-01 7.67E-01 7.96E-01 1.00E+00 1.00E+00 
EOMES 7.68E-01 5.98E-01 7.89E-01 5.52E-01 1.00E+00 7.63E-01 
IL6R 6.31E-01 7.39E-01 7.98E-01 2.22E-01 5.60E-01 5.96E-01 
CCR5 4.52E-01 9.28E-01 8.09E-01 1.33E-01 5.54E-01 3.07E-01 
GZMA 4.02E-01 9.95E-01 8.52E-01 2.78E-01 8.78E-01 7.79E-01 
CD8a 9.58E-01 1.00E+00 9.58E-01 6.68E-01 1.00E+00 9.00E-01 
B3GAT1 1.00E+00 1.00E+00 1.00E+00 1.00E+00 1.00E+00 1.00E+00 
CXCL13 1.00E+00 1.00E+00 1.00E+00 1.00E+00 1.00E+00 1.00E+00 
IL12RbII 1.00E+00 1.00E+00 1.00E+00 1.00E+00 1.00E+00 1.00E+00 
IL13 1.00E+00 1.00E+00 1.00E+00 1.00E+00 1.00E+00 1.00E+00 
IL22 1.00E+00 1.00E+00 1.00E+00 1.00E+00 1.00E+00 1.00E+00 
IL3 1.00E+00 1.00E+00 1.00E+00 1.00E+00 1.00E+00 1.00E+00 
IL4 1.00E+00 1.00E+00 1.00E+00 1.00E+00 1.00E+00 1.00E+00 
MKI67 1.00E+00 1.00E+00 1.00E+00 1.00E+00 1.00E+00 1.00E+00 
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Table 4.2 P-values and FDR for the top 20 differentially expressed genes. 
The list of genes are ranked by the p-values from the combined test for both the Gaussian and binomial parts under the TMM model 
 
Gene Name TMM MAST 
Gaussian Binomial Combine Gaussian Binomial Combine 
P-value FDR P-value FDR P-value FDR P-value FDR P-value FDR P-value FDR 
TMSB15A 2.14E-12 5.31E-10 1.60E-55 3.33E-51 1.57E-55 3.27E-51 4.50E-09 4.66E-07 1.42E-44 3.01E-40 1.35E-44 2.86E-40 
MEX3A 2.01E-10 2.66E-08 1.55E-50 1.62E-46 1.34E-50 1.39E-46 3.73E-08 2.79E-06 1.57E-42 1.67E-38 1.57E-42 1.67E-38 
SPARCL1 2.31E-15 1.42E-12 1.53E-49 1.07E-45 1.29E-49 8.94E-46 1.22E-13 6.46E-11 7.91E-38 5.60E-34 7.32E-38 5.18E-34 
CLU 3.86E-14 1.75E-11 7.64E-43 3.98E-39 7.54E-43 3.93E-39 3.24E-12 1.11E-09 1.36E-33 5.78E-30 1.26E-33 5.23E-30 
IL6ST 2.78E-06 8.37E-05 5.91E-42 2.46E-38 5.24E-42 2.19E-38 5.82E-04 7.40E-03 3.49E-33 1.06E-29 3.17E-33 9.61E-30 
CRYAB 1.90E-13 6.51E-11 4.47E-39 1.55E-35 4.06E-39 1.41E-35 2.62E-11 6.78E-09 1.66E-34 8.82E-31 1.43E-34 7.60E-31 
ALDOC 1.30E-16 9.72E-14 2.84E-36 8.46E-33 2.28E-36 6.79E-33 2.50E-14 1.87E-11 2.93E-29 5.66E-26 2.65E-29 5.11E-26 
OSBPL1A 3.47E-20 6.03E-17 1.09E-35 2.76E-32 9.29E-36 2.35E-32 4.44E-20 1.35E-16 1.71E-33 6.07E-30 1.48E-33 5.23E-30 
HTRA1 1.77E-13 6.16E-11 1.19E-35 2.76E-32 1.01E-35 2.35E-32 3.43E-11 8.68E-09 1.73E-27 2.45E-24 1.46E-27 2.07E-24 
PRNP 6.70E-24 3.50E-20 2.33E-35 4.87E-32 2.24E-35 4.66E-32 5.61E-19 1.32E-15 4.92E-30 1.16E-26 4.04E-30 9.53E-27 
TSPYL2 1.46E-19 2.03E-16 8.68E-35 1.65E-31 8.53E-35 1.62E-31 8.81E-19 1.87E-15 6.39E-29 1.13E-25 6.17E-29 1.09E-25 
BHLHE41 3.97E-12 9.01E-10 1.08E-34 1.88E-31 9.52E-35 1.66E-31 3.60E-08 2.70E-06 6.76E-28 1.03E-24 6.45E-28 9.79E-25 
CD24 4.01E-15 2.39E-12 1.51E-34 2.43E-31 1.37E-34 2.19E-31 9.82E-14 5.35E-11 1.09E-29 2.32E-26 9.27E-30 1.97E-26 
NEUROD6 1.46E-12 3.80E-10 1.62E-32 2.42E-29 1.53E-32 2.28E-29 1.41E-10 3.03E-08 2.14E-30 5.69E-27 1.73E-30 4.59E-27 
ADD3 7.02E-14 2.87E-11 1.18E-31 1.64E-28 9.83E-32 1.37E-28 5.81E-10 9.23E-08 2.65E-22 1.94E-19 2.37E-22 1.68E-19 
BCL11A 5.72E-14 2.44E-11 2.92E-31 3.81E-28 2.42E-31 3.16E-28 1.32E-10 2.90E-08 1.44E-26 1.80E-23 1.16E-26 1.45E-23 
SLC6A1 2.85E-17 2.58E-14 1.04E-30 1.27E-27 8.63E-31 1.06E-27 5.76E-14 3.42E-11 1.35E-21 8.43E-19 1.34E-21 7.50E-19 
NR3C1 5.03E-07 1.93E-05 5.15E-30 5.66E-27 4.30E-30 4.89E-27 1.20E-09 1.68E-07 3.01E-27 4.00E-24 3.06E-27 4.06E-24 
NEUROD2 2.34E-06 7.27E-05 4.56E-30 5.29E-27 4.45E-30 4.89E-27 7.12E-06 2.22E-04 3.74E-28 6.11E-25 3.68E-28 6.01E-25 
ALCAM 5.90E-15 3.33E-12 6.98E-30 7.28E-27 5.98E-30 6.24E-27 1.80E-16 2.25E-13 2.25E-23 1.99E-20 2.13E-23 1.81E-20 
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CAHPTER V 
Efficient estimation of small p-values in permutation tests using importance 
sampling and cross-entropy method
 
Permutation tests are commonly used for estimating p-values from statistical hypothesis testing 
when the sampling distribution of the test statistic under the null hypothesis is not available or 
unreliable for finite sample sizes. One critical challenge for permutation tests in genomic studies 
is that an enormous number of permutations is needed for obtaining reliable estimations of small 
p-values, which requires intensive computational efforts. In this chapter, we develop a 
computationally efficient algorithm for evaluating small p-values from permutation tests based on 
an adaptive importance sampling approach, which uses the cross-entropy method for finding the 
optimal proposal density. Simulation studies and analysis of a real microarray dataset demonstrate 
that our approach achieves considerable gains in computational efficiency comparing with existing 
methods. 
5.1 Introduction 
   Permutation tests are widely used to assess the p-values in statistical hypothesis testing when the 
distribution of the test statistic under the null hypothesis is not available or not reliable due to finite 
samples size. Comparing with parametric methods that usually rely on the asymptotic distributions 
of the test statistics, permutation tests have less stringent assumptions and are easy to implement 
in practice [110]. However, a fundamental challenge for applying permutation tests is when small 
p-values are required to be exactly evaluated, an enormous number of permutations is needed. This 
situation is very common in genomic studies where a large number of tests are performed, since 
the family-wise error rate or false-discovery rate needs to be controlled at an acceptable level for 
adjusting the issue of multiple hypothesis testing. Hence, the p-value of an individual test needs to 
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be small enough to achieve statistical significance. For instance, in a regular genome-wide 
association studies (GWAS) with half a million genetic markers of single nucleotide 
polymorphisms (SNPs), usually a SNP with p-value less than 10-7 needs to be achieved to be 
declared as globally significant [31]; in gene differential expression analysis with microarray or 
RNA-Seq data, usually a gene with p-value less than 10-5 to 10-6 needs to be achieved to be 
declared as differentially expressed [27]. To reliably estimate small p-values at those scales, at 
least 106 to 109 permutations are needed [27,31]. In addition, in both GWAS and gene differential 
expression analysis, it is desirable to rank the statistically significant signals by their p-values so 
that the researchers can follow up with those significant genomic features for further biological 
insights, which also requires the small p-values associated with those signals to be reliably 
estimated. In those situations, it requires large computational efforts if crude permutation 
procedure is used. 
   Permutation tests, together with another type of widely used resampling methods, the bootstrap 
methods [102], belong to the Monte Carlo sampling methods in a broad sense, which construct the 
sampling distribution of the test statistic under the null hypothesis by repeatedly sampling from 
the observed data (For permutation tests, the sampling is without replacement [110]; For bootstrap 
methods, the sampling is with replacement [102,103]). From a Monte Carlo point of view, 
estimating a small p-value is equivalent to estimating the probability of a rare event in Monte Carlo 
simulations. In the operations research field, the adaptive cross-entropy (CE) method introduced 
by Rubinstein et al [111] is an efficient algorithm for rare event simulation in Monte Carlo 
sampling and has been widely used to that end. Our work is inspired by the work of Hu and Su 
that develops an algorithm using the adaptive CE method for efficiently estimating the 
distributions and quintiles of a statistic in non-parametric bootstrap method [112,113]. Based on 
their work, we consider that the adaptive CE method can also be applied in permutation tests for 
efficiently estimating small p-values but more work is needed to achieve that goal. In this chapter, 
we show that the permutation test for paired two-group and unpaired two-group data can be 
respectively characterized by the joint distribution of i.i.d. Bernoulli distributions and the 
conditional Bernoulli distribution, and hence estimating small p-values from permutation tests can 
be fitted in the framework of importance sampling with the aim of finding the optimal importance 
sampling distribution, where the adaptive CE method can be applied. 
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The rest of this chapter is organized as follows. We first provide a general introduction of the 
adaptive CE method in Section 5.2, and then describe the algorithm of applying the adaptive CE 
method for estimating small p-values for paired or unpaired two-group permutation tests in Section 
5.3. Simulation studies and application to a real microarray gene expression dataset are given in 
Section 5.4, followed by discussions about future work in Section 5.5. 
5.2 Introduction of the adaptive CE method 
   In this section, we briefly review the adaptive CE method with some remarks for its practical 
usage. Our discussion mainly follows Chapter 2 and 3 of reference [111], where more details can 
be found. 
5.2.1 Monte Carlo simulation and importance sampling 
We first introduce the notations for permutation tests. Let 
1
[ ,..., ]T
n
x xx  be the observed data 
and T(•) be the test statistic. The p-value is defined as 
0 0
( | ) [ { }| ]-value=Prp T H E I T H                           (5.1) 
where γ is the observed test statistic and conditioning on H0 means under the null hypothesis H0, 
which will be dropped in the following discussion if there is no ambiguity within the context. 
Usually parametric methods seek to derive the asymptotic distribution of T(•) under H0 and 
calculate the p-value based on that asymptotic distribution. When the asymptotic distribution of 
T(•) under H0 is unavailable or unreliable, permutation tests can be used to estimate the p-value, 
which is often performed in the following way: (1) Generate N (N is usually a large number, e.g. 
N = 106) permutated samples 
1
,...,
N
z z  by sampling without replacement of the observed data x; 
(2) Calculate the test statistics 
1
,( ) ), (
N
T Tz z  with the permutated sample 
1
,...,
N
z z ; (3) Estimate 
p-value as
1
1
-value { ( ) }
N
l
l
p I T
N


  z  [110]. 
The above permutation procedure can be viewed as one case of Monte Carlo (MC) simulation 
methods, which can be paraphrased in the following way under the MC simulation framework: the 
probability that the statistic T(•) is greater than or equal to a given threshold value γ under the 
probability distribution ( ; )f v , which is 
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Pr ( ) [ { }]u T E I T    
v v
,                                     (5.2) 
can be estimated by  
1
1
ˆ { ( ) }
N
l
l
u I T
N


  z ,                                            (5.3)  
where 
1
,...,
N
z z  are random samples drawn from ( ; )f v . Equation (5.3) is called the stochastic 
counterpart of equation (5.2) [111]. 
When the p-value is very small, i.e. Pr( )T  is very small, { ( ) }
l
I T z  is called a rare event 
in MC simulation [111]. As we discussed at the beginning of this paper, a large number of 
permutations for generating MC samples are required for estimating a small p-value, which is very 
computationally intensive. One well-known approach for solving that problem is the importance 
sampling (IS) method [111]. Particularly, by drawing MC samples from a proposal density g(•) 
(a.k.a IS density), u can be written as 
( ; ) ( ; )
{ ( ) } ( )d [ { ( ) } ]
( ) ( )
g
f f
u I T g E I T
g g
    
z v z v
z z z z
z zZ
              (5.4) 
and hence can be estimated by 
1
( ; )1
ˆ { ( ) }
( )
N
l
l
l l
f
u I T
N g


 
z v
z
z
                                    (5.5)  
where the subscript g in equation (5.4) means that the expectation is taken with respect to the IS 
density g(•), and 
1
,...,
N
z z  in equation (5.5) are random samples drawn from g(•). It is also well-
known that there exist a proposal density with zero Monte Carlo sampling variance, which is called 
the optimal proposal density [111,114], given by 
* { ( ) } ( ; )( )
I T f
g
u


z z v
z                                         (5.6) 
However, 
*g  cannot be directly used as the proposal density for estimating u in equation (5.5), 
since it contains the unknown constant u, which is the quantity to be estimated. 
5.2.2 The adaptive CE method 
The adaptive CE method [111] provides one way of finding a proposal density ( ; )f θ  that is 
close to the optimal proposal density 
*g   within the same distribution family as ( ; )f v   by 
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minimizing the cross-entropy (a.k.a. the Kullback-Leibler distance) between 
*g  and ( ; )f θ , which 
is defined as 
 
*
* *
* * *
( )
( ), ( ; ) : ( ) ln d
( ; )
( ) ln ( )d ( ) ln ( ; )d
g
g f g
f
g g g f
  
 

 
z
θ z z
z θ
z z z z z θ z
Z
Z Z
D
          (5.7) 
Since the first term in the right-hand side of equation (5.7) does not depend on the parameter θ and 
the second term can be written as 
{ ( ) } ( ; ) 1
ln ( ; )d [ { ( ) }ln ( ; )]
I T f
f E I T f
u u



  v
z z v
z θ z z z θ
Z
, 
therefore the parameter θ that minimizes  *( ), ( ; )g f  θD   is the solution to the following 
optimization problem: 
arg max [ { ( ) }ln ( ; )]E I T f
v
θ
z z θ                                    (5.8) 
   The key idea of the adaptive CE method (see Chapter 3 of [111]) is to solve the optimization 
problem (5.8) adaptively via importance sampling. By importance sampling and changing the 
proposal density to ( ; )
k
f z θ , problem (5.8) can be written as 
( ; )
arg max [ { ( ) } ln ( ; )]
( ; )k
k
f
E I T f
f

θ
θ
z v
z z θ
z θ
                          (5.9) 
The stochastic counterpart of (5.9) is  
1
( ; )1
arg max [ { ( ) } ln ( ; )]
( ; )
N
l
l l
l l k
f
I T f
N f



θ
z v
z z θ
z θ
                    (5.10) 
where 
1
,...,
N
z z  are random samples drawn from the IS density ( ; )
k
f  θ . 
Following [111], problem (5.10) can be solved adaptively using the Procedure 1 below: 
Procedure 1 (The adaptive CE method for rare-event probability estimation) 
A. Adaptive updating step: 
(1) Specify a constant  0,1 . Start with 0 θ v ; Set the iteration counter k = 0. 
(2) At the kth iteration, generate random samples 
1
,...,
N
z z from ( ; )
k
f  θ . Calculate the statistics 
1
,( ) ), (
N
T Tz z , and compute 
k
  as their sample (1 )  quantile, provided 
k
  . If 
k
  , 
set 
k
  . 
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(3) Updating the parameter 
k
θ   with 
1k
θ  , which is the solution to problem (5.10) with   
substituted by 
k
 , i.e. 
0
1
1
( ; )1
arg max [ { ( ) } ln ( ; )]
( ; )
N
l
k l k l
l l k
f
I T f
N f



 
θ
z θ
θ z z θ
z θ
               (5.11) 
Equation (11) will be called the CE formula in the following discussions. 
(4) If 
k
  , set k = k+1 and reiterate from Step (2); otherwise, proceed to the following Step B. 
B. Estimating step: 
Use ( ; )
k
f  θ  as the IS density and generate random samples 
1
,...,
M
z z  from ( ; )
k
f  θ . Estimate u  as 
0
1
( ; )1
ˆ [ { ( ) } ]
( ; )
M
l
l
l l k
f
u I T
M f


 
z θ
z
z θ
. 
   Here we briefly discuss the rationale of the above adaptive CE algorithm: The adaptive updating 
step of the algorithm iteratively generating a sequence of updated parameters { , 0,1...}
k
k θ  and 
a sequence of threshold values{ , 0,1...}
k
k  . According to Rubinstein et al, under rather mild 
regularity conditions, { , 0,1...}
k
k   is monotonically non-decreasing and the target threshold 
value γ can be reached with high probability in a finite number of iterations for small ρ [111,115]. 
Hence, the updated parameters { , 0,1...}
k
k θ  is more and more close to the optimal parameter θ 
that we want to find in problem (5.8). The estimating step is a regular importance sampling that 
uses ( ; )
k
f  θ  as the IS density. 
   To apply the adaptive CE method to permutation tests, we can see from the above discussions 
that the following requirements should be met: (1) The permutation sample space needs to be 
parameterized by a family of distribution ( ; )f v  and the density of ( ; )f v  needs to be evaluated 
for each permutated sample 
l
z  . (2) Random samples should be easily generated from the 
distribution ( ; )f  v . In the next section, we show how to parameterize the permutation sample 
space for one-group and two-group permutation tests and how the adaptive CE methods can be 
applied. 
5.3 Estimating small p-values for permutation tests using the adaptive CE method 
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5.3.1 Permutation test for paired two-group data 
   We first demonstrate how the adaptive CE method can be applied to permutation test for paired 
two-group data. Testing the location of paired two-group data is equivalently to testing if the 
difference between the paired observations is symmetrically distributed around 0 [110]. Following 
the notations in the previous section, let x  be the data vector of the difference between the paired 
observations and 
1 2
[ , ,..., ] ,  1,...,T
l l l ln
z z z l N z   be the lth permutated sample among N 
permutated samples. Under the crude permutation procedure, the permuted samples can be 
obtained by attributing the   or   sign to ix  with equal probability of 1/2 [110]. We define an 
auxiliary variable 
li
s  as an indicator variable that indicates whether the   or   sign is assigned 
to 
i
x   for the lth permutated sample, where 1
li
s    means assigning the    sign and 0
li
s   
assigning the   sign to ix . Next we define ip  as the probability of assigning the   sign to ix . It 
is easy to see 
li
s  follows a Bernoulli distribution given
i
p  , i.e. 1
li
s   with probability 
i
p  and 
0
li
s   with probability 1
i
p . Let 
1
[ ,..., ]T
l l ln
s ss  and 
1 2
[ , ,..., ]T
n
p p pp  be the vector forms for 
li
s  and 
i
p , respectively. Below we will drop the subscript l if there is no ambiguity in the context. 
Note that given 
l
s  , the permutated sample 
l
z   is uniquely determined. Therefore, the 
permutation sample space can be parameterized by the joint distribution of 
l
s , which is n i.i.d. 
Bernoulli distributions with the probability vector p given by 
1
1
( ; ) ( ; ) [ (1 ) ]i i
n
s s
i i
i
f f p p


  z p s p                               (5.12) 
Based on (5.12), we can update the probability vector p  using the adaptive CE method, with the 
starting value 
0
[1/ 2,...,1/ 2]Tp  (i.e. the Bernoulli probabilities under the crude permutation 
procedure. As discussed above, the   or   sign is assigned to ix  with equal probability of 1/2). 
To apply the adaptive CE method (Procedure 1), observe that the optimization of the CE formula 
(5.11) with density ( ; )
l
f z p  [equation (5.12)] is the solution to the following problem: 
1 1
1 0
[ ,..., ] [ ,..., ] 1
1
arg max  ( ) arg max [ { ( ) } ( ; , ) ln ( ; )]
T T
n n
N
k l k l k l
p p p p l
D I T Q f
N


  
  
p p
p p z z p p z p    (5.13) 
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where 
0
0
( ; )
( ; , )
( ; )
l
l k
l k
f
Q
f

z p
z p p
z p
 is the likelihood ratio.  
   Problem (5.13) can be solved analytically by differentiating ( )D p  with p  , which we show 
below. Observe that only the term ln ( ; )
l
f z p  involves p , therefore 
0
1
1
1
0
1
1
1
0
1
0
ln ( ; )( ) 1
[ { ( ) } ( ; , ) ]
ln { (1 ) ]}
1
[ { ( ) } ( ; , ) ]
ln { (1 ) ]}
1
[ { ( ) } ( ; , ) ]
1
[ { ( ) } ( ; ,
li li
li li
N
l
l k l k
li i
n
s s
i iN
i
l k l k
l i
n
s s
i iN
i
l k l k
l i
l k l
fD
I T Q
p N p
p p
I T Q
N p
p p
I T Q
N p
I T Q
N












 
 
 
 

 
 

 





z pp
z z p p
z z p p
z z p p
z z p 1
1
0
1
{ ln (1 ) ln(1 )}
) ]
11
[ { ( ) } ( ; , )( )]
1
n
N
li i li ii
k
l i
N
li li
l k l k
l i i
s p s p
p
s s
I T Q
N p p




   


  




p
z z p p
 
Set 
( )
i
D
p


p
=0, we obtain the following closed form solution for p : 
0
1
0
1
[ { ( ) } ( ; , ) ]
,
[ { ( ) } ( ; , )]
N
l k l k li
l
i N
l k l k
l
I T Q s
p
I T Q









z z p p
z z p p
 for 1,...,i n .             (5.14) 
  Combining this result and Procedure 1, we have the following algorithm for estimating small p-
values for paired two-group permutation test: 
Procedure 2 (Adaptive importance sampling algorithm for paired two-group permutation 
test – AISP1) 
A. Adaptive updating step: 
(1) Specify a small constant  0,1 . Start with the initial probability vector 0 [1/ 2,...,1/ 2]
Tp . 
Set the iteration counter 0k  . 
(2) At the kth iteration, generate random samples 
1
,...,
N
z z  from ( ; )
k
f  p  based on equation (5.12). 
Calculate the statistics 
1
,( ) ), (
N
T Tz z  , and compute 
k
   as their sample (1 )   quantile, 
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provided 
k
  . If 
k
  , set 
k
  . 
(3) Updating the parameter 
k
p  with 
1k
p  according to equation (5.14). 
(4) If 
k
  , set 1k k   and reiterate from Step (2); otherwise, proceed to the following Step B. 
B. Estimating step: 
Use ( ; )
k
f  p  as the IS density and generate random samples 
1
,...,
M
z z  from ( ; )
k
f  p . Estimate the 
p-value as 
0
1
( ; )1
-value [ { ( ) } ]
( ; )
M
l
l
l l k
f
p I T
M f


 
z p
z
z p
. 
5.3.2 Permutation test for unpaired two-group data 
The unpaired two-group data are more common in biomedical studies. Following the notations 
of the previous section: let 
1 2
[ , ,..., ]T
n
x x xx   be the observed data, and 
1 2
[ , ,..., ] ,  1,...,T
l l l ln
z z z l N z  be the lth permutated sample among N permutated samples. To 
assign the group labels to the data, without loss of generality we assume the first k elements of x  
belong to Group 1 and the last m=n-k elements of x  belong to Group 2 with 0 k m  . 
To apply the adaptive CE method, we need to parameterize the permutation sample space of the 
unpaired two-group data. Below we show that the conditional Bernoulli (CB) distribution can be 
used to that end. Our discussion about the CB distribution mainly follows the work by Chen et al 
[116-118]. First, define an auxiliary variable 
1 2
[ , ,..., ]T
l l l ln
d d dd  as a partition vector, where 
,  1,..., ,
li
d i n  is either 1 or 0 with 1 indicating 
i
x  belongs to Group 1 and 0 indicating 
i
x  belongs 
to Group 2 in the permutated sample 
l
z  . For example, suppose 6n   , 2k   and 4m   , then 
[1,0,1,0,0,0]T
l
d  means that 
1 3
{ , }x x  belong to Group 1 and 
2 4 5 6
{ , , , }x x x x  belong to Group 2 in 
the permutated sample. In the following discussions, we will drop the subscript l if there is no 
ambiguity in the context. 
Following [116,119], the conditional distribution of 
1 2
[ , ,..., ]T
n
d d dd  , ~ ( )
i i
d Bernoulli p  
given 
1
,  1,...,
n
ii
d k k n

   is called the CB distribution, the density of which is given by 
1
1 2 1
( ; ) Pr( , ,..., | )
i
n d
n ii
n ii
k
w
f d d d d k
R


  

d w                   (5.15) 
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where 
1 1
Pr( ) (1 )
nn
k i ii i
R d k w
 
                                   (5.16) 
is a normalization constant and 
1
[ ,..., ]T
n
w ww  with / (1 ),  1,2,...,
i i i
w p p i n   , is the vector 
of odds. Under this parameterization, 
i
w ’s (or equivalently, 
i
p ’s ) are the parameters of the CB 
distribution (note that 
k
R  also involves 
i
w ’s). For crude permutation procedure, [1,...,1]
Tw . Our 
adaptive importance sampling algorithm aims at updating 
i
w ’s using the adaptive cross-entropy 
method. Following the discussion in Section 5.2, below we will address two questions to that end: 
(1) How to effectively generate random samples from the CB distribution? (2) How to efficiently 
optimize the CE formula with the density of the CB distribution? 
   Sampling from CB distribution. Chen et al provide five methods for sampling from the CB 
distribution [117,118]. Here we use the drafting sampling algorithm [117,118]. First let 
1,k j
R

 
denote the normalization constant for the conditional distribution of { , }
i
d i j   given 
1
ii j
d k

  , which is defined as 
 1, Pr 1 (1 )k j i ii j
i j
R d k w
 

     .                            (5.17) 
   Following [117,119], the normalization constants 
k
R  and 
1,k j
R

 can be recursively computed 
using the following relationship: 
Procedure 3 (Computation of the normalization constants of CB distribution)  
Define the following quantities: 
1
n i
i jj
T w

  and , ii j i jT T w   , 1,...,i k  , 1,...,j n  . Start with 
0
1R   and 
0,
1
j
R  , 1,...,j n , then 
k
R  and 
1,k j
R

, 1,..., ,  1,...,k n j n   can be computed as 
1
1
1
( 1)
k i
k i k ii
R T R
k


  ,                                        (5.18) 
1 1
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 
  
 

 , 1,...,j n                      (5.19) 
   To sample from CB distribution, we need to further define the following quantities: the first 
quantity is 
1
[ ,..., ]T
n
 π  called the coverage probabilities of CB distribution [118,119], which is 
given as 
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and the second quantity is 
1 2
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n
a a aa , which is called the coverage probability distribution, 
given by 
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We can see a  is normalized from π  to form a legitimate probability distribution. The quantities 
a , π and the normalization constants 
k
R  and 
1,k j
R

 have the following relationship [118,119]: 
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   The drafting sampling algorithm selects the k indices of 1’s (recall that 1 indicates 
i
x  belongs to 
Group 1 and 0 indicates 
i
x  belongs to Group 2) according to a  one by one, which is given below 
[118,119]: 
Procedure 4 (Sampling from CB distribution) 
1. Start with two sets: S   (which will contain k indices of 1’s after the procedure) and 
{1,..., }C n  (which contains the indices to be selected). Set iteration counter 1i  . 
2. While i k , compute kR  and 1,k jR  , j C , { , }iw i C  based on Procedure 3, and compute the 
corresponding a  based on equation (5.21). 
3. Draw ~
i
J a . Set { }
i
S S J  , \{ }
i
C C J  and 1i i  . Return to Step 2. 
4. If i S , then set 1id  ; If i C , the set 0id  . Output 1 2[ , ,..., ]
T
n
d d dd  as the final partition 
vector and determine the permutated sample z  according to d . 
   Optimization of the CE formula with the density of CB distribution. Substituting the CE formula 
(5.11) with the density of CB distribution (5.15), we have the following optimization problem: 
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where ( ; )
l
f d w  is the density of the CB distribution as defined in equation (5.15). Below we give 
the procedure for solving this optimization problem. To simplify notations, drop the constant
1
N
 
and also note that the term 
0
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Further calculation by plugging ( ; )
l
f d w  [see equation (5.15)] in ( )D w  shows that 
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where : ln
i i
w   and 
1
:
N
i l lil
y S d

  for 1,...,i n . From (5.24), using the new parameterization 
1
[ ,..., ]T
n
 θ  and noting that the second term 
1
1
ln
N
n l
l
R S

  does not involve iy , we can see that D 
belongs to exponential families, and 
1
[ ,..., ]T
n
y yy  are the sufficient statistics for θ [116,120]. 
Following standard results of exponential families [120], the first derivatives of D  is 
( )
D
E

 

y y
θ
                                                 (5.25) 
and the MLE of the parameter θ  [or equivalently, the solution to (5.23)] can be obtained by setting 
0
D

θ
, which is the solution to  
85 
 
1
( )
N
ll
E S

  y y π                                             (5.26) 
The second equality in (5.26) follows from the definition of π  in (5.20).  
   Using equation (5.21), (5.26) can be re-written as 
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, 1,...,i n                                     (5.27) 
In the literature, three iterative algorithms have been proposed to solve the MLE of CB distribution, 
which is similar to problem (5.27): (1) A generalized iterative scaling algorithm by [121]. (2) An 
iterative proportional fitting algorithm by [118] and [116]. (3) A Newton-Raphson type algorithm 
by [116]. Following the work of Chen et al [116] and in our implementation, the second algorithm 
is the most efficient method in all of our applications. Below we gives the iterative procedure of 
the algorithm. Details of the procedure can be found in [116,118]. 
Procedure 5 (Optimization of the CE formula with the density of CB distribution) 
1. Sort y  in ascending order and let the sorted values be 1' [ ' ,..., ' ]
T
n
y yy . 
2. Start with (0)
1
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i N
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y
w i n
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until convergence, where (t) means at the tth iteration. 
   The algorithm for unpaired two-group permutation test. Combining these results and Procedure 
1, we have the following adaptive importance sampling algorithm for unpaired two-group 
permutation test: 
Procedure 6 (Adaptive importance sampling algorithm for unpaired two-group permutation 
test – AISP2) 
A. Adaptive updating step: 
(1) Specify a constant  0,1  . Start with the initial parameters 0 [1,...,1]
Tw  (i.e.
0
[1/ 2,...,1/ 2]Tp ). Set the iteration counter 0k  . 
(2) At the kth iteration, generate random samples 
1
,...,
N
z z   from CB distribution ( ; )
k
f  w  
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according to Procedure 4. Calculate the statistics 
1
,( ) ), (
N
T Tz z ,  and compute 
k
  as their sample 
(1 )  quantile, provided 
k
  . If 
k
  , set 
k
  . 
(3) Updating the parameter 
k
w  with 
1k
w  according to Procedure 5. 
(4) If 
k
  , set 1k k   and reiterate from Step (2); otherwise, proceed to the following Step B. 
B. Estimating step: 
Use ( ; )
k
f  w  as the IS density and generate random samples 
1
,...,
M
z z  from ( ; )
k
f  p . Estimate the 
p-value as 
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5.4 Results 
   In this section, we demonstrate the performance of our approach through simulations and on a 
real microarray dataset. 
5.4.1 Simulation studies for unpaired two-group permutation test 
   The first numerical experiment concerns a one-sided permutation test for testing the means of 
two groups. In the first example, we test the means of two groups with sample sizes 20k m  . 
The observed data of the first group are sampled from N(1, 1), N(1.25, 1) and N(1.5, 1) with a 
fixed seed [N(µ, σ) means that the sample is drawn from a normal distribution with mean µ and 
standard deviation σ], and the observed data of the second group are always sampled from N(0, 1). 
Therefore, we have three different combinations of the two groups of data and the p-values of the 
three combinations are respectively on the order of 10-5, 10-6 and 10-7. For each combination, we 
perform the permutation test using the crude permutation procedure and our approach AISP2. We 
also include another approach, the SAMC algorithm, which has a similar goal to our method but 
uses the stochastic approximation Markov chain Monte Carlo algorithm as described in [31], in 
our comparisons. Each procedure is repeated 100 times with different seeds. The test statistic used 
here is the difference of the sample means between the two groups. The number of permutated 
samples used in one single run of the three procedures are as following: For the crude procedure, 
we use two different sets of permutation numbers, Crude-I and Crude-II, which differ by a factor 
of 10. For Crude I procedure, the numbers of permutations are 1000 divided by the scale of the p-
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values, which results in 108, 109 and 1010 permutations. For Crude-II procedure, the numbers of 
permutations are the corresponding numbers of permutations used in Crude-I divided by 10. For 
AISP2, the constant ρ is fixed at 0.1 and 2000 resamples is used in each iteration of the adaptive 
updating step and 10000 resamples is used in the estimating step. For SAMC, we use default values 
of the program, i.e. 2×105 permutated samples for refining the partitions of the test statistic and 
106 permutated samples for the final step of estimating the p-value. The results of the average of 
the estimated p-values from 100 runs, the error metrics that show the precision of the estimates 
and the computation time of each algorithm are shown in Table 5.1. 
   We can see from Table 5.1 that the performance of AISP2 is between Crude-I and Crude -II in 
terms of the precision. Therefore, comparing the computation time with the two crude permutation 
procedures, AISP2 reduces the computation effort by roughly a factor from 25 to 8079, and the 
efficiency increases as the p-value goes smaller. We note that the SAMC algorithm is partly 
implemented in C++ and AISP2 is completely implemented in R, so we should not directly 
compare the computation time between the two methods. But in this example, AISP2 has better 
performance in terms of both precision and computation time than the SAMC algorithm. 
   We also perform another simulation example with samples sizes 100k m   and the order of p-
values of 10-7, 10-8, 10-9 and 10-10. This time we run SAMC with different number of permutated 
samples: SAMC-I - we use 2×105 permutated samples for refining the partitions of the test statistic 
and 5×106 permutated samples for the final step of estimating the p-value; SAMC-II - we use 
2×105 permutated samples for refining the partitions of the test statistic and 106 permutated 
samples for the final step of estimating the p-value. For AISP2, the constant ρ is fixed at 0.1 and 
4000 resamples is used in each iteration of the adaptive updating step and 20000 resamples is used 
in the estimating step. The results of this example are shown Table 5.2. We can see the precision 
of AISP2 decreases comparing with the previous example with 20k m   and is roughly on the 
same scale as SAMC-II. This issue is known as the degeneracy of the likelihood ratios for IS in 
high dimensions [122], which we further discuss in Section 5.5. The computation time of AISP2 
is faster than both SAMC I and II, and the averages of the estimated p-values from the 100 runs 
are similar for all procedures (Table 5.2). 
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5.4.2 Application to a microarray gene expression study 
   The second experiment concerns a differential gene expression analysis of a real microarray 
dataset from a study of high-risk pediatric acute lymphoblastic leukemia (ALL) [8]. The data set 
is comprised of 191 children with ALL split into 67 who are minimal residual disease (MRD) 
positive and 124 who are MRD negative. The MRD status of each patient was assessed at the end 
of induction therapy. The data consist of 54675 expression levels of pretreatment leukemia cells 
for each patient, which were measured using the Affymetrix HG U133 Plus 2.0 platform. One of 
the goals was to identify genes that are differentially expressed between MRD-positive and -
negative samples. It was achieved through the use of R package samr, which computes a modified 
t-statistic for the comparison of two-group data and uses permutations to estimate the p-value 
based on the modified t-statistic [27]. A list of differentially expressed genes between the MRD 
positive and MRD negative patients was identified and the 23 probe set (representing 21 unique 
genes) on the top of the list were selected to construct a classifier to predict the MRD status [8]. 
However, since the number of permutations generated by the samr package was limited, the 23 
probe sets cannot be ranked by their statistical significance. Here we apply the AISP2 method to 
estimate the p-values of the 23 probe sets with higher precision and give a rank of them. The test 
statistic used is still the modified t-statistic as computed in the samr package [27]. For the purpose 
of comparison, we also perform crude permutations for the 23 probe sets. Both procedures are 
repeated 100 times with different seeds for each individual probe set. The numbers of permutations 
for each procedure are: for crude procedure, 108 permutations are generated for each probe set; for 
AISP2, 4000 resamples is used in each iteration of the adaptive updating step and 10000 resamples 
is used in the estimating step. The results are shown in Table 5.3. As expected, AISP2 has 
remarkably better performance than the crude procedure in terms of the precision for those small 
p-values (Table 5.3, see the standard deviation of the estimated p-values). For the computation 
time, the crude procedure takes 9.85×106s of CPU time and AISP2 takes 6.26×105s of CPU time 
on the AMD Opteron 6272, 2.1 GHz CPU. AISP2 saves about 16 times of computation time and 
achieves much higher precision comparing with crude permutation. 
5.5 Discussion and future work 
In this chapter, we present a computationally efficient algorithm for estimating small p-values 
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from permutation tests using the adaptive cross-entropy method. Simulation studies and analysis 
of a real microarray dataset show that our approach achieves significant gains in computational 
efficiency comparing with existing methods. We should also note that the statistics used in our 
examples are very simple, and thus takes less amount of time to compute comparing with the time 
of generating the permutated samples. If the test statistics used in the permutation tests are 
relatively complicated, the crude procedure and SAMC will take even longer time, since both the 
two procedures need much more permutated samples than AISP2. 
   As we see in the second simulation example with 100k m   , one issue with the current 
implementation of the adaptive importance sampling method is that the variances of the estimated 
p-values increase with the sample sizes. The underlying reason for that issue is the number of 
parameters to be updated grows with sample sizes and the likelihood ratios involving in the 
importance sampling become more and more unstable with the number of parameters growing, 
which has been known as the “curse of dimensionality” of the likelihood ratios when using IS in 
high dimensional Monte Carlo simulations [122]. Several methods have been introduced to deal 
with that problem. One method specifically dealing with the degeneracy of the likelihood ratios in 
adaptive CE method is called the “screening method”, which first identifies a subset of the 
parameters that have most significant effects in high dimensional Monte Carlo simulations and 
then only updates that subset of parameters via adaptive CE method [122]. As future work, we will 
consider of using this type of dimension reduction approaches in our method to reduce the variance 
in high-dimension problems. 
   A natural extension of this work is to extend the current adaptive importance re-sampling 
approach for one-group and unpaired two-group data to multiple-group data. To that end, we need 
to parameterize the permutation sample space of multiple-group data by some distributions as we 
have done with one-group and unpaired two-group data. One direction is to sequentially applying 
the CB distribution to multiple groups. For instance, if we have three groups, we can first consider 
the second and third groups as one single group, and then select elements for the first group by the 
CB distribution, and then select elements for the second group using the CB distribution again, 
and the remaining unselected elements are assigned to the third group. Hence, the density of the 
distribution parameterizing the permutation sample space of the three-group data is the product of 
density of two CB distributions. We consider this extension as our future work.
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Table 5.1 Performance of different algorithms on the first two-group permutation test example. 
k = m = 20 
Each procedure is repeated 100 times with different seeds 
 
x1 x2 
  Crude I     Crude II   
?̂? MSE ARE MCRE #samples (time) ?̂? MSE ARE MCRE #samples (time) 
N(1, 1) N(0, 1) 6.70×10-5 5.81×10-13 - 1.14×10-3 108 (2.23×105) 6.72×10-5 5.28×10-12 2.46×10-3 3.44×10-3 107 (2.29×104) 
N(1.25, 1) N(0, 1) 4.76×10-6 4.81×10-15 - 1.47×10-3 109 (2.40×106) 4.77×10-6 5.01×10-14 2.79×10-3 4.72×10-3 108 (2.12×105) 
N(1.5, 1) N(0, 1) 3.67×10-7 3.01×10-17 - 1.50×10-3 1010 (1.97×107) 3.68×10-7 3.63×10-16 2.13×10-3 5.21×10-3 109 (2.17×106) 
 
  AISP2     SAMC   
?̂? MSE ARE MCRE #samples (time) ?̂? MSE ARE MCRE #samples (time) 
6.67×10-5 2.01×10-12 4.36×10-3 2.08×10-3 1.6×104 (9.04×102) 6.62×10-5 1.20×10-11 1.27×10-2 5.03×10-3 1.2×106 (6.72×104) 
4.71×10-6 1.44×10-14 1.02×10-2 2.32×10-3 1.8×104 (2.43×103) 4.66×10-6 4.95×10-14 2.08×10-2 4.21×10-3 1.2×106 (6.72×104) 
3.68×10-7 7.34×10-17 1.90×10-3 2.34×10-3 1.8×104 (2.44×103) 3.63×10-7 4.35×10-16 1.23×10-2 5.57×10-3 1.2×106 (6.97×104) 
 
The meanings of each column: 
N(µ, σ) means the sample is drawn from a normal distribution with mean µ and standard deviation σ. 
pˆ : this is the average of the estimated p-values from 100 runs of each algorithm, where pˆ  from Crude I method is used as the underlying true p-value in the following 
calculation of errors. 
MSE: mean square error, defined as 2
1
1
ˆ( )
N
ii
p p
N 
 , where ˆ ip  is the estimated p-value from the ith ( 1,...,100i  ) run, p is the underlying true p-value and N is 100. 
ARE: absolute relative error, defined as ˆ| ( ) / |p p p , where pˆ  is the average of the 100 estimated p-values from 100 runs of each algorithm. 
MCRE: Monte Carlo relative error, defined as 
/S N
p
, where S  is the sample standard deviation of the 100 estimated p-values from 100 runs of each procedure. 
#samples: this is the total number of permutated samples used for one single run of each algorithm. For SAMC, we used default values of the program, i.e. 2×105 resamples 
for refining the partitions of the test statistic and 106 resamples for the final step of estimating the p-value. 
time: this is the CPU time in seconds of 100 runs on a cluster with 64 cores of AMD Opteron 6272, 2.1 GHz CPU (For Crude I method with 1010 permutations, we split 
the jobs on two clusters. The time reported here is the sum of CPU time with 60 runs on 60 cores of AMD Opteron 6272, 2.1 GHz CPU and 40 runs on 40 cores of AMD 
8214, 2.2 GHz).
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Table 5.2 Performance of different algorithms on the second two-group permutation test example. 
k = m = 100 
Each procedure is repeated 100 times with different seed 
 
x1 x2 
AISP2 SAMC I SAMC II 
?̂? (S.D.*) #samples (time)  ?̂? (S.D.*) #samples (time) ?̂? (S.D.*) #samples (time) 
N(0.5, 1) N(0, 1) 9.54×10-7 
(3.69×10-8) 
3.6×104 
(2.71×104) 
9.58×10-7 
(2.60×10-8) 
5.2×106 
(3.03×105) 
9.45×10-7 
(5.60×10-8) 
1.2×106 
(7.80×104) 
N(0.6, 1) N(0, 1) 2.62×10-8 
(4.35×10-9) 
3.6×104 
(3.34×104) 
2.65×10-8 
(8.37×10-10) 
5.2×106 
(3.03×105) 
2.60×10-8 
(1.71×10-9) 
1.2×106 
(8.02×104) 
N(0.65, 1) N(0, 1) 3.64×10-9 
(1.11×10-9) 
**4×104 
(4.16×104) 
3.89×10-9 
(1.39×10-10) 
5.2×106 
(3.03×105) 
3.82×10-9 
(2.66×10-10) 
1.2×106 
(8.07×104) 
N(0.7, 1) N(0, 1) 5.13×10-10 
(2.47×10-10) 
4×104 
(4.18×104) 
5.41×10-10 
(2.09×10-11) 
5.2×106 
(3.03×105) 
5.19×10-10 
(4.27×10-11) 
1.2×106 
(8.14×104) 
 
*S.D.: this is the sample standard deviation of the estimated p-values from 100 runs of each algorithm. The meanings of the rest columns are the 
same as Table 4.1. 
**Among the 100 runs in this simulation, one single run reach the target threshold value after 5 iterations, and the rest 99 runs all take 4 iterations. 
So the total number of resamples for that single run is 4×104 and the rest is 3.6×104.
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Table 5.3 Estimated exact p-values for the top 23 probe sets of the MRD data. 
Each procedure is repeated 100 times with different seed 
Total CPU time: Crude - 9.85×106s; AISP2 - 6.26×105s 
 
Probe Set ID Gene Symbol Crude P-value (S.D.)* AISP2 P-value (S.D.)* Gene Description 
242747_at --- 2.40×10-9 (6.53×10-9) 2.71×10-9 (7.89×10-10) 
NCI_CGAP_Brn35 Homo sapiens cDNA clone 
IMAGE:2616532 3’ mRNA sequence 
1564310_a_at PARP15 3.80×10-9 (7.89×10-9) 4.39×10-9 (8.51×10-10) poly (ADP-ribose) polymerase family, member 15 
201718_s_at EPB41L2 3.20×10-9 (7.90×10-9) 4.41×10-9 (7.29×10-10) erythrocyte membrane protein band 4.1-like 2 
219032_x_at OPN3 3.02×10-8 (2.58×10-8) 2.89×10-8 (9.21×10-9) opsin 3 
201719_s_at EPB41L2 6.82×10-8 (2.96×10-8) 7.16×10-8 (8.76×10-9) erythrocyte membrane protein band 4.1-like 2 
205429_s_at MPP6 8.98×10-8 (4.06×10-8) 8.67×10-8 (5.01×10-9) 
membrane protein, palmitoylated 6 (MAGUK p55 subfamily 
member 6) 
1553380_at PARP15 1.12×10-7 (5.17×10-8) 1.07×10-7 (1.05×10-8) poly (ADP-ribose) polymerase family, member 15 
207426_s_at TNFSF4 1.65×10-7 (6.05×10-8) 1.58×10-7 (2.61×10-8) 
tumor necrosis factor (ligand) superfamily, member 4 (tax-
transcriptionally activated glycoprotein 1, 34kDa) 
209286_at CDC42EP3 1.76×10-7 (6.15×10-8) 1.73×10-7 (2.52×10-8) CDC42 effector protein (Rho GTPase binding) 3 
221841_s_at KLF4 2.14×10-7 (6.08×10-8) 2.00×10-7 (1.81×10-8) Kruppel-like factor 4 (gut) 
227336_at DTX1 4.17×10-7 (8.82×10-8) 4.27×10-7 (2.48×10-8) deltex homolog 1 (Drosophila) 
225685_at --- 4.75×10-7 (9.85×10-8) 4.89×10-7 (3.02×10-8) CDNA FLJ31353 fis, clone MESAN2000264 
213358_at KIAA0802 6.30×10-7 (1.10×10-7) 6.16×10-7 (4.72×10-8) KIAA0802 
219990_at E2F8 6.57×10-7 (1.05×10-7) 6.60×10-7 (6.28×10-8) E2F transcription factor 8 
204562_at IRF4 6.78×10-7 (1.19×10-7) 6.70×10-7 (4.00×10-8) interferon regulatory factor 4 
213817_at --- 8.91×10-7 (1.32×10-7) 8.71×10-7 (4.90×10-8) CDNA FLJ13601 fis, clone PLACE1010069 
201710_at MYBL2 8.89×10-7 (1.28×10-7) 8.95×10-7 (4.95×10-8) v-myb myeloblastosis viral oncogene homolog (avian)-like 2 
232539_at --- 9.79×10-7 (1.35×10-7) 9.58×10-7 (5.75×10-8) 
MRNA; cDNA DKFZp761H1023 (from clone 
DKFZp761H1023) 
218589_at P2RY5 1.36×10-6 (1.67×10-7) 1.37×10-6 (7.05×10-8) purinergic receptor P2Y, G-protein coupled, 5 
218899_s_at BAALC 1.54×10-6 (1.97×10-7) 1.57×10-6 (6.73×10-8) brain and acute leukemia, cytoplasmic 
225688_s_at PHLDB2 2.04×10-6 (1.86×10-7) 2.06×10-6 (1.31×10-7) pleckstrin homology-like domain, family B, member 2 
242051_at CD99 5.66×10-6 (3.16×10-7) 5.66×10-6 (2.84×10-7) CD99 molecule 
220448_at KCNK12 7.03×10-6 (3.73×10-7) 7.08×10-6 (3.39×10-7)** potassium channel, subfamily K, member 12 
 
*P-value is the average of the estimated p-values from 100 runs of each algorithm; S.D. is the sample standard deviation of the estimated p-values 
from 100 runs of each algorithm. 
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**For this probe set, there is one outlier with p-value of 2.81×10-5 among the 100 runs of AISP2. For that single run, the adaptive updating step does 
not reach the target threshold value after 20 iterations. The p-value and S.D. for this probe set in the table are based on the 99 runs with that outlier 
removed. The estimated p-value and SD based on all the 100 runs are 7.29×10-6 (2.13×10-6).
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CHAPTER VI 
Efficient estimation of small p-values in parametric bootstrap tests using 
Hamiltonian Monte Carlo cross-entropy method
 
   The bootstrap tests as we discussed in Chapter IV for analyzing single-cell high-throughput gene 
expression data, together with permutation tests, are two types of resampling methods that are 
widely used when the asymptotic distribution of the test statistic is unavailable or unreliable due 
to small sample sizes. Similar to permutation tests as we discussed in Chapter V, bootstrap tests 
suffer from the issue of high computational burden when it is required to obtain reliable estimations 
of small p-values. In this chapter, we focus on parametric bootstrap tests and develop an algorithm 
for efficient estimation of small p-values in parametric bootstrap tests. Our approach not only uses 
the principle of the cross-entropy method that we discussed in Chapter V to approximate the 
optimal proposal density, but also incorporates the Hamiltonian Monte Carlo method to efficiently 
sample from the optimal proposal density. Our new method avoids the adaptive updating step in 
the classical adaptive cross-entropy method and hence considerably improves the computational 
efficiency. We apply our method to the problem of testing the variance component in linear mixed-
effects models with demonstrations through simulations and an analysis of gene set differential 
expression with a microarray dataset. Our approach achieves considerable gains in computational 
efficiency when compared with the standard parametric bootstrap procedure. 
6.1 Introduction 
   We first briefly discuss the general parametric bootstrap test procedure in this section. Suppose 
our goal is to test a null hypothesis H0 versus an alternative hypothesis H1 using a test statistic 
T(•), which is constructed under a parametric model (e.g., the linear mixed-effects model as we 
discuss below in Section 6.3). Let γ be the observed test statistic, then the p-value is defined as 
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0Pr |( )p T H  . Parametric bootstrap tests are widely used to estimate the p-value when the 
asymptotic distribution of the test statistic is unavailable or unreliable due to small sample sizes 
[101-103,123-125]. It first fits the model under H0 (denoted as
0
ˆ
Hf  below) and then computes 
the p-value by simulating data from 
0
ˆ
Hf . The procedure is usually performed in the following 
way [102,103]: 
Procedure 1 (The general parametric bootstrap test method) 
(1) Generate N (for e.g., N = 10,000) random samples 1,..., Ny y  from 0
ˆ
Hf . 
(2) Calculate the corresponding test statistics 1 ,( ) ), ( NT Ty y  with the simulated samples 
1,..., Ny y . 
(3) Estimate the p-value as 
1
1
ˆ { ( ) }
N
l
l
p I T
N


  y  (an alternative formula is 
1
{ ( ) } 1
ˆ
1
N
l
l
I T
p
N


 


 y
. The two formulas give almost the same result providing N is large, so 
we use the former throughout this chapter). 
   The above parametric bootstrap test procedure, similar to permutation tests, suffers from the 
same issue of high computational burden when it is required to obtain reliable estimation of small 
p-values, which is a common situation in genomic problems as we discussed in Chapter V. This 
motivates us to develop new methods to improve computational efficiency for parametric 
bootstrap tests. In this chapter, we propose a new algorithm that can dramatically reduce the 
computational time for estimating small parametric bootstrap p-values by combing the cross-
entropy method that we discussed in Chapter V and the Hamiltonian Monte Carlo method. In the 
following sections, we first briefly review the principle of cross-entropy method within the 
framework of parametric bootstrap, and then we introduce our new approach. Next, we apply our 
method to the problem of testing the variance component in linear mixed-effects models using 
parametric bootstrap, and then demonstrate its performance by simulations and an analysis of gene 
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set differential expression with a microarray dataset. We close this chapter with discussions on 
possible extensions of the current approach. 
6.2 Methods 
6.2.1 Estimating small parametric bootstrap p-values using cross-entropy method 
   From the above discussions, we can easily see that the parametric bootstrap test is essentially a 
Monte Carlo sampling procedure, and the problem of estimating small p-values using the 
parametric bootstrap test is equivalent to estimating the small probability 0Pr[ ( ) | ]T Hy   by 
drawing random samples y  from the null model 
0
ˆ
Hf . As we discussed in Chapter V, the cross-
entropy (CE) method [111] can be used to efficiently estimate small probabilities in Monte Carlo 
procedures by updating the parameters of the probability distribution via importance sampling. 
From hereafter we will use 0( ; )f θ  to represent probability distribution of the data under the null 
model 
0
ˆ
Hf  to emphasize that 0θ  is the parameter of the null model. For instance, for parametric 
bootstrap tests in linear mixed-effects models (LMMs) to which we will apply our method (Section 
6.3 below), 0( ; )f θ  is a multivariate normal distribution and 0θ  contains the mean and covariance 
of that multivariate normal distribution. 
Here, we briefly review the CE method under the parametric bootstrap framework. Similar to 
our discussions in Chapter V, the p-value in parametric bootstrap tests is defined as 
0 0
Pr [ ( ) ] [ { ( ) }]p T E I T    θ θy y                                            (6.1) 
and can be estimated by its stochastic counterpart 
1
1
ˆ { ( ) }
N
l
l
p I T
N


  y [111], where 1,..., Ny y  
are random samples drawn from 0( ; )f θ . Applying the CE method to estimate the above p-value 
defined in equation (6.1) essentially follows our discussions in Section 4.2 of Chapter V: let g(•) 
be the proposal density, then by the importance sampling method, p can be written as 
0 0( ; ) ( ; ){ ( ) } ( )d [ { ( ) } ]
( ) ( )
g
f f
p I T g E I T
g g
    
y θ y θ
y y y y
y yY
              (6.2) 
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and hence can be estimated by the stochastic counterpart of (6.2): 
0
1
1 ( ; )
ˆ { ( ) }
( )
N
l
l l
f
p I T
N g


 
y θ
y
y
                                       (6.3) 
where the subscript g in equation (6.2) indicates that the expectation is taken with respect to the 
proposal density g(•), and 1,..., Ny y  in equation (6.3) are random samples drawn from g(•). The 
optimal proposal density [111,114] is 
* 0{ ( ) } ( ; )( )
I T f
g
p


y y θ
y                                         (6.4) 
The adaptive CE method [111] provides one way of finding a proposal density ( ; )f θ  that is 
close to the optimal proposal density *g   within the same distribution family as 0( ; )f θ   by 
minimizing the cross-entropy between *g  and ( ; )f θ , which is defined as 
  
 
 
*
* *
* * *
( )
( ), : ( ) ln d
( ) ln ( )d ( ) l
;
d;n
•;f
f
g
g
g g f
g
g

 

 
y
θ y y
y θ
y y y y y θ y
y
y y
D
                (6.5) 
The first term in the right-hand side of equation (6) does not depend on θ  and the second term 
can be written as 
                            
0
0
( ; )
{ ( ) } ( ; ) 1
ln d [ { ( ) }ln; ];f
I T f
E I T
p
f f
p



  θ
y y θ
y θ y y y θ
y
 
Therefore, the parameter θ  that minimizes   *( ), •;g f θD  is the solution to the following 
optimization problem: 
 
0( ; )
;argmax [ { ( ) }ln ]fE I fT θ
θ
y y θ                                    (6.6) 
Following our discussions in Section 4.2 of Chapter V and [111], problem (6.6) can be solved 
adaptively using the following procedure: 
Procedure 2 (The adaptive CE method for rare-event probability estimation) 
A. Adaptive updating step: 
(1) Specify a constant  0,1  . Start with parameter 0θ ; Set the iteration counter k = 0. 
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(2) At the kth iteration, generate random samples 1,..., Ny y  from ( ; )kf θ . Calculate the statistics 
1 ,( ) ), ( NT Ty y , and compute k  as their sample (1 )  quantile, provided k  . If k  , 
set k  . 
(3) Updating the parameter kθ  with 1kθ , which is the solution to the following problem: 
0
1
1
1 ( ; )
arg max [ { ( ) } ln ( ; )]
( ; )
N
l
k l k l
l l k
f
I T f
N f


 
θ
y θ
θ y y θ
y θ
 
(4) If k  , set k = k+1 and reiterate from Step (2); otherwise, proceed to the following Step B. 
B. Estimating step: 
Use ( ; )kf θ  as the proposal density and generate random samples 1,..., My y  from ( ; )kf θ . 
Estimate p-value as 0
1
1 ( ; )
ˆ [ { ( ) } ]
( ; )
M
l
l
l l k
f
p I T
M f


 
y θ
y
y θ
. 
6.2.2 Limitations of the adaptive CE method 
   As we implement the above adaptive CE method for estimating small p-values in parametric 
bootstrap tests, we found that it does not perform very well: the algorithm either fails to converge 
in some cases, or the estimated results from the converged cases show very large variations (See 
the summary of the simulations in Section 6.3.2). This observation is consistent with several other 
studies, which have also shown that the adaptive CE method for rare event simulation can fail in 
high-dimensional settings [119,122,126,127]. As discussed in [127], one important reason for the 
failure of the adaptive CE method is that the proposal density obtained from the adaptive CE 
method can be far from the optimal proposal density in high dimensions, and thus is suboptimal 
[127]. To overcome this problem, Chan el al developed a new approach that considerably improve 
the adaptive updating procedure in terms of both accuracy and computational time [127], which is 
essentially the underlining theoretical basis for our proposed method for estimating small p-values 
in parametric bootstrap tests. Below we briefly show that how that approach is derived following 
[127]. By re-examination of the definition of CE in equation (6.5), we can see that the second term 
on the right hand side can also be re-written in the following way: 
   **( ) ln d [ln; ];gg f E f y y θ y y θy                                          (6.7) 
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where the subscript *g  in (6.7) means that the expectation is taken with respect to the optimal 
proposal density *g . Hence the parameter θ  that minimizes   *( ), •;g f θD  should maximize 
(6.7), which is the solution to the following optimization problem: 
 *argmax [ n ];lg fE
θ
y θ                                                       (6.8) 
   Suppose we can directly draw random samples from *g  (in the next section we will describe 
several methods to achieve this goal), then problem (6.8) can be solved by maximizing the 
stochastic counterpart of  *[ln ; ]gE f y θ , i.e. 
 
1
1
argmax [ln ];
N
llN
f

θ
y θ                                                   (6.9) 
where 1,..., Ny y  in (6.9) are random samples drawn from 
*g  . After dropping the constant 
1
N
 , 
problem (6.9) can be written as 
 
1
argmax [ln ];
N
ll
f

θ
y θ                                                 (6.10) 
which is, notably, the maximum likelihood estimation (MLE) of θ  under the likelihood function 
 ;f θ  with 1,..., Ny y  drawn from 
*g  . Compared with the adaptive CE method (Procedure 2), 
problem (6.10) does not contain any likelihood ratio or indicator functions, and it is a regular 
problem of finding MLE in statistics, which can be solved either analytically for many commonly 
used distributions [e.g., if   ;f θ  is a multivariate normal distribution], or numerically by widely 
used approaches such as Newton-Raphson or the EM algorithm for other complicated distributions 
[128]. 
6.2.3 Sampling from the optimal proposal density 
   In this section, we briefly review the algorithms for sampling from the optimal proposal density
*g  . From equation (6.4), we can see that *g   is a truncated distribution with the probability 
distribution 0( ; )f y θ  truncated by the constraint ( )T y . In the literature, there are at least three 
sampling algorithms proposed for sampling from a truncated distribution in the form of *g : the 
Gibbs sampler, the hit-and-run sampler and the Hamiltonian Monte Carlo sampler and all these 
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methods are based on Markov chain Monte Carlo (MCMC). The Gibbs sampler is a classical 
method for drawing random samples from truncated distributions that consists of sampling from a 
sequence of conditional distributions, and the details of this approach can be found in [129,130]. 
The hit-and-run sampler is another algorithm that can reduce the problem of sampling from a 
multivariate distribution with a high dimensional constraint (such as *g ) to the problem of sampling 
from a univariate truncated distribution, and the details of this algorithm can be found in [119,131].  
   The Hamiltonian Monte Carlo (HMC) sampler is a more recently developed algorithm that uses 
principle of the Hamiltonian dynamics in physics and has become a powerful tool for sampling 
from many complicated distributions [132-134], and in the following we review the core idea of 
this method. As a concrete example, we consider  ;f θ  as a multivariate normal distribution
( , )nN μ Σ , where  μ  is the mean vector and Σ  is the covariance matrix, and our discussion mainly 
follows [135]. First note that if ~ ( , )nNy μ Σ  , then y can be written as the following linear 
transformation with respect to the random vector x 
1/2 y μ UΛ x                                                          (6.11) 
where x follows the standard multivariate normal distribution ( , )nN 0 I   and 
1/2 1/2( )T T Σ UΛU UΛ UΛ  is the eigen-decomposition of the covariance matrix Σ and the 
columns of U are unit eigenvectors and Λ is a diagonal matrix of the eigenvalues. Hence, our 
following discussion will focus on how to apply HMC to sample from the truncated distribution 
with respect to ( , )nN 0 I , then sampling from the truncated distribution with respect to ( , )nN μ Σ  
is straightforward by applying the linear transformation (6.11) [135]. 
   Following [135], the log density function of ( , )nN 0 I  can be written as the following form: 
1
log ( )
2
Tf c  x x x                                                     (6.12) 
where c is a constant with respect to x. The HMC is a “particle method” and we need to imagine 
the trace of the positions of the consecutive draws of the random samples is like a trajectory of a 
particle travelling according to a potential energy function (which is determined by the probability 
density function) and a kinetic energy function (which is usually introduced artificially to construct 
the Hamiltonian system). The potential energy is determined by the position of the particle and the 
kinetic energy is determined by the momentum of the particle, and the sum of the potential energy 
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function and the kinetic energy function is a Hamiltonian system [132-134]. For the standard 
multivariate normal distribution, we can construct the following Hamiltonian 
( , ) ( ) ( )H U K sx sx                                                    (6.13) 
where 
1
( ) log ( )
2
TU f  x x x x  is the potential energy function (the constant c dropped) and 
1
( )
2
TK s s s  is the artificially introduced kinetic energy function with 
1( ,..., )ns ss  as the vector 
of momentum variables [135,136]. Based on the Hamiltonian (6.13), the evolvement of the particle 
is determined by the following systems of equations according to the Newton's Laws of Motion 
[135,136] 
ii
i
i
i
i
dx H
s
dt s
ds H
x
dt x

 


   

                                                 (6.14) 
where ix  and 
is  denote the ith element of x and s and i = 1,…, n. The two first order differential 
equations in (6.14) can be combined to one equation (note that there are n such equations)  
2
2
,  1,...,i i
d x
x i n
dt
                                               (6.15) 
which has the following analytical solution 
( ) sin( ) cos( ),  1,...,i i ix t a t b t i n                                  (6.16) 
with the constants ia  and ib  determined by the initial conditions (discussed below) as 
0
(0)
(0)
ii
i
t
i i
dx
a s
dt
b x

 

                                               (6.17) 
Following [135], the HMC algorithm iterates with the following two steps: Step 1. Sample the 
initial momentum variables s from ( , )nN 0 I . Step 2. Use the s from Step 1 and the values of x at 
the end of last iteration as initial conditions to determine the constants ia  and ib  according to 
equation (6.17), and then let the particle to travel for a time T. It is shown in [135] that by 
constructing the HMC algorithm in the above way, the two properties of the Hamiltonian dynamics, 
the conservation of energy and the conservation of volume in phase space are met and the detailed 
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balanced condition of the Markov chain Monte Carlo is satisfied. The authors of [135] also show 
that a good choice of the travelling time T is / 2 . 
Next consider the constraint  
( )T y ,                                                          (6.18) 
and we imagine that it is like a wall on the trajectory of the particle. Once the particle hits the wall, 
we let it bounce off the wall and continue travelling with a reflected velocity [135]. The hitting of 
the wall occurs when the inequality (6.18) is saturated (i.e. takes the equality) [135], and the time 
of hitting can be found by solving the following equation 
[ ( )]T t y                                                            (6.19) 
where y(t) is a function of time t that is determined by (6.16) and the linear transformation (6.11). 
The authors of [135] give analytical solutions for (6.19) under the constraints where T(•) is linear 
or quadratic functions of y. In summary, the HMC algorithm for sampling from a truncated 
multivariate normal distribution iterates with the following two steps [135]:  
(1) Sample the initial momentum variables s from ( , )nN 0 I .  
(2) Use the s from step (1) and the values of x at the end of last iteration as initial conditions to 
determine the constants ia  and ib  in equation (6.17), and then let the particle to travel for a time 
T. During time T, if the particle hits the wall [i.e. constraint (6.18), and the time of hitting is 
determined by equation (6.19)], then let it continue travelling with a reflected velocity. 
   For other types of continuous distributions, the HMC sampler can be constructed in a similar 
way as the multivariate normal distributions discussed above, but equation (6.14) usually do not 
have analytical solutions and need to be solved using some numerical methods, such as the leapfrog 
algorithm for which the time is discretized with some small step size ε for L steps [132,134,136], 
and details can be found in [134,136,137]. For discrete distributions, the HMC sampler can be 
constructed using the technique Gaussian augmentation (or exponential augmentation) by 
introducing auxiliary variables that follow Gaussian (or exponential) distributions, and details can 
be found in [138,139]. 
   As a note for the three MCMC sampling algorithms mentioned above, the authors of [135] 
compare the performance of the HMC sampler and the Gibbs sampler and find that the HMC 
sampler is much more efficient, since the runtime of the Gibbs sampler increase linearly with the 
dimensions and it is very slow when the constraint like (6.18) “imposes high correlations among 
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coordinates” [135]. Comparisons of the performance between the hit-and-run sampler and the 
HMC sampler is of our future interest, but some studies note that the hit-and-run sampler suffers 
a similar problem of slow convergence in the cases where the constrained sample space impose 
high correlations [135,140]. 
   Combining the above discussions, the complete algorithm for the estimation of small p-values 
in parametric bootstrap tests can be summarized below: 
Procedure 3 (MCMC cross-entropy method for parametric bootstrap tests – MCMC-CE) 
A. Parameters updating step: 
1. Generate N random samples 1,..., Ny y  from the optimal proposal density 
*g  using one of the 
MCMC sampling approaches described above (for e.g., the HMC sampler). 
2. Solve the maximization problem (6.10) with 1,..., Ny y  and obtain the proposal density  •;f θ . 
B. Estimating step: 
Use  •;f θ   as the proposal density and generate M random samples 1,..., Ny y   from  •;f θ  . 
Estimate p-value as 
1
01 ( ; )ˆ { ( ) }
( ; )
M
l
l
l l
f
p I T
M f


 
θ
y
y θ
y
. 
   Compared with the adaptive CE method (Procedure 2), the MCMC-CE method (Procedure 3) 
finds the proposal density by drawing samples from *g  and solve the maximization problem (6.10)                    
in a single step instead of in an adaptive fashion through multiple steps. Therefore, it not only 
considerably improves computational efficiency, but also gives more robust and numerically stable 
estimations, as noted and studied in [127]. 
6.3 Application: parametric bootstrap tests for variance components in LMMs 
   We apply our MCMC-CE approach to the problem of testing the variance components in LMMs 
using parametric bootstrap. Following the notations in [141], we consider the LMMs of the 
following form: 
2~ N { , ( )}n Y Xβ V τ  
with  
1
( )
J
j jj


 V τ I K ,                                                  (6.20) 
where Y is an n × 1 vector of data following the multivariate normal distribution with mean Xβ 
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and variance σ2V(τ), X is an n × p design matrix for covariates (fixed effects), β is a p × 1 vector 
of fixed-effect parameters, I is the n × n identity matrix, Kj’s, j = 1,…, J, are n × n known positive 
semidefinite matrices, σ2 is the variance parameter for the error term, τj’s, j = 1,…, J, are the scaled 
variance component parameters such that σ2τj is the jth variance component [141]. This form of 
LMMs are widely used for analyzing a variety types of data in practice. For instance, in multi-
level random effect models Kj is given by Tj jΖ Z , where Zj is an n × qj design matrix for the jth 
random effect factor [99,141]. In genomic studies, Liu et al develops a method for testing the 
association between a gene set/pathway (i.e. a group of genes with relevant biological functions) 
and a continuous outcome using the LMM representations of linear-square kernel machine [107]. 
In their model, the effect of a gene set/pathway is modeled non-parametrically using a kernel 
function and can be represented by a single variance component LMM [i.e. J =1 written in the 
form of model (11)], where the matrix K1 corresponds to the kernel matrix [107]. Nowadays this 
type of models are also widely used in genome-wide association studies (GWAS) to test the 
associations between a phenotype and a set of common and rare single nucleotide polymorphisms 
(SNPs) [142,143]. 
   In all the applications discussed above, the goal is to test the significance of a single variance 
component, which can be written as the following hypothesis test problem: 
0 : 0jH    v.s. 1 : 0jH                                                     (6.21) 
for the jth variance component. In genomic studies, the score-type statistic of the form 
 ( ) ( )T jT   Y Xβ K Y Xβ                                                   (6.22) 
proposed by Lin and colleagues has attracted considerable attention [107,141-143]. The score 
statistic (6.22) is computed under the null model that has fewer variance component parameters 
than the alternative model, and hence can reduce the computational time considerably compared 
with other types of tests such as the likelihood ratio test, so that it has been widely used in high-
throughput genomic studies, for which the computational burden is often significant [107,142,143]. 
In the literature, several methods have been used to approximate the distribution of T under H0, 
such as the Satterthwaite method [107] or the Davies method [141-144]. As noted in [143], for 
large sample studies these methods perform generally well for controlling type I error rate and 
achieving adequate power, but when the sample size is small, the type I error rate is often not well-
controlled at genome-wide small α levels (e.g. <10-6) [143]. Hence, resampling-based approaches 
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are recommended for that situation, which can correctly control the type I error rate [143]. Below 
we use the parametric bootstrap to estimate the p-value using the score statistic (6.22) and show 
how our MCMC-CE method can be used to efficiently reduce the computational time. 
6.3.1 Test the variance component for LMMs with a single variance component 
   In LMMs with a single variance component, to test the variance component τ (we drop the 
subscript j in this section, since there is only one variance component), note that under the null 
model H0, 0( ; )f θ  is a multivariate normal distribution of the form (6.20) with 
2
0 0 0( , )
Tθ Xβ , 
and the parameters β0 and 
2
0  are estimated under the null model H0 (the subscript ‘0’ is to 
emphasize that fact), which is a regular linear regression model, and  0V τ  is simply the identity 
matrix I with no unknown parameters. Implementation of the general parametric bootstrap test 
(Procedure 1) is straightforward by first estimating parameters β0 and 
2
0  and computing the 
observed score statistic γ according to equation (6.22) and then simulating data from the null model 
2
0 0
ˆ ˆN { , }n Xβ I  following Procedure 1. 
   To apply the MCMC-CE method, note that under the null model β0 is estimated by 
1
0
ˆ ( )T Tβ X X X Y , hence the constraint ( )T y  can be written as  
1 1[ ( ) ] [ ( ) ]T T T T T    Y X X X X Y K Y X X X X Y  
which can be further written as the following quadratic constraint function with respect to Y : 
1 1[ ( ) ] [ ( ) ] 0T T T T T T     Y I X X X X K I X X X X Y                           (6.23) 
Therefore, the optimal proposal density *g   is a truncated distribution with 2
0 0
ˆ ˆN { , }n Xβ I  
truncated by constraint (6.23), and random samples from *g  can be drawn using one of the three 
MCMC algorithms reviewed in Section 6.2.3. The implementation of the MCMC-CE method 
follows Procedure 3. In our applications, we use the HMC algorithm as implemented in the R 
package tmg [135] to draw random samples from *g , and hence we name our approach as HMC-
CE below. 
Simulations. We conduct simulation studies to compare the general parametric bootstrap test 
(below named as brute-force PB) and the HMC-CE method for the variance component test in 
LMMs with a single variance component. The following single-level clustered random-effect 
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model is used in the simulations: 
0ij j ijY b e    
with 
2~ (0,  )j bb N   and 
2~ (0,  )ij ee N                                     (6.24) 
where Yij is the outcome of subject i in cluster j (i = 1,…, nj; j = 1,…, m; m is the number of clusters 
and nj is the number of subjects in cluster j), bj and eij are respectively the random effect of cluster 
j and the random error at subject level, 2
b  and 
2
e  are the variances for bj and eij, and 
m
jj
N n  
is the total number of subjects. The goal is to test the significance of the variance component 2
b , 
i.e.  
H0: 
2 0b    v.s. H1: 
2 0b   
If we compare model (6.24) to the alternative form in (6.20), we can see that here the matrix K is 
a N × N block diagonal matrix that can be written as 
T
ZZ where Z is an N × m design matrix with 
indicators of cluster indices denoting which subject belongs to which cluster. 
   In our simulations, we fix the following parameters: 0 5  , 
2 1e  ,  6jn   for all j’s,  j = 1,…, 
m, and tune the effect size and sample size by varying 2
b  and m. In the first simulated experiment, 
we fix m at m = 5 and vary b  for three different values 1.75, 1.9 and 2.0 respectively, which give 
different p-values on the orders of 10-5, 10-6 and 10-7 (Table 6.1). Then we use the brute-force 
parametric bootstrap and the HMC-CE method to estimate the p-values in a more accurate fashion. 
For the brute-force parametric bootstrap, the number of re-samples used equals to 10 divided by 
the order of the three p-values, which gives 106, 107 and 108 number of re-samples (Table 6.1). 
For the HMC-CE, we draw 10000 samples using the HMC method in the parameter updating step 
to obtain the proposal density, and 2000 samples from the proposal density to estimate the p-values 
in the estimating step (see Procedure 3). For both methods, we repeated 50 times with different 
random seeds and use the average of the 50 estimated p-values as the final point estimation of the 
p-values ( pˆ  in Table 6.1). We also calculate the standard deviation (S.D.) for the 50 estimated p-
values and record the computational time. The results of this experiment are shown in Table 6.1. 
   In the second simulated experiment, we fix b  at 1.3b  and vary m for three different values 
6, 8 and 9 respectively, then we perform exactly the same procedure as that in the first experiment. 
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The results of this experiment are shown in Table 6.2. 
   From Table 6.1 and Table 6.2, we can see that the brute-force parametric bootstrap and HMC-
CE give almost the same estimated p-values. In terms of precision, HMC-CE reduces the S.D. 
roughly by a factor of 10 compared with the brute-force method and hence is much more accurate. 
Lastly, but importantly, the HMC-CE reduces the computational time roughly by a factor ranging 
from 300 to 10000 compared with the brute-force method, and the gain in computational efficiency 
are more considerable as the p-value goes smaller. 
   In the above two numerical experiments, we also apply the adaptive CE method (Procedure 2). 
We find that this method fails to converge to a close-to-optimal proposal density after reaching the 
maximum number of iterations (which is set as 20 here) in approximate 30% of the times, and in 
those converged cases the estimated p-values show very large variations and the average over 
different repetitions (not shown here) deviates substantially from those of the brute-force PB and 
the HMC-CE shown in Table 6.1 and 6.2. Though we do not know the reason for the failure of the 
adaptive CE method and will further investigate this algorithm in the future, we note that our 
findings are consistent with several other studies that have also shown that the adaptive CE method 
has some issues in terms of robustness and numerical stability in some high-dimensional settings 
[119,122,126,127]. 
 
Table 6.1 Simulation results of parametric bootstrap tests for variance component in LMMs 
with a single random effect – varying effect size. 
σb Brute-force HMC-CE 
 
?̂? 
(S.D.) 
#samples 
(time) 
?̂? 
(S.D.) 
#samples 
(time) 
1.75 
1.58×10-5 
(7.63×10-6) 
106 
(2.69×105) 
1.51×10-5 
(8.38×10-7) 
1.2×104 
(8.94×102) 
1.9 
2.42×10-6 
(1.57×10-6) 
107 
(3.42×106) 
2.47×10-6 
(1.02×10-7) 
1.2×104 
(1.32×103) 
2.0 
7.97×10-7 
(3.41×10-7) 
108 
(1.76×107*) 
7.89×10-7 
(3.38×10-8) 
1.2×104 
(1.87×103) 
 
*For this p-value, we split the computational jobs on two clusters and the computational time here 
is the sum of CPU time in seconds with 25 runs on 64 cores of AMD Opteron 6272, 2.1 GHz CPU 
and 25 runs on 80 cores of AMD 8214, 2.2 GHz. For others, the computational time is CPU time 
in seconds on 64 cores of AMD Opteron 6272, 2.1 GHz. 
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Table 6.2 Simulation results of parametric bootstrap tests for variance component in LMMs 
with a single random effect – varying sample size. 
m Brute-force HMC-CE 
 
?̂? 
(S.D.) 
#samples 
(time) 
?̂? 
(S.D.) 
#samples 
(time) 
6 
6.51×10-5 
(2.78×10-5) 
106 
(3.71×105) 
6.54×10-5 
(3.16×10-6) 
1.2×104 
(1.26×103) 
8 
1.09×10-6 
(6.21×10-7) 
107 
(4.13×106) 
1.02×10-6 
(7.34×10-8) 
1.2×104 
(1.83×103) 
9 
4.58×10-7 
(2.31×10-7) 
108 
(2.37×107*) 
4.65×10-7 
(2.57×10-8) 
1.2×104 
(2.41×103) 
 
*For this p-value, we split the computational jobs on two clusters and the computational time here 
is the sum of CPU time in seconds with 25 runs on 64 cores of AMD Opteron 6272, 2.1 GHz CPU 
and 25 runs on 80 cores of AMD 8214, 2.2 GHz. For others, the computational time is CPU time 
in seconds on 64 cores of AMD Opteron 6272, 2.1 GHz. 
 
6.3.2 Test one variance component in LMMs with multiple variance components 
   For LMMs with multiple variance components [i.e. J ≥ 2 in model (6.20)], to test the significance 
of the jth variance component τj [see formula (6.21)], note that 0( ; )f θ  now is a multivariate 
normal distribution with mean Xβ0 and covariance  20 0V τ , which is computed under the null 
model H0 without τj. Also note that the matrix  0V τ  contains one or more variance components 
other than τj, and we use \J jτ  to denote those variance components excluding τj. Implementation 
of the brute-force parametric bootstrap test is again straightforward by first fitting the H0 model 
2
0 0 0 \
ˆ ˆˆN { , ( )}n J jXβ V τ , and then simulating data following Procedure 1. 
   To apply the MCMC-CE method, we need to estimate β0 first. Note that the regular generalized 
least-square estimator  
2 1 1 2 1
0 0 0 \ 0 0 \
ˆ ˆ ˆˆ ˆ{ [ ( )] } [ ( )]T TJ j J j 
  β X V τ X X V τ Y                         (6.25) 
in LMMs depends on 
\J jτ , and all the parameters β0, \J jτ  and σ0 have to be estimated iteratively 
by maximizing the likelihood (or restricted likelihood) function of the LMM model [99,145]. 
Hence the constraint  
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0 0
ˆ ˆ( ) ( )T jT    Y Xβ K Y Xβ                                          (6.26) 
cannot be written as a quadratic constraint function that solely depends on Y as in the case of single 
variance component LMMs. To solve this problem, we use the following approximated method: 
Since the ordinary least square estimator 
1
0,
ˆ ( )T TOLS
β X X X Y  is also an unbiased estimator of 
β0 [146], so we use 0,
ˆ
OLSβ  to approximate the general least-square estimator (6.25) in LMMs, and 
hence use 
1 1[ ( ) ] [ ( ) ]T T T T TOLS jT 
    Y X X X X Y K Y X X X X Y                  (6.27) 
to approximate the constraint (6.26). As long as OLST  is not far away from T, we can still generate 
random samples from a probability density function truncated by the constraint (6.27) that is close 
to the optimal proposal density *g , which is named as *
ag  hereafter. Therefore, 
*
ag  is a truncated 
distribution with 
2
0 0 0 \
ˆ ˆˆN { , ( )}n J jXβ V τ  distribution truncated by the constraint (6.27), and similar 
to the single variance component LMMs case, random samples from *
ag  can be drawn using the 
HMC sampler and the implementation of the HMC-CE method then follows with Procedure 3. 
Simulations. We conduct simulation studies to compare the brute-force parametric bootstrap and 
the HMC-CE method for testing one variance component in LMMs with multiple variance 
components. The following two-level clustered random-effect model is used in the simulations: 
0ijk i ij ijkY b b e     
with 
2
1~ (0,  )ib N  , 
2
2~ (0,  )ijb N  and 
2~ (0,  )ijk ee N                        (6.28) 
In this model, there are two levels of clustering: some small clusters (level-2 cluster) are nested in 
some big clusters (level-1 cluster), and the subjects are nested in level-2 clusters [99]. The 
meanings of the symbols in model (6.28) are: Yijk is the outcome of subject k in the jth level-2 
cluster of the ith level-1 cluster (k = 1,…, nij; j = 1,…, mi; i = 1,…, l; l is the number of  level-1 
clusters;  mi is the number of level-2 clusters in the ith level-1 cluster; nij is the number of subjects 
in the jth level 2 cluster of the ith level 1 cluster), bi, bij and eijk are respectively the two random 
effects correspond to level-1 cluster, level-2 cluster and the random error at subject level, 2
1 , 
2
2  
and 2
e  are the variances of bi, bij and eijk, and 
i
i
l m
ijm j
N n   is the total number of 
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observations. The goal is to test the significance of the variance component 2
2 , i.e.  
H0: 
2
2 0    v.s. H1: 
2
2 0   
Suppose Yijk’s are ordered according to the indices of clusters (first by the indices of level-1 cluster, 
then by the level-2 cluster), then if we compare model (6.28) to its alternative form (6.20), we can 
see that here the matrix K2 (the subscript 2 means we are testing the 2nd variance component 
2
2 ) 
is a N × N block diagonal matrix that can be written as 
T
ZZ with Z as an  ( )
l
ii
N m   design matrix 
with indicators of level-2 cluster indices denoting which subject belongs to which level-2 cluster. 
   In our simulations, we fix the following parameters: 
0 1  , 1 1  , 0.5e  , 5l  , 5im   for 
all i’s, 4ijn   for all i’s and j’s (j = 1,…, mi; i = 1,…, l), and tune the effect size by varying the 
parameter σ2 at three different values 0.375, 0.4 and 0.45 respectively, which give different p-
values on the orders of 10-5, 10-6 and 10-7 (Table 6.3). Then we use the brute-force parametric 
bootstrap and the HMC-CE method to estimate the p-values similarly as that in the single variance 
component LMM case, and for both methods the numbers of re-samples and repetitions, and the 
summary statistics calculated (point estimation of the p-values, S.D. and time) are the same as in 
Section 6.3.1. The results of this experiment are shown in Table 6.3. 
   From Table 6.3, we can see that the brute-force parametric bootstrap and HMC-CE give almost 
the same estimated p-values. In terms of precision, HMC-CE reduces the S.D. roughly by a factor 
of 6 compared with the brute-force method (note that here the variations of the HMC-CE increase 
a bit compared with the single random-effect LMM case, since we use *
0g  to approximate the 
optimal proposal density *g  as discussed above). Regarding the computational time, the HMC-CE 
reduces the time roughly by a factor ranging from 230 to 9000 compared with the brute-force 
method, and the gain in computational efficiency is more considerable as the p-value goes smaller, 
which is similar to the single random-effect LMM case. 
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Table 6.3 Simulation results of parametric bootstrap tests for one variance component in 
LMMs with multiple variance components. 
σ2 Brute-force HMC-CE 
 
?̂? 
(S.D.) 
#samples 
(time) 
?̂? 
(S.D.) 
#samples 
(time) 
0.375 
2.41×10-5 
(9.76×10-6) 
106 
(8.79×105) 
2.49×10-5 
(1.53×10-6) 
1.2×104 
(3.76×103) 
0.4 
6.38×10-6 
(2.41×10-6) 
107 
(1.04×107) 
6.32×10-6 
(3.89×10-7) 
1.2×104 
(4.42×104) 
0.45 
2.35×10-7 
(1.42×10-7) 
108 
(4.53×107*) 
2.29×10-7 
(2.71×10-8) 
1.2×104 
(4.97×103) 
 
*For this p-value, we split the computational jobs on two clusters and the computational time here 
is the sum of CPU time in seconds with 25 runs on 64 cores of AMD Opteron 6272, 2.1 GHz CPU 
and 25 runs on 80 cores of AMD 8214, 2.2 GHz. For others, the computational time is CPU time 
in seconds on 64 cores of AMD Opteron 6272, 2.1 GHz. 
 
6.3.3 Application to gene set differential expression analysis 
   In this section, we demonstrate our method to the gene set differential expression analysis with 
a real microarray gene expression dataset from a study of patients with prostate cancer [147]. The 
microarray dataset is comprised of 22 prostate cancer patients (there are also normal patients, 
which are not relevant to the analysis here) with four clinicopathological variables recorded: 
prostate-specific antigen (PSA) level (continuous variable), age (continuous variable), Gleason 
score (categorical variable) and pathologic stage (categorical variable) [147]. Prostate tissue 
samples are collected from these patients and the expression levels of 22500 genes in these samples 
are measured by Affymetrix GeneChip Human Genome U133A 2.0 Array [147]. The dataset is 
available in NCBI Gene Expression Omnibus under accession number GSE3868. 
   The goal of our analysis here is to test the associations of a gene set with PSA levels, and the 
model we used to fit the data is a LMM with a single variance component as described in [107]. 
Using the notations of model (6.20), the outcome Y is the log-transformed PSA levels, the fixed-
effect covariates X contains the variables age, Glean score and pathologic stage, and the matrix K 
in the random-effect part is the matrix of a kernel function for representing a smooth non-
parametric function that models the effect of the gene set. See [107] for details of this model. In 
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our analysis, we use the Gaussian kernel following [107], and fit the model with the R package 
nlme [99,148]. 
  The gene set annotation file is downloaded from the Broad Institute Gene Set Enrichment 
Analysis project website (http://software.broadinstitute.org/gsea/index.jsp), which contains the 
annotations for a collection of 13261 curated gene sets. Since the computational time will be 
overwhelming if all the 13261 gene sets are tested by parametric bootstrap and our purpose here 
is to demonstrate the strength of the HMC-CE method for efficiently estimating small p-values in 
parametric bootstrap tests, therefore we first do the following screening tests to filter out those 
non-significant or less-significant gene sets: we first fit the above LMM model and calculate the 
p-values using parametric bootstrap with 1000 resamples, which filters out those gene sets with p-
values approximately greater than 0.001; then we calculate the p-values for the remaining gene 
sets using parametric bootstrap with 10000 resamples, which filters out those gene sets with p-
values approximately greater than 0.0001. For the remaining gene sets after the second-round of 
filtering, we use the brute-force parametric bootstrap and the HMC-CE method to test the effect 
of the gene sets as what we have done in the above simulation part. For the brute-force parametric 
bootstrap, the number of re-samples used for testing each gene set is 108. For HMC-CE, we use 
10000 samples drawn by the HMC sampler in the parameter updating step and 2000 samples in 
the estimating step. For both methods, we repeat 50 times with different seeds and calculate the 
point estimation and S.D. of the p-values in the same way as in the above simulation part. 
   Table 6.4 shows the results of the top 14 significant gene sets with p-values < 0.0001. As 
expected, the HMC-CE method considerably reduces the variations for estimating those small p-
values in parametric bootstrap tests and reduces the computational time roughly by a factor of 
1900. 
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Table 6.4 Estimated p-values for the top 14 differentially expressed gene sets. 
 
Total CPU time: Brute-force – 1.27×108s; HMC-CE – 6.74×104s* 
 
Geneset Name Systematic Name Number of Genes 
Brute-force P-value 
(S.D.) 
HMC-CE P-value 
(S.D.) 
Description 
ACTIVATION_OF_JNK_AC
TIVITY 
M7654 16 
6.42×10-9 
(5.95×10-9) 
6.96×10-9 
(6.18×10-10) 
Genes annotated by the GO term GO:0007257. The initiation 
of the activity of the inactive enzyme JUN kinase by 
phosphorylation by a JUN kinase kinase (JNKK). 
YU_MYC_TARGETS_UP M1249 42 
1.37×10-8 
(1.32×10-8) 
1.12×10-8 
(2.24×10-9) 
Genes up-regulated in B cell lymphoma tumors expressing an 
activated form of MYC 
REACTOME_CHOLESTER
OL_BIOSYNTHESIS 
M16227 24 
1.81×10-8 
(1.49×10-8) 
1.93×10-8 
(2.41×10-9) 
Genes involved in Cholesterol biosynthesis 
REACTOME_DOWNREGU
LATION_OF_SMAD2_3_S
MAD4_TRANSCRIPTION
AL_ACTIVITY 
M669 20 
8.73×10-8 
(6.31×10-8) 
8.96×10-8 
(7.26×10-9) 
Genes involved in Downregulation of SMAD2/3:SMAD4 
transcriptional activity 
ST_P38_MAPK_PATHWAY M12012 37 
1.82×10-7 
(1.03×10-7) 
1.76×10-7 
(9.84×10-9) 
p38 MAPK Pathway 
IKEDA_MIR30_TARGETS_
UP 
M2379 116 
5.26×10-7 
(2.13×10-7) 
5.37×10-7 
(2.48×10-8) 
Genes up-regulated in hypertrophic hearts (due to expression 
of constitutively active form of PPP3CA [GeneID=5530]) and 
predicted to be targets of miR-30 microRNA. 
PID_AURORA_B_PATHW
AY 
M14 39 
7.41×10-7 
(2.84×10-7) 
7.27×10-7 
(4.31×10-8) 
Aurora B signaling 
GSE4984_UNTREATED_V
S_VEHICLE_CTRL_TREA
TED_DC_UP 
M6500 149 
1.13×10-6 
(3.36×10-7) 
1.04×10-6 
(9.47×10-8) 
Genes up-regulated in monocyte-derived dendritic cells: 
untreated versus vehicle. 
GEORGES_CELL_CYCLE_
MIR192_TARGETS 
M11038 62 
2.59×10-6 
(4.12×10-7) 
2.71×10-6 
(1.94×10-7) 
Experimentally validated direct targets of 
MIR192 [GeneID=406967] microRNA; MIR192 caused cell 
cycle arrest in HCT116 cells (colon cancer). 
NEUROGENESIS M11351 93 
5.76×10-6 
(5.87×10-7) 
5.69×10-6 
(3.32×10-7) 
Genes annotated by the GO term GO:0022008. Generation of 
cells within the nervous system. 
RB_DN.V1_DN M2799 126 
6.82×10-6 
(6.12×10-7) 
6.76×10-6 
(4.73×10-7) 
Genes down-regulated in primary keratinocytes from RB1 
[Gene ID=5925] skin specific knockout mice. 
LUI_THYROID_CANCER_
CLUSTER_4 
M4333 16 
9.07×10-6 
(7.49×10-7) 
9.13×10-6 
(7.26×10-7) 
genes with similar expression profiles across follicular thyroid 
carcinoma (FTC) samples. 
GAVIN_FOXP3_TARGETS
_CLUSTER_P7 
M1736 90 
2.24×10-5 
(1.03×10-6) 
2.18×10-5 
(1.07×10-6) 
Cluster P7 of genes with similar expression profiles in 
peripheral T lymphocytes after FOXP3[GeneID=50943] loss 
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of function (LOF). 
BOYLAN_MULTIPLE_MY
ELOMA_C_CLUSTER_UP 
M1367 38 
8.13×10-5 
(2.97×10-6) 
8.09×10-5 
(3.41×10-6) 
Up-regulated in group C of tumors arising from 
overexpression of BCL2L1 and MYC [GeneID=598;4609] in 
plasma cells. 
 
*For brute-force parametric bootstrap, we split the computational jobs on two clusters and the computational time is the sum of CPU time in seconds 
with 25 runs on 64 cores of AMD Opteron 6272, 2.1 GHz CPU and 25 runs on 80 cores of AMD 8214, 2.2 GHz. For HMC-CE, the computational 
time is CPU time in seconds on 64 cores of AMD Opteron 6272, 2.1 GHz.
115 
 
6.4 Discussion 
   In this chapter, we present an algorithm for efficient estimation of small p-values in parametric 
bootstrap tests by combining the principle of the cross-entropy method to approximate the optimal 
proposal density and the HMC method for efficient sampling from the optimal proposal density. 
We apply our method to parametric bootstrap tests for variance components in LMMs and the 
underlying probability distribution in LMMs from which the bootstrapped samples are simulated 
is a multivariate normal distribution [see Procedure 1 and model (6.20)]. However, our approach 
is a more general method for estimation of small p-values in parametric bootstrap tests and can be 
applied to the cases where the underlying probability distribution is other than multivariate normal. 
As we have discussed in Section 6.2.2 and 6.2.3, the core of the algorithm is how to sample from 
the optimal proposal density *g , which is essentially a multivariable truncated distribution, and 
this can be achieved with the various MCMC sampling methods as discussed in Section 6.2.3. 
Meanwhile, developing more efficient sampling algorithms for generating random samples from 
high dimensional truncated distributions is still an interesting and ongoing research topic. 
   Also the principle of the proposed method is not limited to the application of parametric bootstrap 
tests. As discussed in Section 6.2.1, the problem of estimating p-values in parametric bootstrap 
tests is essentially estimating the normalization constant of a multivariate truncated distribution, 
and the same idea can be applied to estimating the normalization constant of an arbitrary 
complicated distribution. One such example is the problem of estimating the normalization 
constant (i.e. the marginal likelihood) of the posterior distribution in Bayesian statistics, as noted 
in [127]. These extensions are considered as our future work. 
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Chapter VII 
Summary and Discussion
 
   In this dissertation, we have developed several new statistical methods for differential expression 
analysis with a variety of study designs and propose novel algorithms to improve the 
computational efficiency of resampling-based test methods in genomic studies. We close the 
dissertation by summary of the major contribution of our work and discussion about possible 
extensions and future work. 
7.1 Statistical methods for differential expression analysis 
   The focus of the first part of this dissertation (Chapter II, III and IV) is the application of 
statistical methods for differential expression analysis with real data. We consider the major 
contribution of our work in Chapter II as the proposition of the three models that characterize the 
different pattern of differential expression and splicing of genes in RNA-Seq data (Section 2.2 in 
Chapter II). As discussed in the end of Chapter II, a future research direction is to extend the 
method to incorporate biological replicates. 
   The contribution of the work in Chapter III is that we introduce a new statistic, the gene-level 
differential score, for joint testing differential expression and differential splicing of genes, which 
gives improved statistical power. Future work for this chapter is to improve the computational 
efficiency of the permutation test procedure. This is also relevant to the work in the second part of 
the dissertation, which is discussed in the next section. 
     In Chapter IV, we apply the two-part mixed model to single-cell gene expression data and use 
the automatic differentiation technique for efficiently fitting the model. The development of a user-
friendly software package for differential expression analysis with single-cell gene expression data 
is the future work of this chapter. In addition, automatic differentiation is a powerful tool for 
117 
 
optimization and fitting complex statistical models [97,98], and we consider applying this 
technique to genomic data and other types of data as a direction in our future research. 
7.2 Resampling methods, Monte Carlo simulation and the cross-entropy method 
   In the second part of this dissertation, we have developed two methods to improve the 
computational efficiency of resampling-based test methods. In Chapter V, we present a fast 
algorithm for evaluating small p-values from permutation tests based on the adaptive CE method 
[111]. The contribution of this work is that we reformulate the problem of estimating small p-
values in permutation tests to the problem of rare event probability estimation in the Monte Carlo 
simulation framework, and parameterize the permutation sample space for the paired two-group 
data with the i.i.d. Bernoulli distributions and for the unpaired two-group data with the conditional 
Bernoulli distribution. Through this process, the CE method can be readily applied to the 
estimation of small p-values in permutation tests, which considerably improves the computational 
efficiency. 
   In Chapter VI, we present an algorithm for efficient estimation of small p-values in parametric 
bootstrap tests. The contribution of this work is that we again reformulate the problem of 
estimating small p-values in parametric bootstrap tests to the problem of rare event probability 
estimation in the Monte Carlo simulations, and more importantly, we incorporate the work of the 
improved cross-entropy method [127] and propose to efficiently sample from the optimal proposal 
density using the Hamiltonian Monte Carlo method [134,135], which avoids the adaptive updating 
step in the classical CE method and hence improves both computational efficiency and numerical 
stability of the algorithm. 
   From the basis of our current work in this part, several interesting questions about future research 
topics arise. One of them is if the above two approaches can be extended to resampling-based tests 
for more complex data. One example is permutation tests for linear or generalized linear models, 
where other covariates are involved in these models (note that our work in Chapter V consists of 
only two groups of data, which is simpler than those models). Several permutation test methods 
have been proposed for those models and these methods involves the permutations of the residuals 
[149,150]. Examples of permutation tests for other types of complex data, such as correlated data, 
can be found in [110]. Directly applying the CE method to permutation tests for those complex 
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data is not trivial, because the foundation of the CE method is importance sampling, which requires 
the sample space to be fully parameterized by a family of distributions and finding a good family 
of distributions to parameterize the permutation sample space (like we have used the conditional 
Bernoulli for unpaired two-group data in Chapter V) for those complex data needs more efforts. 
Rather than the cross-entropy method, we note that several MCMC-based methods are also 
proposed for improving the computational efficiency in resampling-based test [31] and rare event 
probability estimation [151]. Compared with the CE method, those approaches do not require a 
fully parameterized family of distributions for constructing the Markov chain [31,151] and 
therefore may have more general applications in complex data. On the other hand, we should also 
note that an important difference between MCMC-based method and importance sampling is that 
the former generates correlated samples while the latter generated independent samples [119,152], 
therefore importance-sampling, in cases where it can be applied, often requires smaller number of 
samples than MCMC-based methods (as shown in Section 5.4.1 in Chapter V). 
   Another question is regarding the extension of the practical usage of our approaches. Although 
our proposed algorithms have achieved considerable gains in computational efficiency for 
estimating small p-values in resampling-based tests and we have demonstrated they are useful to 
identify the top differential expressed genomic features (Section 5.4.2 in Chapter V and Section 
6.3.3 in Chapter VI), applying them to each gene for a total of about 20000 genes still takes very 
long computational time. This problem is still a limitation for the practical usage of our approaches. 
One possible solution is to incorporate the early stopping rule for resampling-based multiple 
testing [58]. The principle of the early stopping rule is similar to that of the ad hoc procedure for 
filtering out those non-significant or less significant gene sets in the analysis of gene set differential 
expression in Section 6.3.3 in Chapter VI, which stops further testing the non-significant genomic 
features with a small number of resamples, however the early stopping rule proposed in [58] 
provides a rigorous way to control false discovery rate and theoretically tractable bounds on testing 
errors [58]. Other methods for saving computational time in resampling-based tests with similar 
early-stopping principle can be found in [153,154]. Combining those methods and extending the 
practical usage of our current approaches is another direction of our future work. 
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APPENDIX 
Supplementary Methods and Results for CHAPTER II
 
A.1 Methods for estimating the MLEs and the confidence intervals for the three models 
The original likelihood functions for the three models are: 
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We adopt the two data reduction techniques introduced in [155]: (i) We take only read types with 
non-zero mapped reads and further group them to form larger read categories; (ii) For each 
condition k, we compute the total sampling rate for each isoform i 
1
J
kij
d
j
ef
kiw a   (denote 
 1 2,  , 
T
k k k kJW w w w as the total sampling rate vector for all isoforms) without enumerating each 
particular sampling rate 
kija . The reduced likelihood functions and the EM algorithm that calculate 
the MLE for each model are derived below. 
Model 0 
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The likelihood for model 0 [equation (A.1)] can be reduced to 
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The MLE of 
0  can be obtained by maximizing the log-likelihood of (A.4), which in the matrix 
form is: 
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subjects to the constraint 
0 0   . 
We define nkij as the number of reads mapped to type sj from isoform i in condition k, regard it as 
hidden data, and derive the EM algorithm solving (A.5) as follows 
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where 
0 i  is the ith element of 0  and the superscripts (m) and (m+1) denote the mth and (m+1)th 
iterations. The algorithm iterates until 
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Model 1 
The likelihood for model 1 [equation (A.2)] can be reduced to: 
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The MLE of 
1  and   can be obtained by maximizing the log-likelihood of (A.6), which in the 
matrix form is: 
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Similar to model 0, we define nkij as the number of reads mapped to type sj from isoform i in 
condition k, and use it as the hidden data, and derive the EM algorithm solving (A.7) as follows: 
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where 
1 i  is the ith element of i , τk is the kth element of τ; and the superscripts (m) and (m+1) 
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Model 2 
The likelihood for model 2 [equation (A.3)] can be reduced to: 
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To obtain the MLE of θ, note that all the k ’s are independent and the likelihood function (A.8) 
can be factorized as the product of the likelihood function for each condition k. Therefore, we can 
compute the MLE of each k  in condition k as 
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subjects to constraint 0k  .  
To solve (A.9), similar to model 0, we define nkij as the number of reads mapped to type sj from 
isoform i in condition k, and use it as the hidden data, and derive the EM algorithm solving (A.9) 
as follows 
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where  ki  is the ith element of k  and the superscripts (m) and (m+1) denote the mth and (m+1)th 
iterations. The algorithm iterates until 
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   To estimate the confidence intervals for the MLEs, we apply similar strategy of importance 
sampling as introduced in [9]. We approximate the distribution of the MLEs by multivariate t 
distributions of 5df   with mean as the point estimations of the MLEs and covariance matrix as 
the inverse of observed Fisher information matrix. We generate 50,000 random samples 
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The 95% confidence interval of the MLE is computed as an interval around the point estimation 
of the MLE that contains 95% of the posterior weight. 
A.2 Usage of the rSeqDiff package 
In this section, we briefly outline the analysis pipeline of the rSeqDiff package, which is used in 
the analyses of the ESRP and ASD RNA-Seq datasets (see main text of Chapter II). Detailed 
instructions for the usage of the package are provided on the website of the package [156]. 
Figure A.1 illustrates the pipeline of rSeqDiff, which includes the following three steps starting 
from raw RNA-Seq read data in FASTQ or FASTA format: (1) For each condition, map the reads 
to the transcript sequences. We use Bowtie [85] for read mapping in our analyses of the ESRP and 
ASD RNA-Seq datasets. After this step, the sequence alignment files in either SAM format [157] 
or Eland-multiple format should be generated. (2) Use rSeq (a software tool for RNA-Seq data 
analysis developed by the authors. Detailed description of its usage is provided on its website [158]) 
to process the sequence alignment files to generate the “.sampling_rates” files which contain the 
sampling rate matrix Ak, the read count vector Nk and the sum of sampling-rate vector Wk for each 
gene. (rSeq can also generate BED format files that can be used for visualizing the reads mapped 
to a particular gene in USCS genome browser or CisGenome Browser [159]). (3) Process the 
“.sampling_rates” files using rSeqDiff and obtaining the list of genes classified to each of the three 
models and the estimates of gene and isoform abundances for each gene. 
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Figure A.1 The analysis pipeline of rSeqDiff.
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A.3 Results of simulation studies 
   We study the type I error and statistical power of the proposed hLRT through simulations. For 
each of the three models, we simulate the isoform abundance of a gene under that model and 
calculate the proportions of the simulated samples that have been correctly classified to the true 
underlying model (i.e., true classification rate). Default significance level α = 0.05 is used 
throughout the simulations. Figure A.2 shows a hypothetical gene that is used in the simulations. 
The gene has three exons and two isoforms, with the middle exon of length 60 bp being 
differentially used. We assume two hypothetical conditions being compared with 50 million reads 
and 55 million reads, respectively. We use   and   to denote the isoform 
abundances under the two conditions. The sampling rate matrices for the two conditions are: 
, 
. 
 
 
Figure A.2 A hypothetical gene used in the simulations.  
The length of the skipping exon (red) is 60 bp and the lengths of the two shared exons (green) are 
1200 bp and 600 bp respectively.  and  denote the isoform abundances under condition 1 
(50 million reads in total);  and  denote the isoform abundances under condition 2 (55 
million reads in total).
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Simulations under model 0. Let G denote the gene abundance and  denote the abundance ratio 
between isoform 1 and G. The abundances of the two isoforms under the two conditions are given 
by:  and . G and  are the factors varying in the simulation, 
with G=0.1, 1, 10, 100, 1000, 10000 and =0.01, 0.02, 0.05, 0.1, 0.2, 0.3, 0.4, 0.45, 0.49, 0.5. For 
each combination of G and , we calculate  and simulate 1000 random samples of read counts 
according to  with . We run the algorithm with the 
1000 samples as the input and calculate the rates that the samples are correctly classified as model 
0. Table A.1 shows the true classification rate. This rate is above 95% for all cells, which shows 
that the type I error rate is controlled at 0.05. 
 
Table A.1 Summary of true classification rate under model 0. 
 
 
 
0.01 0.02 0.05 0.1 0.2 0.3 0.4 0.45 0.49 0.5 
0.1 0.968 0.966 0.97 0.974 0.971 0.966 0.973 0.964 0.974 0.984 
1 0.97 0.978 0.972 0.974 0.966 0.954 0.954 0.944 0.965 0.952 
10 0.97 0.972 0.954 0.944 0.973 0.954 0.972 0.958 0.951 0.963 
100 0.962 0.958 0.958 0.961 0.955 0.958 0.968 0.953 0.963 0.962 
1000 0.964 0.962 0.954 0.959 0.955 0.954 0.955 0.96 0.963 0.966 
10000 0.968 0.965 0.965 0.963 0.974 0.966 0.956 0.965 0.965 0.97 
 
Simulations under model 1. Let G denote the total gene abundance of the two conditions,  and 
 denote the ratios of the gene abundances between the two conditions with  and  
denote abundance ratio between isoform 1 and the gene fixing the condition. Then the abundances 
of the two isoforms under the two conditions are given by 
  
and 
. G and  are the parameters varying in the simulations, with G=0.1, 
1, 10, 100, 1000, 10000 and =0.01, 0.02, 0.05, 0.1, 0.2, 0.3, 0.4, 0.45, 0.49, 0.5 (When =0.5, 
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the true underlying model degenerates to model 0). For each combination of G and  , 1000 
random samples of read counts were simulated according to the following steps: 
(i) simulate ; 
(ii) calculate , , and  as described above; 
(iii) simulate , with . 
We repeat the above steps 1000 times and obtain 1000 random samples of read counts from the 
true underlying model 1 for each combination of G and . The observed true classification rate is 
summarized in Table A.2. As expected, the true classification rate depends on G and : For genes 
with relative low abundance ( ),when G is fixed and  increases close to 0.5, the true 
underlying model tends to degenerate to model 0 and the power decreases consequently; For genes 
with relative high abundance ( ), the proposed hLRT has a high power to identify genes 
from the true underlying model 1 across a wide range of . Overall, the power is reasonably high 
for . 
 
Table A.2 Summary of true classification rate under model 1. 
 
   τ1 
G 
0.01 0.02 0.05 0.1 0.2 0.3 0.4 0.45 0.49 0.5 
0.1 0.426 0.404 0.406 0.359 0.216 0.078 0.031 0.008 0.012 0.02 
1 0.998 0.997 0.999 0.996 0.992 0.961 0.36 0.097 0.022 0.014 
10 0.998 0.997 0.99 0.981 0.977 0.971 0.969 0.79 0.049 0.029 
100 0.982 0.977 0.975 0.977 0.973 0.973 0.976 0.971 0.374 0.032 
1000 0.973 0.963 0.97 0.976 0.973 0.971 0.975 0.977 0.965 0.02 
10000 0.973 0.985 0.974 0.979 0.972 0.967 0.979 0.978 0.982 0.013 
 
Simulations under model 2. Let G denote the total gene abundance of the two conditions,  and 
 denote the ratios of the gene abundance between the two conditions with ,  and 
1
 0,  0.5uniform～
11 12 21 22
 kij kij kin Poisson a ～ 1,2;  1,2;  1,2,3k i j  
1
1
0.1 10G  1
100G 
1
1G 
1
2 1 2 1   1
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 denote abundance ratio between isoform 1 and the gene in condition 1 and condition 2, 
respectively and  denote the difference between  and  (i.e.  . Note when 
, the true underlying model degenerates to model 1; when  and , the 
true underlying model degenerates to model 0). Then the abundances of the two isoforms under 
the two conditions are  and . G and 
 are the parameters varying in the simulations, with G=0.1, 1, 10, 100, 1000, 10000 and 
=0.01, 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.75, 0.8, 0.9, 0.95, 0.99. For each combination of G and
, 1000 random samples of read counts were simulated according to the following steps: 
(i) simulate ; 
(ii) calculate : ; 
(iii) simulate  ; 
(iv) calculate : ; 
(v) calculate , , and  as described above; 
(vi) simulate , with . 
   We repeat the above steps 1000 times and obtain 1000 random samples of read counts from the 
true underlying model 2 for each combination of G and  . The true classification rate is 
summarized in Table A.3. As expected, when G is fixed and  decreases close to 0, the true 
underlying model tends to degenerate to model 1. Therefore the power decreases consequently. 
Overall, the power is reasonably high for . 
 
Table A.3 Summary of true classification rate under model 2. 
Δψ 
G 
0.01 0.05 0.1 0.2 0.3 0.4 0.5 0.6 0.75 0.8 0.9 0.95 0.99 
0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 
1 0.011 0.011 0.008 0.022 0.039 0.035 0.05 0.081 0.136 0.144 0.219 0.233 0.272 
10 0.016 0.033 0.057 0.138 0.246 0.386 0.55 0.692 0.822 0.883 0.93 0.949 0.956 
100 0.037 0.114 0.294 0.665 0.892 0.936 0.967 0.975 0.989 0.987 0.994 0.993 0.995 
1000 0.063 0.54 0.881 0.975 0.987 0.998 0.994 0.999 0.996 0.997 1 1 1 
10000 0.301 0.952 0.989 1 1 0.999 1 1 1 0.999 1 1 1 
2
 1 2 1 2    
0  0  1 2 0.5  
 11 1 1 12 1 1 , 1G G        21 2 2 22 2 2,  1G G       
 

 1 ,  1uniform ～
2 2 1   
 1 0,  0.5uniform～
2 2 11  
11 12 21 22
 kij kij kin Poisson a ～ 1,2;  1,2;  1,2,3k i j  

1
10G 
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   In summary, the simulations show that the proposed hLRT approach has well controlled type I 
error at α=0.05 and decent statistical power for detecting differential expression and differential 
splicing for genes with moderate to high abundance. In particular, the hLRT still has good power 
in the situation where the gene is lowly expressed in one condition but moderately or highly 
expressed in the other conditions. In that case, the gene will be classified as model 1 (differential 
expression but no differential splicing). See simulations under model 1. When  is small, it 
represents the situation that the gene and its isoforms are lowly expressed in condition 1 but highly 
or lowly expressed in condition 2. The lack of power to detect differential expression or splicing 
occurs when the gene is expressed lowly in both conditions. This is well expected and is an inherent 
problem in the differential analysis from RNA-Seq data. In real data analysis, genes with very low 
expression levels in all the conditions are usually filtered out prior to the analysis. By default, 
rSeqDiff filters out genes with less than 5 reads in all the conditions. 
A.4 Supplemental methods and results for the analysis of the ESRP1 dataset 
   This dataset was published in Shen et al [52], where 76 bp single end RNA-Seq experiments 
were performed on the MDA-MB-231 cell line with ectopic expression of the ESRP1 gene and an 
empty vector (EV) as control. The resulting dataset contains 136 million reads for the ESRP1 
sample and 120 million reads for the EV sample from Illumina GA II sequencer, and the dataset is 
available at the NCBI SRA depository (accession numbers SRR436885 and SRR436886). For the 
164 RT-PCR tested alternative exons, their genome coordinate, junctions read counts, ψESRP1, ψEV 
and Δψ values from MATS and RT-PCR are all provided in the supplemental table 1 of [52]. As 
Shen et al mentioned in [52], the first 50bp segments of the reads had a high mapping rate to the 
human genome and the last 25bp segment had a much lower mapping rate, so they used the first 
50bp of each read for their analysis. To make our analysis comparable with theirs, we also use the 
first 50bp of each read in our analysis.  
   For the analysis using rSeqDiff with its default settings, referred as rSeqDiff (all reads) in the 
main text, we first map the reads to Ensembl transcript annotations of the human genome hg19 
[52] using Bowtie with up to 3bp mismatches. Then we use rSeq [158] to generate the 
“.sampling_rates” files that contain the sampling rate matrix Ak, the read count vector Nk and the 
1
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sum of sampling-rate vector Wk of each gene for both the two conditions. Next we apply rSeqDiff 
to the “.sampling_rates” files with its default settings with significance level α=0.05 for the hLRT 
and genes with less than 5 reads in both conditions are filtered out. For the analysis of Cuffdiff 2, 
we exactly follow the pipeline described in the user manual [160]. Briefly, we first map the reads 
to Ensembl transcript annotations of the human genome, and then run Cuffdiff 2 with its default 
settings. The isoform structure of the genes and the reads mapped to the genes are visualized using 
CisGenome Browser [159]. 
A.5 Supplemental methods and results for the analysis of the ASD dataset  
   The dataset was published in Voineagu et al [57], where 73bp single-end RNA-Seq experiments 
were performed on three autistic brain samples with down-regulated A2BP1 gene levels (a.k.a. 
FOX1, an important neuronal specific splicing factor that regulates alternative splicing in the brain) 
and 3 control brain samples with normal A2BP1 levels using Illumina GA II sequencer. The data 
is available at the NCBI SRA depository (accession number SRP007483) [57]. The authors of [7] 
used the Basic Local Alignment Tool (BLAT) to align the reads to their cDNA-derived alternative 
splicing junctions database and applied Fisher’s exact test and Bonfeeroni-Hochberg correction to 
identify differentially spliced exons associated with autism, which is an exon-based method similar 
to MATS. As the authors mentioned, they separately pooled the reads for ASD and control to 
generate sufficient read coverage for the quantitative analysis of alternative splicing events. To 
make the results comparable, we also separately pooled the reads for ASD and control in our 
analysis.  
   For the analysis with rSeqDiff, we first map the reads to UCSC transcript annotations of the 
human genome (hg19) using Bowtie with up to 3bp mismatches. Then we use rSeq [158] to 
generate the “.sampling_rates” files that contain the sampling rate matrix Ak, the read count vector 
Nk and the sum of sampling-rate vector Wk of each gene for both the two conditions (see Section 
A.2). Next we apply rSeqDiff to the “.sampling_rates” files with its default settings, where 
significance level α=0.05 for the hLRT and genes with less than 5 reads in both conditions are 
filtered out. For the analysis with Cuffdiff 2, we exactly follow the pipeline described in its user 
manual [160]. Briefly, we first map the reads to UCSC transcript annotations of the human genome, 
and then run Cuffdiff 2 with its default settings. The isoform structure of the genes and the reads 
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mapped to the genes are visualized using CisGenome Browser [159]. 
   Below are some supplementary results for the analysis of the ASD dataset: Figure A.3A shows 
the scatter plot of the p values from the likelihood ratio test between model 1 and 0 v.s. the log2 
fold changes of the estimated gene abundance (“volcano plot”), which can be used for visualizing 
differential expression of each gene; Figure A.3B shows the scatter plot of the p-values from the 
likelihood ratio test between model 2 and 0 v.s. the T values for all genes, which can be used for 
visualizing differential splicing of each gene; Figure A.4 shows the scatter plot of the log 2 fold 
changes of transcript abundances between ASD and control samples estimated by rSeqDiff and 
Cuffdiff 2 (genes with low read counts or failed to be tested by Cuffdiff 2 are excluded); Table A.4 
compares the estimated differentially used exon inclusion levels for the five RT-PCR validated 
genes between rSeqDiff and the exon-based method in [57];  Table A.5 is the comparison of 
differential spliced genes across biological replicates. 
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Figure A.3 Scatter plots for examing differential expression and differential splicing. 
(A) Plot of the -log 10 based p-values from the likelihood ratio test between model 1 and 0 v.s. the 
log2 fold changes of the estimated gene abundance, which can be used for visualizing differential 
expression of each gene. The red box highlights the SCIN gene that is shown as an example in 
Figure 5 of the main text. (B) Plot of the -log 10 based p-values from the likelihood ratio test 
between model 2 and 0 v.s the T values, which can be used for visualizing differential splicing of 
each gene. The red box highlights the BACE1 gene that is shown as an example in Figure 5 of the 
main text.
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Figure A.4 Comparison between rSeqDiff and Cuffdiff 2 with the ASD dataset.  
The log2 fold changes of isoform abundances between ASD and control samples estimated by 
rSeqDiff and Cuffdiff 2 are plotted. Transcripts classified as model 0, model 1 and model 2 are 
shown in green, blue and red, respectively. The solid line is the regression line. The dashed line is 
the y=x line, which represents perfect agreement of the two methods
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Table A.4 Comparison of differential spliced genes across biological replicates in the ASD 
dataset. 
 
ASD sample ID Control sample 
ID 
Number of DS 
genes 
identified 
Number of DS genes 
overlapping with 
Pool (%) 
PCC-
ASD 
PCC-
control 
A_AN09730_22 C_AN00142_09 1614 1352 (83.8%) 0.803 0.825 
A_AN17777_41 C_AN10028_41 2015 1610 (79.9%) 0.876 0.841 
A_AN19511_09 C_AN12240_41 1212 989 (81.6%) 0.812 0.832 
 
DS: differential spliced;  
Pool: separately pooling the reads of the biological replicates in ASD and control, which is the 
way that we handled biological replicates as described in the main text  (1769 DS genes are 
identified); 
PCC-ASD: Pearson Correlation Coefficient of the estimated abundance of the overlapping DS 
transcripts with Pool in ASD; 
PCC-control: Pearson Correlation Coefficient of the estimated abundance of the overlapping DS 
transcripts with Pool in control. 
 
 
Table A.5 Comparison of the estimated differentially used exon inclusion levels for the five 
RT-PCR validated genes between rSeqDiff and the exon-based method. 
 
Gene Isoform include 
the alternative 
exon 
Isoforms skip 
the alternative 
exon 
%inc ASD* 
(rSeqDiff/exon-
based) 
%inc control* 
(rSeqDiff/exon-
based) 
%inc difference* 
(rSeqDiff/exon-
based) 
RPN2 NM_001135771 NM_002951 23.8% / 22% 62.4% / 69% -38.6% / -47% 
EHBP1 NM_015252, 
NM_001142614 
NM_001142615, 
NM_001142616 
62.9% / 51% 93.8% / 90% -30.9% / -39% 
GRIN1 NM_001185091, 
NM_001185090 
NM_021569, 
NM_007327, 
NM_000832 
14.2% / 8% 38.7% / 44% -24.5% / -36% 
SORBS1 NM_001034954, 
NM_001034955 
NM_001034956 18.5% / 1% 49.1% / 35% -30.6% / -34% 
NRCAM NM_001193583, 
NM_00193582 
NM_005010, 
NM_001193584 
28.8% / 33% 62.1% / 65% -33.3% / -32% 
 
*%inc: exon inclusion level
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